BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schoeman D, Fielding BC. Coronavirus envelope protein: current knowledge. Virol J. 2019;16:69. [PMID: 31133031 DOI: 10.1186/s12985-019-1182-0] [Cited by in Crossref: 759] [Cited by in F6Publishing: 618] [Article Influence: 253.0] [Reference Citation Analysis]
Number Citing Articles
1 Argentinian AntiCovid Consortium. Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells. Sci Rep 2020;10:21779. [PMID: 33311634 DOI: 10.1038/s41598-020-78711-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
2 Dubey A, Lobo CL, Gs R, Shetty A, Hebbar S, El-Zahaby SA. Exosomes: Emerging Implementation of Nanotechnology for Detecting and Managing Novel Corona Virus- SARS-CoV-2. Asian J Pharm Sci 2021. [PMID: 34630723 DOI: 10.1016/j.ajps.2021.08.004] [Reference Citation Analysis]
3 Tadesse DB, Gebrewahd GT, Demoz GT. Knowledge, attitude, practice and psychological response toward COVID-19 among nurses during the COVID-19 outbreak in northern Ethiopia, 2020. New Microbes New Infect 2020;38:100787. [PMID: 33072339 DOI: 10.1016/j.nmni.2020.100787] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
4 Barua A, Grot N, Plawski A. The basis of mink susceptibility to SARS-CoV-2 infection. J Appl Genet 2022. [PMID: 35396646 DOI: 10.1007/s13353-022-00689-w] [Reference Citation Analysis]
5 Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J Neuroimmunol 2020;350:577436. [PMID: 33212316 DOI: 10.1016/j.jneuroim.2020.577436] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
6 Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J, Zhao D, Xu D, Gong Q, Liao J, Yang H, Hou W, Zhang Y. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395:809-815. [PMID: 32151335 DOI: 10.1016/s0140-6736(20)30360-3] [Cited by in Crossref: 1648] [Cited by in F6Publishing: 1018] [Article Influence: 824.0] [Reference Citation Analysis]
7 Qasem A, Shaw AM, Elkamel E, Naser SA. Coronavirus Disease 2019 (COVID-19) Diagnostic Tools: A Focus on Detection Technologies and Limitations. Curr Issues Mol Biol 2021;43:728-48. [PMID: 34287238 DOI: 10.3390/cimb43020053] [Reference Citation Analysis]
8 Alam I, Kamau AA, Kulmanov M, Jaremko Ł, Arold ST, Pain A, Gojobori T, Duarte CM. Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2. Front Cell Infect Microbiol 2020;10:405. [PMID: 32850499 DOI: 10.3389/fcimb.2020.00405] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
9 Berber B, Aydin C, Kocabas F, Guney-Esken G, Yilancioglu K, Karadag-Alpaslan M, Caliseki M, Yuce M, Demir S, Tastan C. Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics. Gene Ther 2021;28:290-305. [PMID: 33318646 DOI: 10.1038/s41434-020-00209-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Beeckmans S, Van Driessche E. Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study. Front Mol Biosci 2021;8:671923. [PMID: 34109214 DOI: 10.3389/fmolb.2021.671923] [Reference Citation Analysis]
11 Richard SA, Kampo S, Esquijarosa Hechavarria M. Elucidating the pivotal role of convalescent plasma therapy in critically ill COVID-19 patients: A review. Hematol Rep 2020;12:8630. [PMID: 33324480 DOI: 10.4081/hr.2020.8630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Wong NA, Saier MH Jr. The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis. Int J Mol Sci 2021;22:1308. [PMID: 33525632 DOI: 10.3390/ijms22031308] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
13 Mukherjee S, Bhattacharyya D, Bhunia A. Host-membrane interacting interface of the SARS coronavirus envelope protein: Immense functional potential of C-terminal domain. Biophys Chem 2020;266:106452. [PMID: 32818817 DOI: 10.1016/j.bpc.2020.106452] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
14 Mariano G, Farthing RJ, Lale-Farjat SLM, Bergeron JRC. Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be. Front Mol Biosci. 2020;7:605236. [PMID: 33392262 DOI: 10.3389/fmolb.2020.605236] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
15 Al-Hatamleh MAI, Hatmal MM, Alshaer W, Rahman ENSEA, Mohd-Zahid MH, Alhaj-Qasem DM, Yean CY, Alias IZ, Jaafar J, Ferji K, Six JL, Uskoković V, Yabu H, Mohamud R. COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes. Eur J Pharmacol 2021;896:173930. [PMID: 33545157 DOI: 10.1016/j.ejphar.2021.173930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Bridwell R, Long B, Gottlieb M. Neurologic complications of COVID-19. Am J Emerg Med 2020;38:1549.e3-7. [PMID: 32425321 DOI: 10.1016/j.ajem.2020.05.024] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 32.5] [Reference Citation Analysis]
17 Sheta SM, El-sheikh SM. Nanomaterials and metal-organic frameworks for biosensing applications of mutations of the emerging viruses. Analytical Biochemistry 2022. [DOI: 10.1016/j.ab.2022.114680] [Reference Citation Analysis]
18 Kiremitler NB, Kemerli MZ, Kayaci N, Karagoz S, Pekdemir S, Sarp G, Sanduvac S, Onses MS, Yilmaz E. Nanostructures for the Prevention, Diagnosis, and Treatment of SARS-CoV-2: A Review. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.2c00181] [Reference Citation Analysis]
19 Li J, Jia H, Tian M, Wu N, Yang X, Qi J, Ren W, Li F, Bian H. SARS-CoV-2 and Emerging Variants: Unmasking Structure, Function, Infection, and Immune Escape Mechanisms. Front Cell Infect Microbiol 2022;12:869832. [DOI: 10.3389/fcimb.2022.869832] [Reference Citation Analysis]
20 Kosciuk T, Lin H. N-Myristoyltransferase as a Glycine and Lysine Myristoyltransferase in Cancer, Immunity, and Infections. ACS Chem Biol 2020;15:1747-58. [PMID: 32453941 DOI: 10.1021/acschembio.0c00314] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
21 Conrad KP. Might proton pump or sodium-hydrogen exchanger inhibitors be of value to ameliorate SARs-CoV-2 pathophysiology? Physiol Rep 2021;8:e14649. [PMID: 33369281 DOI: 10.14814/phy2.14649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Bhandari R, Khanna G, Kuhad A. Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic. Eur J Pharmacol 2021;890:173643. [PMID: 33065092 DOI: 10.1016/j.ejphar.2020.173643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
23 Gajjela BK, Zhou MM. Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling. Drug Discov Today 2021:S1359-6446(21)00454-2. [PMID: 34743903 DOI: 10.1016/j.drudis.2021.10.016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Berhanu L, Berihun G, Walle Z, Teshome D, Gizeyatu A, Abebe M, Hassen S, Ademas A, Wagaye B, Adane M. COVID-19 Prevention Practices and Associated Factors Among Farmers in Peri-Urban Areas of Northeastern Ethiopia. J Multidiscip Healthc 2021;14:1843-52. [PMID: 34285502 DOI: 10.2147/JMDH.S321456] [Reference Citation Analysis]
25 Kucukoglu K, Faydalı N, Bul D. What are the drugs having potential against COVID-19? Med Chem Res 2020;:1-21. [PMID: 32929317 DOI: 10.1007/s00044-020-02625-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Gutiérrez-Álvarez J, Honrubia JM, Sanz-Bravo A, González-Miranda E, Fernández-Delgado R, Rejas MT, Zúñiga S, Sola I, Enjuanes L. Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice. Proc Natl Acad Sci U S A 2021;118:e2111075118. [PMID: 34686605 DOI: 10.1073/pnas.2111075118] [Reference Citation Analysis]
27 Jia Y, Cao J, Wei Z. Bioinformatics Analysis of Spike Proteins of Porcine Enteric Coronaviruses. Biomed Res Int 2021;2021:6689471. [PMID: 34307666 DOI: 10.1155/2021/6689471] [Reference Citation Analysis]
28 Chakraborty S, Mallajosyula V, Tato CM, Tan GS, Wang TT. SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand? Adv Drug Deliv Rev 2021;172:314-38. [PMID: 33482248 DOI: 10.1016/j.addr.2021.01.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
29 Chai J, Cai Y, Pang C, Wang L, McSweeney S, Shanklin J, Liu Q. Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1. Nat Commun 2021;12:3433. [PMID: 34103506 DOI: 10.1038/s41467-021-23533-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Pecetta S, Kratochvil S, Kato Y, Vadivelu K, Rappuoli R. Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines. Pharmacol Rev 2022;74:313-39. [PMID: 35101964 DOI: 10.1124/pharmrev.120.000285] [Reference Citation Analysis]
31 Kibenge F, Mckibbon A, Kibenge M, Wang Y. Bioinformatics Analysis Identifies a Small ORF in the Genome of Fish Nidoviruses of Genus Oncotshavirus Predicted to Encode a Novel Integral Protein. Microbiology Research 2021;12:753-64. [DOI: 10.3390/microbiolres12040055] [Reference Citation Analysis]
32 Shepley-McTaggart A, Sagum CA, Oliva I, Rybakovsky E, DiGuilio K, Liang J, Bedford MT, Cassel J, Sudol M, Mullin JM, Harty RN. SARS-CoV-2 Envelope (E) Protein Interacts with PDZ-Domain-2 of Host Tight Junction Protein ZO1. bioRxiv 2020:2020. [PMID: 33398268 DOI: 10.1101/2020.12.22.422708] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Du L, Chen YM, Li Y, Yuan W, Wang JS. Prevalence of depression during the SARS, MERS, and COVID-19 pandemics: A protocol for overview of systematic reviews. Medicine (Baltimore) 2020;99:e22235. [PMID: 32957366 DOI: 10.1097/MD.0000000000022235] [Reference Citation Analysis]
34 Aldaais EA, Yegnaswamy S, Albahrani F, Alsowaiket F, Alramadan S. Sequence and structural analysis of COVID-19 E and M proteins with MERS virus E and M proteins-A comparative study. Biochem Biophys Rep 2021;26:101023. [PMID: 34013072 DOI: 10.1016/j.bbrep.2021.101023] [Reference Citation Analysis]
35 Wang L, Jiang M, Qu J, Zhou N, Zhang X. Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic. Infect Agent Cancer 2020;15:56. [PMID: 32983254 DOI: 10.1186/s13027-020-00322-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Singh A, Thakur M, Sharma LK, Chandra K. Designing a multi-epitope peptide based vaccine against SARS-CoV-2. Sci Rep 2020;10:16219. [PMID: 33004978 DOI: 10.1038/s41598-020-73371-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
37 Vlachakis D, Papakonstantinou E, Mitsis T, Pierouli K, Diakou I, Chrousos G, Bacopoulou F. Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic. Food Chem Toxicol 2020;146:111805. [PMID: 33038452 DOI: 10.1016/j.fct.2020.111805] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
38 Salimi S, Hamlyn JM. COVID-19 and Crosstalk With the Hallmarks of Aging. J Gerontol A Biol Sci Med Sci 2020;75:e34-41. [PMID: 32544216 DOI: 10.1093/gerona/glaa149] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
39 Dimonaco NJ, Salavati M, Shih BB. Computational Analysis of SARS-CoV-2 and SARS-Like Coronavirus Diversity in Human, Bat and Pangolin Populations. Viruses 2020;13:E49. [PMID: 33396801 DOI: 10.3390/v13010049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
40 Brahim Belhaouari D, Fontanini A, Baudoin JP, Haddad G, Le Bideau M, Bou Khalil JY, Raoult D, La Scola B. The Strengths of Scanning Electron Microscopy in Deciphering SARS-CoV-2 Infectious Cycle. Front Microbiol 2020;11:2014. [PMID: 32973730 DOI: 10.3389/fmicb.2020.02014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
41 Gutiérrez-Álvarez J, Honrubia JM, Fernández-Delgado R, Wang L, Castaño-Rodríguez C, Zúñiga S, Sola I, Enjuanes L. Genetically Engineered Live-Attenuated Middle East Respiratory Syndrome Coronavirus Viruses Confer Full Protection against Lethal Infection. mBio 2021;12:e00103-21. [PMID: 33653888 DOI: 10.1128/mBio.00103-21] [Reference Citation Analysis]
42 Zehra Z, Luthra M, Siddiqui SM, Shamsi A, Gaur NA, Islam A. Corona virus versus existence of human on the earth: A computational and biophysical approach. Int J Biol Macromol 2020;161:271-81. [PMID: 32512089 DOI: 10.1016/j.ijbiomac.2020.06.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
43 Cicconofri G, Noselli G, DeSimone A. The biomechanical role of extra-axonemal structures in shaping the flagellar beat of Euglena gracilis. Elife 2021;10:e58610. [PMID: 33899736 DOI: 10.7554/eLife.58610] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Kalantari H, Tabrizi AHH, Foroohi F. Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran. Gene Rep 2020;21:100910. [PMID: 33047096 DOI: 10.1016/j.genrep.2020.100910] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
45 Akhter J, Quéromès G, Pillai K, Kepenekian V, Badar S, Mekkawy AH, Frobert E, Valle SJ, Morris DL. The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2. Viruses 2021;13:425. [PMID: 33800932 DOI: 10.3390/v13030425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Bhattacharya R, Dev K, Sourirajan A. Antiviral activity of bioactive phytocompounds against coronavirus: An update. J Virol Methods 2021;290:114070. [PMID: 33497729 DOI: 10.1016/j.jviromet.2021.114070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Scheller C, Krebs F, Minkner R, Astner I, Gil-Moles M, Wätzig H. Physicochemical properties of SARS-CoV-2 for drug targeting, virus inactivation and attenuation, vaccine formulation and quality control. Electrophoresis 2020;41:1137-51. [PMID: 32469436 DOI: 10.1002/elps.202000121] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 19.0] [Reference Citation Analysis]
48 Chang TJ, Yang DM, Wang ML, Liang KH, Tsai PH, Chiou SH, Lin TH, Wang CT. Genomic analysis and comparative multiple sequences of SARS-CoV2. J Chin Med Assoc 2020;83:537-43. [PMID: 32349035 DOI: 10.1097/JCMA.0000000000000335] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
49 Baghchechi M, Dunn J, Jaipaul N, Jacob SE. Art of prevention: Life in the time of coronavirus. Int J Womens Dermatol 2020;6:137-41. [PMID: 32363228 DOI: 10.1016/j.ijwd.2020.03.046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Khan T, Khan MA, Karam K, Ullah N, Mashwani ZU, Nadhman A. Plant in vitro Culture Technologies; A Promise Into Factories of Secondary Metabolites Against COVID-19. Front Plant Sci 2021;12:610194. [PMID: 33777062 DOI: 10.3389/fpls.2021.610194] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
51 Panahi Y, Dadkhah M, Talei S, Gharari Z, Asghariazar V, Abdolmaleki A, Matin S, Molaei S. Can anti-parasitic drugs help control COVID-19? Future Virol 2022. [PMID: 35359702 DOI: 10.2217/fvl-2021-0160] [Reference Citation Analysis]
52 Merarchi M, Dudha N, Das BC, Garg M. Natural products and phytochemicals as potential anti-SARS-CoV-2 drugs. Phytother Res 2021. [PMID: 34132421 DOI: 10.1002/ptr.7151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Li L, Wu Y, Wang J, Yan H, Lu J, Wan Y, Zhang B, Zhang J, Yang J, Wang X, Zhang M, Li Y, Miao L, Zhang H. Potential treatment of COVID-19 with traditional chinese medicine: What herbs can help win the battle with SARS-CoV-2? Engineering (Beijing) 2021. [PMID: 34729244 DOI: 10.1016/j.eng.2021.08.020] [Reference Citation Analysis]
54 Troyano-Hernáez P, Reinosa R, Holguín Á. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week. Viruses 2021;13:243. [PMID: 33557213 DOI: 10.3390/v13020243] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
55 Saxena A, Khare D, Agrawal S, Singh A, Dubey AK. Recent advances in materials science: a reinforced approach toward challenges against COVID-19. Emergent Mater 2021;:1-17. [PMID: 33644691 DOI: 10.1007/s42247-021-00179-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
56 Erukainure OL, Atolani O, Muhammad A, Katsayal SB, Ebhuoma OO, Ibeji CU, Mesaik MA. Targeting the initiation and termination codons of SARS-CoV-2 spike protein as possible therapy against COVID-19: the role of novel harpagide 5-O-β-D-glucopyranoside from Clerodendrum volubile P Beauv. (Labiatae). J Biomol Struct Dyn 2020;:1-14. [PMID: 33140706 DOI: 10.1080/07391102.2020.1840439] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
57 Ningombam SS, Kumar R, Tanwar P. Mutant strains of SARS-CoV-2 are more prone to infect obese patient: a review. Wien Klin Wochenschr 2021;133:383-92. [PMID: 33595720 DOI: 10.1007/s00508-021-01819-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Gul R, Kim UH, Alfadda AA. Renin-angiotensin system at the interface of COVID-19 infection. Eur J Pharmacol 2021;890:173656. [PMID: 33086029 DOI: 10.1016/j.ejphar.2020.173656] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
59 Lotfi F, Akbarzadeh-Khiavi M, Lotfi Z, Rahbarnia L, Safary A, Zarredar H, Baghbanzadeh A, Naghili B, Baradaran B. Micronutrient therapy and effective immune response: a promising approach for management of COVID-19. Infection 2021. [PMID: 34160789 DOI: 10.1007/s15010-021-01644-3] [Reference Citation Analysis]
60 Singh R, Goel S, Bourgeade P, Aleya L, Tewari D. Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19. Environ Sci Pollut Res Int 2021;28:55925-51. [PMID: 34491498 DOI: 10.1007/s11356-021-16280-5] [Reference Citation Analysis]
61 Giovanetti M, Angeletti S, Benvenuto D, Ciccozzi M. A doubt of multiple introduction of SARS-CoV-2 in Italy: A preliminary overview. J Med Virol 2020;92:1634-6. [PMID: 32190908 DOI: 10.1002/jmv.25773] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 18.5] [Reference Citation Analysis]
62 Lubin JH, Zardecki C, Dolan EM, Lu C, Shen Z, Dutta S, Westbrook JD, Hudson BP, Goodsell DS, Williams JK, Voigt M, Sarma V, Xie L, Venkatachalam T, Arnold S, Alvarado LHA, Catalfano K, Khan A, McCarthy E, Staggers S, Tinsley B, Trudeau A, Singh J, Whitmore L, Zheng H, Benedek M, Currier J, Dresel M, Duvvuru A, Dyszel B, Fingar E, Hennen EM, Kirsch M, Khan AA, Labrie-Cleary C, Laporte S, Lenkeit E, Martin K, Orellana M, de la Campa MO, Paredes I, Wheeler B, Rupert A, Sam A, See K, Zapata SS, Craig PA, Hall BL, Jiang J, Koeppe JR, Mills SA, Pikaart MJ, Roberts R, Bromberg Y, Hoyer JS, Duffy S, Tischfield J, Ruiz FX, Arnold E, Baum J, Sandberg J, Brannigan G, Khare SD, Burley SK. Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemic. bioRxiv 2020:2020. [PMID: 33299989 DOI: 10.1101/2020.12.01.406637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
63 Alharbi YM, Bima AI, Elsamanoudy AZ. An Overview of the Perspective of Cellular Autophagy: Mechanism, Regulation, and the Role of Autophagy Dysregulation in the Pathogenesis of Diseases. J Microsc Ultrastruct 2021;9:47-54. [PMID: 34350099 DOI: 10.4103/JMAU.JMAU_33_20] [Reference Citation Analysis]
64 Gu Y, Cao J, Zhang X, Gao H, Wang Y, Wang J, He J, Jiang X, Zhang J, Shen G, Yang J, Zheng X, Hu G, Zhu Y, Du S, Zhu Y, Zhang R, Xu J, Lan F, Qu D, Xu G, Zhao Y, Gao D, Xie Y, Luo M, Lu Z. Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2. Cell Res 2021. [PMID: 34837059 DOI: 10.1038/s41422-021-00595-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
65 Verkhivker GM. Molecular Simulations and Network Modeling Reveal an Allosteric Signaling in the SARS-CoV-2 Spike Proteins. J Proteome Res 2020;19:4587-608. [PMID: 33006900 DOI: 10.1021/acs.jproteome.0c00654] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
66 [DOI: 10.1101/2020.02.04.934232] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
67 Kozlov EM, Ivanova E, Grechko AV, Wu WK, Starodubova AV, Orekhov AN. Involvement of Oxidative Stress and the Innate Immune System in SARS-CoV-2 Infection. Diseases 2021;9:17. [PMID: 33668325 DOI: 10.3390/diseases9010017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Kholodilov IS, Litov AG, Klimentov AS, Belova OA, Polienko AE, Nikitin NA, Shchetinin AM, Ivannikova AY, Bell-Sakyi L, Yakovlev AS, Bugmyrin SV, Bespyatova LA, Gmyl LV, Luchinina SV, Gmyl AP, Gushchin VA, Karganova GG. Isolation and Characterisation of Alongshan Virus in Russia. Viruses 2020;12:E362. [PMID: 32224888 DOI: 10.3390/v12040362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
69 Alikiaii B, Heidari Z, Fazeli A, Rahimi Varposhti M, Moradi Farsani D, Fattahpour S, Rafiee S, Bagherniya M. Evaluation of the effectiveness of the Nutritional Risk Screening System 2002 (NRS-2002) in COVID-19 patients admitted to the intensive care unit. Int J Clin Pract 2021;:e14934. [PMID: 34606153 DOI: 10.1111/ijcp.14934] [Reference Citation Analysis]
70 Dugail I, Amri EZ, Vitale N. High prevalence for obesity in severe COVID-19: Possible links and perspectives towards patient stratification. Biochimie. 2020;179:257-265. [PMID: 32649962 DOI: 10.1016/j.biochi.2020.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
71 Sheikhzadeh E, Eissa S, Ismail A, Zourob M. Diagnostic techniques for COVID-19 and new developments. Talanta 2020;220:121392. [PMID: 32928412 DOI: 10.1016/j.talanta.2020.121392] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 18.0] [Reference Citation Analysis]
72 Tolksdorf B, Nie C, Niemeyer D, Röhrs V, Berg J, Lauster D, Adler JM, Haag R, Trimpert J, Kaufer B, Drosten C, Kurreck J. Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence. Viruses 2021;13:2030. [PMID: 34696460 DOI: 10.3390/v13102030] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Emrani J, Ahmed M, Jeffers-Francis L, Teleha JC, Mowa N, Newman RH, Thomas MD. SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review. Int J Biol Macromol 2021;193:1249-73. [PMID: 34756970 DOI: 10.1016/j.ijbiomac.2021.10.172] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Mhatre S, Srivastava T, Naik S, Patravale V. Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review. Phytomedicine 2021;85:153286. [PMID: 32741697 DOI: 10.1016/j.phymed.2020.153286] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
75 Lagousi T, Routsias J, Spoulou V. Development of an Enzyme-Linked Immunosorbent Assay (ELISA) for Accurate and Prompt Coronavirus Disease 2019 (COVID-19) Diagnosis Using the Rational Selection of Serological Biomarkers. Diagnostics (Basel) 2021;11:1970. [PMID: 34829317 DOI: 10.3390/diagnostics11111970] [Reference Citation Analysis]
76 Rotondo JC, Martini F, Maritati M, Mazziotta C, Di Mauro G, Lanzillotti C, Barp N, Gallerani A, Tognon M, Contini C. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants. Viruses 2021;13:1687. [PMID: 34578269 DOI: 10.3390/v13091687] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
77 Pequeno P, Mendel B, Rosa C, Bosholn M, Souza JL, Baccaro F, Barbosa R, Magnusson W. Air transportation, population density and temperature predict the spread of COVID-19 in Brazil. PeerJ 2020;8:e9322. [PMID: 32547889 DOI: 10.7717/peerj.9322] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 20.0] [Reference Citation Analysis]
78 Mandal SM, Panda S. Inhaler with electrostatic sterilizer and use of cationic amphiphilic peptides may accelerate recovery from COVID-19. Biotechniques 2020;69:206-10. [PMID: 32929995 DOI: 10.2144/btn-2020-0042] [Reference Citation Analysis]
79 Aljehani YM, Othman SA, Telmesani NK, Alghamdi RA, AlBuainain HM, Alghamdi ZM, Zakaria HM, Alreshaid FT, Busbait SA, Alqarzaie AA, Alharbi TM, Alnajim RK. Stress and psychological resilience among general surgery residents during COVID-19 pandemic. Saudi Med J 2020;41:1344-9. [PMID: 33294893 DOI: 10.15537/smj.2020.12.25577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Alavi M, Asare-Addo K, Nokhodchi A. Lectin Protein as a Promising Component to Functionalize Micelles, Liposomes and Lipid NPs against Coronavirus. Biomedicines 2020;8:E580. [PMID: 33297444 DOI: 10.3390/biomedicines8120580] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
81 Ishola AA, Adedirin O, Joshi T, Chandra S. QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors. Comput Biol Med 2021;134:104483. [PMID: 34020129 DOI: 10.1016/j.compbiomed.2021.104483] [Reference Citation Analysis]
82 Li CX, Noreen S, Zhang LX, Saeed M, Wu PF, Ijaz M, Dai DF, Maqbool I, Madni A, Akram F, Naveed M, Li JH. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies. Biomed Pharmacother 2021;146:112550. [PMID: 34959116 DOI: 10.1016/j.biopha.2021.112550] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Möller S, Theiß J, Deinert TIL, Golat K, Heinze J, Niemeyer D, Wyrwa R, Schnabelrauch M, Bogner E. High-Sulfated Glycosaminoglycans Prevent Coronavirus Replication. Viruses 2022;14:413. [DOI: 10.3390/v14020413] [Reference Citation Analysis]
84 Zhan X, Dowell S, Shen Y, Lee DL. Chloroquine to fight COVID-19: A consideration of mechanisms and adverse effects? Heliyon 2020;6:e04900. [PMID: 32935064 DOI: 10.1016/j.heliyon.2020.e04900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
85 Chandramouli V, Niraj SK, Nair KG, Joseph J, Aruni W. Phytomolecules Repurposed as Covid-19 Inhibitors: Opportunity and Challenges. Curr Microbiol 2021;78:3620-33. [PMID: 34448061 DOI: 10.1007/s00284-021-02639-x] [Reference Citation Analysis]
86 Nyayanit DA, Yadav PD, Kharde R, Cherian S. Natural Selection Plays an Important Role in Shaping the Codon Usage of Structural Genes of the Viruses Belonging to the Coronaviridae Family. Viruses 2020;13:E3. [PMID: 33375017 DOI: 10.3390/v13010003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Zhu W, Yang J, Lu S, Jin D, Wu S, Pu J, Luo XL, Liu L, Li Z, Xu J. Discovery and Evolution of a Divergent Coronavirus in the Plateau Pika From China That Extends the Host Range of Alphacoronaviruses. Front Microbiol 2021;12:755599. [PMID: 34691006 DOI: 10.3389/fmicb.2021.755599] [Reference Citation Analysis]
88 Monticolo F, Palomba E, De Santis R, Assentato L, Triscino V, Langella MC, Lanzotti V, Chiusano ML. anti-HCoV: A web resource to collect natural compounds against human coronaviruses. Trends Food Sci Technol 2020;106:1-11. [PMID: 32982062 DOI: 10.1016/j.tifs.2020.09.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
89 Awadasseid A, Wu Y, Tanaka Y, Zhang W. Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China. Int J Biol Sci 2020;16:1846-60. [PMID: 32398954 DOI: 10.7150/ijbs.45018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
90 Lo CW, Matsuura R, Iimura K, Wada S, Shinjo A, Benno Y, Nakagawa M, Takei M, Aida Y. UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins. Sci Rep 2021;11:13804. [PMID: 34226623 DOI: 10.1038/s41598-021-93231-7] [Reference Citation Analysis]
91 Singh L, Bajaj S, Gadewar M, Verma N, Ansari MN, Saeedan AS, Kaithwas G, Singh M. Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis. Front Immunol 2021;12:660632. [PMID: 34305892 DOI: 10.3389/fimmu.2021.660632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Tang P, Cui E, Song Y, Yan R, Wang J. Porcine deltacoronavirus and its prevalence in China: a review of epidemiology, evolution, and vaccine development. Arch Virol 2021;166:2975-88. [PMID: 34524535 DOI: 10.1007/s00705-021-05226-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Nguyen T, Duong Bang D, Wolff A. 2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics. Micromachines (Basel) 2020;11:E306. [PMID: 32183357 DOI: 10.3390/mi11030306] [Cited by in Crossref: 138] [Cited by in F6Publishing: 105] [Article Influence: 69.0] [Reference Citation Analysis]
94 Turk C, Turk S, Temirci ES, Malkan UY, Haznedaroglu İC. In vitro analysis of the renin-angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus. J Renin Angiotensin Aldosterone Syst 2020;21:1470320320928872. [PMID: 32490715 DOI: 10.1177/1470320320928872] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
95 [DOI: 10.1101/2020.04.09.033522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
96 Hussain A, Yang H, Zhang M, Liu Q, Alotaibi G, Irfan M, He H, Chang J, Liang XJ, Weng Y, Huang Y. mRNA vaccines for COVID-19 and diverse diseases. J Control Release 2022;345:314-33. [PMID: 35331783 DOI: 10.1016/j.jconrel.2022.03.032] [Reference Citation Analysis]
97 de Leeuw AJM, Oude Luttikhuis MAM, Wellen AC, Müller C, Calkhoven CF. Obesity and its impact on COVID-19. J Mol Med (Berl) 2021;99:899-915. [PMID: 33824998 DOI: 10.1007/s00109-021-02072-4] [Reference Citation Analysis]
98 Çolak Ş, Genç Yavuz B, Yavuz M, Özçelik B, Öner M, Özgültekin A, Şenbayrak S. Effectiveness of ozone therapy in addition to conventional treatment on mortality in patients with COVID-19. Int J Clin Pract 2021;75:e14321. [PMID: 33971067 DOI: 10.1111/ijcp.14321] [Reference Citation Analysis]
99 Misra SS, Ahirwar AK, Sakarde A, Kaim K, Ahirwar P, Jahid M, Sorte SR, Lokhande SL, Kaur AP, Kumawat R. COVID-19 infection in pregnancy: a review of existing knowledge. Horm Mol Biol Clin Investig 2022. [PMID: 35172416 DOI: 10.1515/hmbci-2021-0081] [Reference Citation Analysis]
100 Pham MQ, Vu KB, Han Pham TN, Thuy Huong LT, Tran LH, Tung NT, Vu VV, Nguyen TH, Ngo ST. Rapid prediction of possible inhibitors for SARS-CoV-2 main protease using docking and FPL simulations. RSC Adv 2020;10:31991-6. [DOI: 10.1039/d0ra06212j] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
101 Shao T, Wang W, Duan M, Pan J, Xin Z, Liu B, Zhou F, Wang G. Application of Bayesian phylogenetic inference modelling for evolutionary genetic analysis and dynamic changes in 2019-nCoV. Brief Bioinform 2021;22:896-904. [PMID: 32743639 DOI: 10.1093/bib/bbaa154] [Reference Citation Analysis]
102 Capasso C, Nocentini A, Supuran CT. Protease inhibitors targeting the main protease and papain-like protease of coronaviruses. Expert Opin Ther Pat 2021;31:309-24. [PMID: 33246378 DOI: 10.1080/13543776.2021.1857726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
103 Senger MR, Evangelista TCS, Dantas RF, Santana MVDS, Gonçalves LCS, de Souza Neto LR, Ferreira SB, Silva-Junior FP. COVID-19: molecular targets, drug repurposing and new avenues for drug discovery. Mem Inst Oswaldo Cruz 2020;115:e200254. [PMID: 33027420 DOI: 10.1590/0074-02760200254] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
104 Varughese JK, Joseph Libin KL, Sindhu KS, Rosily AV, Abi TG. Investigation of the inhibitory activity of some dietary bioactive flavonoids against SARS-CoV-2 using molecular dynamics simulations and MM-PBSA calculations. J Biomol Struct Dyn 2021;:1-16. [PMID: 33618628 DOI: 10.1080/07391102.2021.1891139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
105 Bordallo B, Bellas M, Cortez AF, Vieira M, Pinheiro M. Severe COVID-19: what have we learned with the immunopathogenesis? Adv Rheumatol 2020;60:50. [PMID: 32962761 DOI: 10.1186/s42358-020-00151-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
106 Hashemian SMR, Pourhanifeh MH, Hamblin MR, Shahrzad MK, Mirzaei H. RdRp inhibitors and COVID-19: Is molnupiravir a good option? Biomed Pharmacother 2021;146:112517. [PMID: 34902743 DOI: 10.1016/j.biopha.2021.112517] [Reference Citation Analysis]
107 Qiu T, Mao T, Wang Y, Zhou M, Qiu J, Wang J, Xu J, Cao Z. Identification of potential cross-protective epitope between a new type of coronavirus (2019-nCoV) and severe acute respiratory syndrome virus. J Genet Genomics 2020;47:115-7. [PMID: 32171450 DOI: 10.1016/j.jgg.2020.01.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
108 Yang N, Shen HM. Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19. Int J Biol Sci. 2020;16:1724-1731. [PMID: 32226290 DOI: 10.7150/ijbs.45498] [Cited by in Crossref: 216] [Cited by in F6Publishing: 208] [Article Influence: 108.0] [Reference Citation Analysis]
109 Jha P, Singh P, Arora S, Sultan A, Nayek A, Ponnusamy K, Syed MA, Dohare R, Chopra M. Integrative multiomics and in silico analysis revealed the role of ARHGEF1 and its screened antagonist in mild and severe COVID-19 patients. J Cell Biochem 2022. [PMID: 35037717 DOI: 10.1002/jcb.30213] [Reference Citation Analysis]
110 Zheng Y, Wang L, Ben S. Meta-analysis of chest CT features of patients with COVID-19 pneumonia. J Med Virol 2021;93:241-9. [PMID: 32579236 DOI: 10.1002/jmv.26218] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
111 Ahmadi K, Hosseinpour M, Rismani E, Hassaniazad M, Mafakher L, Jahantigh HR, Eftekhar E, Gouklani H. Characterization of SARS-CoV-2 isolated from a patient in Iran compared to SARS-CoV-2 different variants. J Biomol Struct Dyn 2022;:1-16. [PMID: 35007466 DOI: 10.1080/07391102.2021.2017354] [Reference Citation Analysis]
112 Li Q, Peng W, Ou Y. Prediction and analysis of key protein structures of 2019-nCoV. Future Virology 2020;15:349-57. [DOI: 10.2217/fvl-2020-0020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
113 Kumar V. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us. Int Rev Immunol 2021;40:5-53. [PMID: 32744465 DOI: 10.1080/08830185.2020.1800688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
114 Matsuura R, Lo CW, Wada S, Somei J, Ochiai H, Murakami T, Saito N, Ogawa T, Shinjo A, Benno Y, Nakagawa M, Takei M, Aida Y. SARS-CoV-2 Disinfection of Air and Surface Contamination by TiO2 Photocatalyst-Mediated Damage to Viral Morphology, RNA, and Protein. Viruses 2021;13:942. [PMID: 34065382 DOI: 10.3390/v13050942] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past. Front Immunol 2020;11:1949. [PMID: 32849654 DOI: 10.3389/fimmu.2020.01949] [Cited by in Crossref: 90] [Cited by in F6Publishing: 72] [Article Influence: 45.0] [Reference Citation Analysis]
116 Busto M, Tarifa EE, Cristaldi M, Badano JM, Vera CR. Simulation of thermal sanitization of air with heat recovery as applied to airborne pathogen deactivation. Int J Environ Sci Technol . [DOI: 10.1007/s13762-022-03948-9] [Reference Citation Analysis]
117 Benzigar MR, Bhattacharjee R, Baharfar M, Liu G. Current methods for diagnosis of human coronaviruses: pros and cons. Anal Bioanal Chem 2021;413:2311-30. [PMID: 33219449 DOI: 10.1007/s00216-020-03046-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
118 Singh R, Kang A, Luo X, Jeyanathan M, Gillgrass A, Afkhami S, Xing Z. COVID-19: Current knowledge in clinical features, immunological responses, and vaccine development. FASEB J 2021;35:e21409. [PMID: 33577115 DOI: 10.1096/fj.202002662R] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
119 Yadav R, Chaudhary JK, Jain N, Chaudhary PK, Khanra S, Dhamija P, Sharma A, Kumar A, Handu S. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19. Cells 2021;10:821. [PMID: 33917481 DOI: 10.3390/cells10040821] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
120 Campos EVR, Pereira AES, de Oliveira JL, Carvalho LB, Guilger-Casagrande M, de Lima R, Fraceto LF. How can nanotechnology help to combat COVID-19? Opportunities and urgent need. J Nanobiotechnology 2020;18:125. [PMID: 32891146 DOI: 10.1186/s12951-020-00685-4] [Cited by in Crossref: 58] [Cited by in F6Publishing: 41] [Article Influence: 29.0] [Reference Citation Analysis]
121 Bhatia R, Narang RK, Rawal RK. A Summary of Viral Targets and Recently Released PDB IDs of SARS-CoV-2. TOVJ 2020;14:7-8. [DOI: 10.2174/1874357902014010007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
122 Zhou ZJ, Qiu Y, Pu Y, Huang X, Ge XY. BioAider: An efficient tool for viral genome analysis and its application in tracing SARS-CoV-2 transmission. Sustain Cities Soc 2020;63:102466. [PMID: 32904401 DOI: 10.1016/j.scs.2020.102466] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
123 Jain AS, Sushma P, Dharmashekar C, Beelagi MS, Prasad SK, Shivamallu C, Prasad A, Syed A, Marraiki N, Prasad KS. In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2. Saudi J Biol Sci 2021;28:1040-51. [PMID: 33424398 DOI: 10.1016/j.sjbs.2020.11.049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
124 Alphandéry E. The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis. Bioconjug Chem 2020;31:1873-82. [PMID: 32639742 DOI: 10.1021/acs.bioconjchem.0c00287] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
125 Generoso JS, Barichello de Quevedo JL, Cattani M, Lodetti BF, Sousa L, Collodel A, Diaz AP, Dal-Pizzol F. Neurobiology of COVID-19: how can the virus affect the brain? Braz J Psychiatry 2021:S1516-44462021005003203. [PMID: 33605367 DOI: 10.1590/1516-4446-2020-1488] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
126 Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res 2020;21:224. [PMID: 32854739 DOI: 10.1186/s12931-020-01479-w] [Cited by in Crossref: 172] [Cited by in F6Publishing: 1] [Article Influence: 86.0] [Reference Citation Analysis]
127 Isaac-Lam MF. Molecular modeling of the interaction of ligands with ACE2-SARS-CoV-2 spike protein complex. In Silico Pharmacol 2021;9:55. [PMID: 34631362 DOI: 10.1007/s40203-021-00114-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Bamola VD, Chaudhry R. Recent discovery and development on SARS-CoV-2: A review of current literature. J Family Med Prim Care 2020;9:5113-21. [PMID: 33409173 DOI: 10.4103/jfmpc.jfmpc_851_20] [Reference Citation Analysis]
129 Badraoui R, Alrashedi MM, El-May MV, Bardakci F. Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19. J Biomol Struct Dyn 2020;:1-10. [PMID: 32752936 DOI: 10.1080/07391102.2020.1803139] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
130 Wang BX. Susceptibility and prognosis of COVID-19 patients with cardiovascular disease. Open Heart 2020;7:e001310. [PMID: 32587104 DOI: 10.1136/openhrt-2020-001310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Fadaka AO, Sibuyi NRS, Martin DR, Klein A, Madiehe A, Meyer M. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease. Int J Mol Sci 2021;22:9431. [PMID: 34502340 DOI: 10.3390/ijms22179431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Sengupta P, Dutta S, Roychoudhury S, D’souza UJA, Govindasamy K, Kolesarova A. COVID-19, Oxidative Stress and Male Reproduction: Possible Role of Antioxidants. Antioxidants 2022;11:548. [DOI: 10.3390/antiox11030548] [Reference Citation Analysis]
133 Yadav AK, Verma D, Kumar A, Kumar P, Solanki PR. The perspectives of biomarker-based electrochemical immunosensors, artificial intelligence and the Internet of Medical Things toward COVID-19 diagnosis and management. Mater Today Chem 2021;20:100443. [PMID: 33615086 DOI: 10.1016/j.mtchem.2021.100443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
134 Shalash AO, Hussein WM, Skwarczynski M, Toth I. Key Considerations for the Development of Safe and Effective SARS-CoV-2 Subunit Vaccine: A Peptide-Based Vaccine Alternative. Adv Sci (Weinh) 2021;8:e2100985. [PMID: 34176237 DOI: 10.1002/advs.202100985] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
135 Parkhe P, Verma S. Evolution, Interspecies Transmission, and Zoonotic Significance of Animal Coronaviruses. Front Vet Sci 2021;8:719834. [PMID: 34738021 DOI: 10.3389/fvets.2021.719834] [Reference Citation Analysis]
136 Khamassi Khbou M, Daaloul Jedidi M, Bouaicha Zaafouri F, Benzarti M. Coronaviruses in farm animals: Epidemiology and public health implications. Vet Med Sci 2021;7:322-47. [PMID: 32976707 DOI: 10.1002/vms3.359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
137 Dubey A, Lobo CL, Gs R, Shetty A, Hebbar S, El-zahaby SA. Exosomes: Emerging implementation of nanotechnology for detecting and managing novel corona virus- SARS-CoV-2. Asian Journal of Pharmaceutical Sciences 2022;17:20-34. [DOI: 10.1016/j.ajps.2021.08.004] [Reference Citation Analysis]
138 Franchini M, Liumbruno GM. Convalescent Plasma for the Treatment of Severe COVID-19. Biologics 2021;15:31-8. [PMID: 33574654 DOI: 10.2147/BTT.S272063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
139 Wang N, Ferhan AR, Yoon BK, Jackman JA, Cho NJ, Majima T. Chemical design principles of next-generation antiviral surface coatings. Chem Soc Rev 2021;50:9741-65. [PMID: 34259262 DOI: 10.1039/d1cs00317h] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 [DOI: 10.1101/2020.02.02.931162] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
141 Hadizadeh F. Supplementation with vitamin D in the COVID-19 pandemic? Nutr Rev 2021;79:200-8. [PMID: 32679589 DOI: 10.1093/nutrit/nuaa081] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
142 Kumar S, Shanker OR, Kumari N, Tripathi M, Chandra PS, Dixit AB, Banerjee J. Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets. Expert Opin Ther Targets 2021;25:509-19. [PMID: 34232801 DOI: 10.1080/14728222.2021.1953475] [Reference Citation Analysis]
143 Moreno T, Pintó RM, Bosch A, Moreno N, Alastuey A, Minguillón MC, Anfruns-Estrada E, Guix S, Fuentes C, Buonanno G, Stabile L, Morawska L, Querol X. Tracing surface and airborne SARS-CoV-2 RNA inside public buses and subway trains. Environ Int 2021;147:106326. [PMID: 33340987 DOI: 10.1016/j.envint.2020.106326] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 9.5] [Reference Citation Analysis]
144 Yung CS, Fok KCH, Leung CN, Wong YW. What every orthopaedic surgeon should know about COVID-19: A review of the current literature. J Orthop Surg (Hong Kong) 2020;28:230949902092349. [DOI: 10.1177/2309499020923499] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
145 Huang SW, Wang SF. SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity. Int J Mol Sci 2021;22:3060. [PMID: 33802729 DOI: 10.3390/ijms22063060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
146 Sarkar A, Sen D, Sharma A, Muttineni RK, Debnath S. Structure-Based Virtual Screening and Molecular Dynamics Simulation to Identify Potential SARS-CoV-2 Spike Receptor Inhibitors from Natural Compound Database. Pharm Chem J 2021;:1-13. [PMID: 34426710 DOI: 10.1007/s11094-021-02441-w] [Reference Citation Analysis]
147 Afzal A, Iqbal N, Feroz S, Ali A, Ehsan MA, Khan SA, Rehman A. Rapid antibody diagnostics for SARS-CoV-2 adaptive immune response. Anal Methods 2021;13:4019-37. [PMID: 34555136 DOI: 10.1039/d1ay00888a] [Reference Citation Analysis]
148 Agrawal L, Poullikkas T, Eisenhower S, Monsanto C, Bakku RK, Chen MH, Kalra RS. Viroinformatics-Based Analysis of SARS-CoV-2 Core Proteins for Potential Therapeutic Targets. Antibodies (Basel) 2021;10:3. [PMID: 33440681 DOI: 10.3390/antib10010003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
149 Hathout RM, Kassem DH. Uniting Electroceutical and Cosmeceutical Interventions in Combating Coronavirus Using Ԑ-Poly-l-Lysine. Sci Pharm 2021;89:2. [DOI: 10.3390/scipharm89010002] [Reference Citation Analysis]
150 Junaid K, Ejaz H, Abdalla AE, Abosalif KOA, Ullah MI, Yasmeen H, Younas S, Hamam SSM, Rehman A. Effective Immune Functions of Micronutrients against SARS-CoV-2. Nutrients 2020;12:E2992. [PMID: 33003648 DOI: 10.3390/nu12102992] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
151 Santana MVS, Silva-Jr FP. De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning. BMC Chem 2021;15:8. [PMID: 33531083 DOI: 10.1186/s13065-021-00737-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
152 Wang K, Luo J, Tan F, Liu J, Ni Z, Liu D, Tian P, Li W. Acute Pancreatitis as the Initial Manifestation in 2 Cases of COVID-19 in Wuhan, China. Open Forum Infect Dis. 2020;7:ofaa324. [PMID: 32959016 DOI: 10.1093/ofid/ofaa324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
153 Mandal N, Padhi AK, Rath SL. Molecular insights into the differential dynamics of SARS-CoV-2 variants of concern. Journal of Molecular Graphics and Modelling 2022. [DOI: 10.1016/j.jmgm.2022.108194] [Reference Citation Analysis]
154 Meraj G, Farooq M, Singh SK, Romshoo SA, Sudhanshu, Nathawat MS, Kanga S. Coronavirus pandemic versus temperature in the context of Indian subcontinent: a preliminary statistical analysis. Environ Dev Sustain 2020;:1-11. [PMID: 32837278 DOI: 10.1007/s10668-020-00854-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
155 Thümmler L, Schwarzkopf S, Knop D, Ross JA, Berg V, Horn PA, Lindemann M. Comparison of SARS-CoV-2- and HCoV-Specific T Cell Response Using IFN-γ ELISpot. Diagnostics (Basel) 2021;11:1439. [PMID: 34441374 DOI: 10.3390/diagnostics11081439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Arenas A, Borge C, Carbonero A, Garcia-Bocanegra I, Cano-Terriza D, Caballero J, Arenas-Montes A. Bovine Coronavirus Immune Milk Against COVID-19. Front Immunol 2021;12:637152. [PMID: 33833758 DOI: 10.3389/fimmu.2021.637152] [Reference Citation Analysis]
157 Sahoo S, Mahapatra SR, Parida BK, Rath S, Dehury B, Raina V, Mohakud NK, Misra N, Suar M. DBCOVP: A database of coronavirus virulent glycoproteins. Comput Biol Med 2021;129:104131. [PMID: 33276297 DOI: 10.1016/j.compbiomed.2020.104131] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
158 Rath SL, Tripathy M, Mandal N. How Does Temperature Affect the Dynamics of SARS-CoV-2 M Proteins? Insights from Molecular Dynamics Simulations. J Membr Biol 2022. [PMID: 35552785 DOI: 10.1007/s00232-022-00244-y] [Reference Citation Analysis]
159 Nawaz MS, Fournier-Viger P, Shojaee A, Fujita H. Using artificial intelligence techniques for COVID-19 genome analysis. Appl Intell (Dordr) 2021;:1-18. [PMID: 34764587 DOI: 10.1007/s10489-021-02193-w] [Cited by in Crossref: 11] [Article Influence: 11.0] [Reference Citation Analysis]
160 Xu C, Ke Z, Liu C, Wang Z, Liu D, Zhang L, Wang J, He W, Xu Z, Li Y, Yang Y, Huang Z, Lv P, Wang X, Han D, Li Y, Qiao N, Liu B. Systemic In Silico Screening in Drug Discovery for Coronavirus Disease (COVID-19) with an Online Interactive Web Server. J Chem Inf Model 2020;60:5735-45. [PMID: 32786695 DOI: 10.1021/acs.jcim.0c00821] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
161 León G, Herrera M, Vargas M, Arguedas M, Sánchez A, Segura Á, Gómez A, Solano G, Corrales-Aguilar E, Risner K, Narayanan A, Bailey C, Villalta M, Hernández A, Sánchez A, Cordero D, Solano D, Durán G, Segura E, Cerdas M, Umaña D, Moscoso E, Estrada R, Gutiérrez J, Méndez M, Castillo AC, Sánchez L, Sánchez R, Gutiérrez JM, Díaz C, Alape A. Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19. Sci Rep 2021;11:9825. [PMID: 33972631 DOI: 10.1038/s41598-021-89242-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
162 Su H, Zhou F, Huang Z, Ma X, Natarajan K, Zhang M, Huang Y, Su H. Molecular Insights into Small‐Molecule Drug Discovery for SARS‐CoV‐2. Angew Chem 2021;133:9873-86. [DOI: 10.1002/ange.202008835] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
163 Kim J, Yoon J, Park JE. Construction of Porcine Epidemic Diarrhea Virus-Like Particles and Its Immunogenicity in Mice. Vaccines (Basel) 2021;9:370. [PMID: 33920460 DOI: 10.3390/vaccines9040370] [Reference Citation Analysis]
164 Lubin JH, Zardecki C, Dolan EM, Lu C, Shen Z, Dutta S, Westbrook JD, Hudson BP, Goodsell DS, Williams JK, Voigt M, Sarma V, Xie L, Venkatachalam T, Arnold S, Alfaro Alvarado LH, Catalfano K, Khan A, McCarthy E, Staggers S, Tinsley B, Trudeau A, Singh J, Whitmore L, Zheng H, Benedek M, Currier J, Dresel M, Duvvuru A, Dyszel B, Fingar E, Hennen EM, Kirsch M, Khan AA, Labrie-Cleary C, Laporte S, Lenkeit E, Martin K, Orellana M, Ortiz-Alvarez de la Campa M, Paredes I, Wheeler B, Rupert A, Sam A, See K, Soto Zapata S, Craig PA, Hall BL, Jiang J, Koeppe JR, Mills SA, Pikaart MJ, Roberts R, Bromberg Y, Hoyer JS, Duffy S, Tischfield J, Ruiz FX, Arnold E, Baum J, Sandberg J, Brannigan G, Khare SD, Burley SK. Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first 6 months of the COVID-19 pandemic. Proteins 2021. [PMID: 34580920 DOI: 10.1002/prot.26250] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
165 Kumar BK, Rohit A, Prithvisagar KS, Rai P, Karunasagar I, Karunasagar I. Deletion in the C-terminal region of the envelope glycoprotein in some of the Indian SARS-CoV-2 genome. Virus Res 2021;291:198222. [PMID: 33166565 DOI: 10.1016/j.virusres.2020.198222] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
166 Seewoodhary M. An overview of diabetic retinopathy and other ocular complications of diabetes mellitus. Nurs Stand 2021;36:71-6. [PMID: 34032037 DOI: 10.7748/ns.2021.e11696] [Reference Citation Analysis]
167 Behl T, Kaur I, Aleya L, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Bungau S. CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target. Sci Total Environ 2021;808:152072. [PMID: 34863742 DOI: 10.1016/j.scitotenv.2021.152072] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Chi G, Memar Montazerin S, Lee JJ, Kazmi SHA, Shojaei F, Fitzgerald C, Gibson CM. Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID-19: Network meta-analysis of randomized controlled trials. J Med Virol 2021. [PMID: 34370328 DOI: 10.1002/jmv.27259] [Reference Citation Analysis]
169 Khazeei Tabari MA, Khoshhal H, Tafazoli A, Khandan M, Bagheri A. Applying computer simulations in battling with COVID-19, using pre-analyzed molecular and chemical data to face the pandemic. Inform Med Unlocked 2020;21:100458. [PMID: 33102687 DOI: 10.1016/j.imu.2020.100458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
170 Wei JT, Liu YX, Zhu YC, Qian J, Ye RZ, Li CY, Ji XK, Li HK, Qi C, Wang Y, Yang F, Zhou YH, Yan R, Cui XM, Liu YL, Jia N, Li SX, Li XJ, Xue FZ, Zhao L, Cao WC; Cheeloo EcoHealth Consortium (CLEC). Impacts of transportation and meteorological factors on the transmission of COVID-19. Int J Hyg Environ Health 2020;230:113610. [PMID: 32896785 DOI: 10.1016/j.ijheh.2020.113610] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 9.5] [Reference Citation Analysis]
171 Hutchison JM, Capone R, Luu DD, Shah KH, Hadziselimovic A, Van Horn WD, Sanders CR. Recombinant SARS-CoV-2 envelope protein traffics to the trans-Golgi network following amphipol-mediated delivery into human cells. J Biol Chem 2021;297:100940. [PMID: 34237302 DOI: 10.1016/j.jbc.2021.100940] [Reference Citation Analysis]
172 Yadav S, Sadique MA, Ranjan P, Kumar N, Singhal A, Srivastava AK, Khan R. SERS Based Lateral Flow Immunoassay for Point-of-Care Detection of SARS-CoV-2 in Clinical Samples. ACS Appl Bio Mater 2021;4:2974-95. [DOI: 10.1021/acsabm.1c00102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
173 Ou Z, Ouzounis C, Wang D, Sun W, Li J, Chen W, Marlière P, Danchin A. A Path toward SARS-CoV-2 Attenuation: Metabolic Pressure on CTP Synthesis Rules the Virus Evolution. Genome Biol Evol 2020;12:2467-85. [PMID: 33125064 DOI: 10.1093/gbe/evaa229] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
174 Kumar Y, Yadav R, Bhatia A. Can natural detergent properties of bile acids be used beneficially in tackling coronavirus disease-19? Future Virology 2020;15:779-82. [DOI: 10.2217/fvl-2020-0210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Majid S, Khan MS, Rashid S, Niyaz A, Farooq R, Bhat SA, Wani HA, Qureshi W. COVID-19: Diagnostics, Therapeutic Advances, and Vaccine Development. Curr Clin Microbiol Rep 2021;:1-15. [PMID: 33614398 DOI: 10.1007/s40588-021-00157-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Ibezim A, Onuku RS, Ibezim A, Ntie-Kang F, Nwodo NJ, Adikwu MU. Structure-based virtual screening and molecular dynamics simulation studies to discover new SARS-CoV-2 main protease inhibitors. Sci Afr 2021;14:e00970. [PMID: 34541426 DOI: 10.1016/j.sciaf.2021.e00970] [Reference Citation Analysis]
177 Pryzdial ELG, Sutherland MR, Lin BH, Horwitz M. Antiviral anticoagulation. Res Pract Thromb Haemost 2020;4:774-88. [PMID: 32685886 DOI: 10.1002/rth2.12406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
178 Tizaoui K, Zidi I, Lee KH, Ghayda RA, Hong SH, Li H, Smith L, Koyanagi A, Jacob L, Kronbichler A, Shin JI. Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19). Int J Biol Sci 2020;16:2906-23. [PMID: 33061805 DOI: 10.7150/ijbs.48812] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
179 Singh PK, Kulsum U, Rufai SB, Mudliar SR, Singh S. Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. J Lab Physicians 2020;12:154-60. [PMID: 32884216 DOI: 10.1055/s-0040-1715790] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
180 Chavda VP, Hossain MK, Beladiya J, Apostolopoulos V. Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena. Biologics 2021;1:337-56. [DOI: 10.3390/biologics1030020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Mendonça-Gomes JM, Charlie-Silva I, Guimarães ATB, Estrela FN, Calmon MF, Miceli RN, Sanches PRS, Bittar C, Rahal P, Cilli EM, Ahmed MAI, Vogel CFA, Malafaia G. Shedding light on toxicity of SARS-CoV-2 peptides in aquatic biota: A study involving neotropical mosquito larvae (Diptera: Culicidae). Environ Pollut 2021;289:117818. [PMID: 34333265 DOI: 10.1016/j.envpol.2021.117818] [Reference Citation Analysis]
182 Mojica-Crespo R, Morales-Crespo MM. [Pandemic COVID-19, the new health emergency of international concern: A review]. Semergen 2020;46 Suppl 1:65-77. [PMID: 32425491 DOI: 10.1016/j.semerg.2020.05.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
183 Orlowski S, Mourad JJ, Gallo A, Bruckert E. Coronaviruses, cholesterol and statins: Involvement and application for Covid-19. Biochimie 2021;189:51-64. [PMID: 34153377 DOI: 10.1016/j.biochi.2021.06.005] [Reference Citation Analysis]
184 Moakes RJA, Davies SP, Stamataki Z, Grover LM. Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS-COV-2. Adv Mater 2021;33:e2008304. [PMID: 34060150 DOI: 10.1002/adma.202008304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
185 Randhawa PK, Scanlon K, Rappaport J, Gupta MK. Modulation of Autophagy by SARS-CoV-2: A Potential Threat for Cardiovascular System. Front Physiol 2020;11:611275. [PMID: 33329064 DOI: 10.3389/fphys.2020.611275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
186 Khurana P, Varshney R, Gupta A. A Network-Biology led Computational Drug repurposing Strategy to prioritize therapeutic options for COVID-19. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e09387] [Reference Citation Analysis]
187 Qu L, Li J, Ren H. COVID-19: the epidemiology and treatment.Br J Hosp Med (Lond). 2020;81:1-9. [PMID: 33135928 DOI: 10.12968/hmed.2020.0580] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
188 Mecenas P, Bastos RTDRM, Vallinoto ACR, Normando D. Effects of temperature and humidity on the spread of COVID-19: A systematic review. PLoS One 2020;15:e0238339. [PMID: 32946453 DOI: 10.1371/journal.pone.0238339] [Cited by in Crossref: 78] [Cited by in F6Publishing: 65] [Article Influence: 39.0] [Reference Citation Analysis]
189 Salahshoori I, Mobaraki-asl N, Seyfaee A, Mirzaei Nasirabad N, Dehghan Z, Faraji M, Ganjkhani M, Babapoor A, Shadmehr SZ, Hamrang A. Overview of COVID-19 Disease: Virology, Epidemiology, Prevention Diagnosis, Treatment, and Vaccines. Biologics 2021;1:2-40. [DOI: 10.3390/biologics1010002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
190 Bahrami A, Arabestani MR, Taheri M, Farmany A, Zadeh FN, Hosseini SM, Nozari H, Nouri F. Exploring the Role of Heavy Metals and Their Derivatives on the Pathophysiology of COVID-19. Biol Trace Elem Res 2021. [PMID: 34448983 DOI: 10.1007/s12011-021-02893-x] [Reference Citation Analysis]
191 Savina K, Sreekumar R, Soonu VK, Variyar EJ. Various vaccine platforms in the field of COVID-19. Beni-Suef Univ J Basic Appl Sci 2022;11. [DOI: 10.1186/s43088-022-00215-1] [Reference Citation Analysis]
192 Kanzawa M, Spindler H, Anglemyer A, Rutherford GW. Will Coronavirus Disease 2019 Become Seasonal? J Infect Dis 2020;222:719-21. [PMID: 32609334 DOI: 10.1093/infdis/jiaa345] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
193 Rotty IE, Kristanto E, Sekeon S, Liwe HR, Ekawardani N. COVID-19: Comparison of immunogenicity response between natural and post-vaccination infections. F1000Res 2022;11:212. [DOI: 10.12688/f1000research.75537.1] [Reference Citation Analysis]
194 [DOI: 10.1101/2020.09.09.287508] [Cited by in Crossref: 23] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
195 Rudrapal M, Issahaku AR, Agoni C, Bendale AR, Nagar A, Soliman MES, Lokwani D. In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2. J Biomol Struct Dyn 2021;:1-17. [PMID: 34182889 DOI: 10.1080/07391102.2021.1944909] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Gediz Erturk A, Sahin A, Bati Ay E, Pelit E, Bagdatli E, Kulu I, Gul M, Mesci S, Eryilmaz S, Oba Ilter S, Yildirim T. A Multidisciplinary Approach to Coronavirus Disease (COVID-19). Molecules 2021;26:3526. [PMID: 34207756 DOI: 10.3390/molecules26123526] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
197 Stasi A, Castellano G, Ranieri E, Infante B, Stallone G, Gesualdo L, Netti GS. SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure. J Clin Med 2020;9:E4057. [PMID: 33334050 DOI: 10.3390/jcm9124057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
198 Srivastava V, Ahmad A. New perspective towards therapeutic regimen against SARS-CoV-2 infection. J Infect Public Health 2021;14:852-62. [PMID: 34118735 DOI: 10.1016/j.jiph.2021.05.009] [Reference Citation Analysis]
199 Sarkar C, Mondal M, Torequl Islam M, Martorell M, Docea AO, Maroyi A, Sharifi-Rad J, Calina D. Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives. Front Pharmacol 2020;11:572870. [PMID: 33041814 DOI: 10.3389/fphar.2020.572870] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 15.5] [Reference Citation Analysis]
200 Lauro R, Irrera N, Eid AH, Bitto A. Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children? Pathogens 2021;10:476. [PMID: 33920011 DOI: 10.3390/pathogens10040476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
201 De Maio F, Lo Cascio E, Babini G, Sali M, Della Longa S, Tilocca B, Roncada P, Arcovito A, Sanguinetti M, Scambia G, Urbani A. Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis. Microbes Infect. 2020;22:592-597. [PMID: 32891874 DOI: 10.1016/j.micinf.2020.08.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
202 Montaño LM, Sommer B, Gomez-verjan JC, Morales-paoli GS, Ramírez-salinas GL, Solís-chagoyán H, Sanchez-florentino ZA, Calixto E, Pérez-figueroa GE, Carter R, Jaimez-melgoza R, Romero-martínez BS, Flores-soto E. Theophylline: Old Drug in a New Light, Application in COVID-19 through Computational Studies. IJMS 2022;23:4167. [DOI: 10.3390/ijms23084167] [Reference Citation Analysis]
203 Bezemer GFG, Garssen J. TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target. Front Pharmacol 2020;11:601685. [PMID: 33519463 DOI: 10.3389/fphar.2020.601685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
204 Chatterjee S, Mishra S, Chowdhury KD, Ghosh CK, Saha KD. Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view. Life Sci 2021;278:119580. [PMID: 33991549 DOI: 10.1016/j.lfs.2021.119580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Bukhari Q, Jameel Y. Will Coronavirus Pandemic Diminish by Summer? SSRN Journal. [DOI: 10.2139/ssrn.3556998] [Cited by in Crossref: 114] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
206 Gowri A, Ashwin Kumar N, Suresh Anand BS. Recent advances in nanomaterials based biosensors for point of care (PoC) diagnosis of Covid-19 - A minireview. Trends Analyt Chem 2021;137:116205. [PMID: 33531721 DOI: 10.1016/j.trac.2021.116205] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
207 Verkhivker G. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2. Int J Mol Sci 2020;21:E8268. [PMID: 33158276 DOI: 10.3390/ijms21218268] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
208 Khan S, Hussain A, Vahdani Y, Kooshki H, Mahmud Hussen B, Haghighat S, Fatih Rasul M, Jamal Hidayat H, Hasan A, Edis Z, Haj Bloukh S, Kasravi S, Mahdi Nejadi Babadaei M, Sharifi M, Bai Q, Liu J, Hu B, Akhtari K, Falahati M. Exploring the interaction of quercetin-3-O-sophoroside with SARS-CoV-2 main proteins by theoretical studies: A probable prelude to control some variants of coronavirus including Delta. Arab J Chem 2021;14:103353. [PMID: 34909059 DOI: 10.1016/j.arabjc.2021.103353] [Reference Citation Analysis]
209 Hasöksüz M, Kiliç S, Saraç F. Coronaviruses and SARS-COV-2. Turk J Med Sci 2020;50:549-56. [PMID: 32293832 DOI: 10.3906/sag-2004-127] [Cited by in Crossref: 68] [Cited by in F6Publishing: 1] [Article Influence: 34.0] [Reference Citation Analysis]
210 Bordallo B, Bellas M, Cortez AF, Vieira M, Pinheiro M. Severe COVID-19: what have we learned with the immunopathogenesis? Adv Rheumatol 2020;60:50. [PMID: 32962761 DOI: 10.1186/s42358-020-00151-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 11.5] [Reference Citation Analysis]
211 Algunmeeyn A, El-Dahiyat F, Altakhineh MM, Azab M, Babar ZU. Understanding the factors influencing healthcare providers' burnout during the outbreak of COVID-19 in Jordanian hospitals. J Pharm Policy Pract 2020;13:53. [PMID: 32974035 DOI: 10.1186/s40545-020-00262-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
212 Crespi B, Alcock J. Conflicts over calcium and the treatment of COVID-19. Evol Med Public Health 2021;9:149-56. [PMID: 33732462 DOI: 10.1093/emph/eoaa046] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
213 Randhawa GS, Soltysiak MPM, El Roz H, de Souza CPE, Hill KA, Kari L. Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study. PLoS One 2020;15:e0232391. [PMID: 32330208 DOI: 10.1371/journal.pone.0232391] [Cited by in Crossref: 300] [Cited by in F6Publishing: 78] [Article Influence: 150.0] [Reference Citation Analysis]
214 Singh Tomar PP, Arkin IT. SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine. Biochem Biophys Res Commun 2020;530:10-4. [PMID: 32828269 DOI: 10.1016/j.bbrc.2020.05.206] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 21.5] [Reference Citation Analysis]
215 Acter T, Uddin N, Das J, Akhter A, Choudhury TR, Kim S. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Sci Total Environ 2020;730:138996. [PMID: 32371230 DOI: 10.1016/j.scitotenv.2020.138996] [Cited by in Crossref: 124] [Cited by in F6Publishing: 93] [Article Influence: 62.0] [Reference Citation Analysis]
216 Albashir AAD. Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors and Coronavirus Disease 2019 (COVID-19). South Med J 2021;114:51-6. [PMID: 33398362 DOI: 10.14423/SMJ.0000000000001200] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
217 Falcó I, Randazzo W, Sánchez G, Vilarroig J, Climent J, Chiva S, Chica A, Navarro-Laboulais J. Experimental and CFD evaluation of ozone efficacy against coronavirus and enteric virus contamination on public transport surfaces. J Environ Chem Eng 2021;9:106217. [PMID: 34422551 DOI: 10.1016/j.jece.2021.106217] [Reference Citation Analysis]
218 Wang Y, Fang S, Wu Y, Cheng X, Zhang LK, Shen XR, Li SQ, Xu JR, Shang WJ, Gao ZB, Xia BQ. Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates. Acta Pharmacol Sin 2021. [PMID: 34294887 DOI: 10.1038/s41401-021-00732-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Zhou G, Zhao Q. Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2. Int J Biol Sci 2020;16:1718-23. [PMID: 32226289 DOI: 10.7150/ijbs.45123] [Cited by in Crossref: 142] [Cited by in F6Publishing: 134] [Article Influence: 71.0] [Reference Citation Analysis]
220 Nadershahbaz M, Bidaki R, Azimi S, Saghafi F. COVID-19-infected woman along with tuberculosis and psychogenic non-epileptic seizures: A case report. Clin Case Rep 2021;9:e04964. [PMID: 34721851 DOI: 10.1002/ccr3.4964] [Reference Citation Analysis]
221 Ahmadirad N, Ghasemi Z. COVID-19 and Central Nervous System: Entry Routes And. Basic Clin Neurosci 2020;11:217-24. [PMID: 32855781 DOI: 10.32598/bcn.11.covid19.2360.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
222 Nagu P, Parashar A, Behl T, Mehta V. CNS implications of COVID-19: a comprehensive review. Rev Neurosci 2021;32:219-34. [PMID: 33550782 DOI: 10.1515/revneuro-2020-0070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
223 Yuan X, Yang C, He Q, Chen J, Yu D, Li J, Zhai S, Qin Z, Du K, Chu Z, Qin P. Current and Perspective Diagnostic Techniques for COVID-19. ACS Infect Dis 2020;6:1998-2016. [PMID: 32677821 DOI: 10.1021/acsinfecdis.0c00365] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 18.5] [Reference Citation Analysis]
224 Mohapatra S, Menon NG, Mohapatra G, Pisharody L, Pattnaik A, Menon NG, Bhukya PL, Srivastava M, Singh M, Barman MK, Gin KY, Mukherji S. The novel SARS-CoV-2 pandemic: Possible environmental transmission, detection, persistence and fate during wastewater and water treatment. Sci Total Environ 2021;765:142746. [PMID: 33092831 DOI: 10.1016/j.scitotenv.2020.142746] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
225 Sabalza M, Heckler I, Elhage A, Venkataraman I, Henry B. COVID-19: Testing Landscape Post-Infection, -Vaccination, and Future Perspectives. Viral Immunol 2022. [PMID: 35020523 DOI: 10.1089/vim.2021.0121] [Reference Citation Analysis]
226 Neumaier F, Zlatopolskiy BD, Neumaier B. Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics. Pharmaceutics 2020;12:E1247. [PMID: 33371500 DOI: 10.3390/pharmaceutics12121247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
227 Fiscon G, Salvadore F, Guarrasi V, Garbuglia AR, Paci P. Assessing the impact of data-driven limitations on tracing and forecasting the outbreak dynamics of COVID-19. Comput Biol Med 2021;135:104657. [PMID: 34303266 DOI: 10.1016/j.compbiomed.2021.104657] [Reference Citation Analysis]
228 Minakshi R, Jan AT, Rahman S, Kim J. A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host. Front Cell Infect Microbiol 2020;10:575404. [PMID: 33262955 DOI: 10.3389/fcimb.2020.575404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
229 Dharmashekara C, Pradeep S, Prasad SK, Jain AS, Syed A, Prasad KS, Patil SS, Beelagi MS, Srinivasa C, Shivamallu C. Virtual screening of potential phyto-candidates as therapeutic leads against SARS-CoV-2 infection. Environmental Challenges 2021;4:100136. [DOI: 10.1016/j.envc.2021.100136] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
230 Sankar M, Ramachandran B, Pandi B, Mutharasappan N, Ramasamy V, Prabu PG, Shanmugaraj G, Wang Y, Muniyandai B, Rathinasamy S, Chandrasekaran B, Bayan MF, Jeyaraman J, Halliah GP, Ebenezer SK. In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19. Front Mol Biosci 2021;8:637122. [PMID: 34291081 DOI: 10.3389/fmolb.2021.637122] [Reference Citation Analysis]
231 Liang T, Qiu J, Niu X, Ma Q, Zhou C, Chen P, Zhang Q, Chen M, Yang Z, Liu S, Li L. 3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor. Front Pharmacol 2020;11:603830. [PMID: 33519467 DOI: 10.3389/fphar.2020.603830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Hekman RM, Hume AJ, Goel RK, Abo KM, Huang J, Blum BC, Werder RB, Suder EL, Paul I, Phanse S, Youssef A, Alysandratos KD, Padhorny D, Ojha S, Mora-Martin A, Kretov D, Ash PEA, Verma M, Zhao J, Patten JJ, Villacorta-Martin C, Bolzan D, Perea-Resa C, Bullitt E, Hinds A, Tilston-Lunel A, Varelas X, Farhangmehr S, Braunschweig U, Kwan JH, McComb M, Basu A, Saeed M, Perissi V, Burks EJ, Layne MD, Connor JH, Davey R, Cheng JX, Wolozin BL, Blencowe BJ, Wuchty S, Lyons SM, Kozakov D, Cifuentes D, Blower M, Kotton DN, Wilson AA, Mühlberger E, Emili A. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell 2020;80:1104-1122.e9. [PMID: 33259812 DOI: 10.1016/j.molcel.2020.11.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
233 Liang KH, Chang TJ, Wang ML, Tsai PH, Lin TH, Wang CT, Yang DM. Novel biosensor platforms for the detection of coronavirus infection and severe acute respiratory syndrome coronavirus 2. J Chin Med Assoc 2020;83:701-3. [PMID: 32349033 DOI: 10.1097/JCMA.0000000000000337] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
234 Kundu S, Al Banna MH, Sayeed A, Begum MR, Brazendale K, Hasan MT, Habiba SJ, Abid MT, Khan MA, Chowdhury S, Kormoker T, Proshad R, Khan MSI. Knowledge, attitudes, and preventive practices toward the COVID-19 pandemic: an online survey among Bangladeshi residents. Z Gesundh Wiss 2021;:1-15. [PMID: 34414065 DOI: 10.1007/s10389-021-01636-5] [Reference Citation Analysis]
235 Switzer C, Loeb M. Evaluating the relationship between myocarditis and mRNA vaccination. Expert Rev Vaccines 2021;:1-7. [PMID: 34738500 DOI: 10.1080/14760584.2022.2002690] [Reference Citation Analysis]
236 Petrova NV, Ganina KK, Tarasov SA. [Susceptibility of animal species to experimental SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus; Sarbecovirus) infection]. Vopr Virusol 2021;66:103-11. [PMID: 33993680 DOI: 10.36233/0507-4088-47] [Reference Citation Analysis]
237 Li YD, Chi WY, Su JH, Ferrall L, Hung CF, Wu TC. Coronavirus vaccine development: from SARS and MERS to COVID-19. J Biomed Sci 2020;27:104. [PMID: 33341119 DOI: 10.1186/s12929-020-00695-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 23.0] [Reference Citation Analysis]
238 Cavezzi A, Menicagli R, Troiani E, Corrao S. COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis. F1000Res 2022;11:102. [DOI: 10.12688/f1000research.108667.1] [Reference Citation Analysis]
239 Gómez SA, Rojas-Valencia N, Gómez S, Egidi F, Cappelli C, Restrepo A. Binding of SARS-CoV-2 to Cell Receptors: A Tale of Molecular Evolution. Chembiochem 2021;22:724-32. [PMID: 32986926 DOI: 10.1002/cbic.202000618] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
240 Shirani F, Khorvash F, Arab A. Review on selected potential nutritional intervention for treatment and prevention of viral infections: possibility of recommending these for Coronavirus 2019. International Journal of Food Properties 2020;23:1722-36. [DOI: 10.1080/10942912.2020.1825483] [Reference Citation Analysis]
241 Karakuş E, Erdemir E, Demirbilek N, Liv L. Colorimetric and electrochemical detection of SARS-CoV-2 spike antigen with a gold nanoparticle-based biosensor. Anal Chim Acta 2021;1182:338939. [PMID: 34602210 DOI: 10.1016/j.aca.2021.338939] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
242 Rahman MS, Hoque MN, Islam MR, Islam I, Mishu ID, Rahaman MM, Sultana M, Hossain MA. Mutational insights into the envelope protein of SARS-CoV-2. Gene Rep 2021;22:100997. [PMID: 33319124 DOI: 10.1016/j.genrep.2020.100997] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
243 Piccolella S, Crescente G, Faramarzi S, Formato M, Pecoraro MT, Pacifico S. Polyphenols vs. Coronaviruses: How Far Has Research Moved Forward? Molecules 2020;25:E4103. [PMID: 32911757 DOI: 10.3390/molecules25184103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
244 Mao X, Guo L, Fu P, Xiang C. The status and trends of coronavirus research: A global bibliometric and visualized analysis. Medicine 2020;99:e20137. [DOI: 10.1097/md.0000000000020137] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
245 Tadesse DB, Gebremeskel GG, Asefa GG, Abay M, Demoz GT. The burden, admission, and outcome of COVID-19 in Africa: protocol for a systematic review and meta-analysis. Emerg Microbes Infect 2020;9:1372-8. [PMID: 32538295 DOI: 10.1080/22221751.2020.1775499] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
246 Dick K, Chopra A, Biggar KK, Green JR. Multi-schema computational prediction of the comprehensive SARS-CoV-2 vs. human interactome. PeerJ 2021;9:e11117. [PMID: 33868814 DOI: 10.7717/peerj.11117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
247 Rahman S, Montero MTV, Rowe K, Kirton R, Kunik F Jr. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol 2021;14:601-21. [PMID: 33705239 DOI: 10.1080/17512433.2021.1902303] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
248 Rabiei M, Kashanian S, Samavati SS, Derakhshankhah H, Jamasb S, McInnes SJP. Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery. J Drug Target 2021;:1-11. [PMID: 34415800 DOI: 10.1080/1061186X.2021.1971236] [Reference Citation Analysis]
249 Pandey SC, Pande V, Sati D, Upreti S, Samant M. Vaccination strategies to combat novel corona virus SARS-CoV-2. Life Sci 2020;256:117956. [PMID: 32535078 DOI: 10.1016/j.lfs.2020.117956] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 14.5] [Reference Citation Analysis]
250 Ali SG, Ansari MA, Alzohairy MA, Almatroudi A, Alomary MN, Alghamdi S, Rehman S, Khan HM. Natural Products and Nutrients against Different Viral Diseases: Prospects in Prevention and Treatment of SARS-CoV-2. Medicina (Kaunas) 2021;57:169. [PMID: 33673004 DOI: 10.3390/medicina57020169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
251 Islam F, Bibi S, Meem AFK, Islam MM, Rahaman MS, Bepary S, Rahman MM, Rahman MM, Elzaki A, Kajoak S, Osman H, ElSamani M, Khandaker MU, Idris AM, Emran TB. Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19. Int J Mol Sci 2021;22:12638. [PMID: 34884440 DOI: 10.3390/ijms222312638] [Reference Citation Analysis]
252 Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res 2020;21:224. [PMID: 32854739 DOI: 10.1186/s12931-020-01479-w] [Cited by in Crossref: 112] [Cited by in F6Publishing: 82] [Article Influence: 56.0] [Reference Citation Analysis]
253 Alothaid H, Aldughaim MSK, El Bakkouri K, AlMashhadi S, Al-Qahtani AA. Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment. Channels (Austin) 2020;14:403-12. [PMID: 33092458 DOI: 10.1080/19336950.2020.1837439] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
254 Payus AO, Jeffree MS, Ohn MH, Tan HJ, Ibrahim A, Chia YK, Raymond AA. Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19. Neurol Sci 2021. [PMID: 34853897 DOI: 10.1007/s10072-021-05785-z] [Reference Citation Analysis]
255 Ghodake GS, Shinde SK, Kadam AA, Saratale RG, Saratale GD, Syed A, Elgorban AM, Marraiki N, Kim DY. Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures. Biosens Bioelectron 2021;177:112969. [PMID: 33434780 DOI: 10.1016/j.bios.2021.112969] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
256 Obajuluwa AO, Okiki PA, Obajuluwa TM, Afolabi OB. In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV-2 genomic data. Pan Afr Med J 2020;37:285. [PMID: 33654512 DOI: 10.11604/pamj.2020.37.285.24663] [Reference Citation Analysis]
257 Letícia de Oliveira Toledo S, Sousa Nogueira L, das Graças Carvalho M, Romana Alves Rios D, de Barros Pinheiro M. COVID-19: Review and hematologic impact. Clin Chim Acta 2020;510:170-6. [PMID: 32659224 DOI: 10.1016/j.cca.2020.07.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
258 Timmers LFSM, Peixoto JV, Ducati RG, Bachega JFR, de Mattos Pereira L, Caceres RA, Majolo F, da Silva GL, Anton DB, Dellagostin OA, Henriques JAP, Xavier LL, Goettert MI, Laufer S. SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions. Sci Rep 2021;11:11998. [PMID: 34099808 DOI: 10.1038/s41598-021-91585-6] [Reference Citation Analysis]
259 Pitsillou E, Liang J, Hung A, Karagiannis TC. The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling. Journal of Molecular Graphics and Modelling 2022;114:108193. [DOI: 10.1016/j.jmgm.2022.108193] [Reference Citation Analysis]
260 Janik E, Bartos M, Niemcewicz M, Gorniak L, Bijak M. SARS-CoV-2: Outline, Prevention, and Decontamination. Pathogens 2021;10:114. [PMID: 33498679 DOI: 10.3390/pathogens10020114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
261 Chitranshi N, Gupta VK, Rajput R, Godinez A, Pushpitha K, Shen T, Mirzaei M, You Y, Basavarajappa D, Gupta V, Graham SL. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CLpro targeting repurposed drug candidates. J Transl Med 2020;18:278. [PMID: 32646487 DOI: 10.1186/s12967-020-02448-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
262 Maghool F, Valiani A, Safari T, Emami MH, Mohammadzadeh S. Gastrointestinal and renal complications in SARS-CoV-2-infected patients: Role of immune system. Scand J Immunol 2021;93:e12999. [PMID: 33190306 DOI: 10.1111/sji.12999] [Reference Citation Analysis]
263 Cavezzi A, Menicagli R, Troiani E, Corrao S. COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis. F1000Res 2022;11:102. [DOI: 10.12688/f1000research.108667.2] [Reference Citation Analysis]
264 Keyhan SO, Fallahi HR, Motamedi A, Khoshkam V, Mehryar P, Moghaddas O, Cheshmi B, Firoozi P, Yousefi P, Houshmand B. Reopening of dental clinics during SARS-CoV-2 pandemic: an evidence-based review of literature for clinical interventions. Maxillofac Plast Reconstr Surg 2020;42:25. [PMID: 32793519 DOI: 10.1186/s40902-020-00268-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Tregoning JS, Brown ES, Cheeseman HM, Flight KE, Higham SL, Lemm NM, Pierce BF, Stirling DC, Wang Z, Pollock KM. Vaccines for COVID-19. Clin Exp Immunol 2020;202:162-92. [PMID: 32935331 DOI: 10.1111/cei.13517] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 23.0] [Reference Citation Analysis]
266 Kaur N, Singh R, Dar Z, Bijarnia RK, Dhingra N, Kaur T. Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2. Infect Genet Evol 2021;89:104490. [PMID: 32745811 DOI: 10.1016/j.meegid.2020.104490] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
267 Darlington CD, Mammen RJ, Mammen KJ. COVID-19 and its impact on genitourinary malignancies. Indian J Urol 2020;36:163-70. [PMID: 33082630 DOI: 10.4103/iju.IJU_167_20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
268 Savitt AG, Manimala S, White T, Fandaros M, Yin W, Duan H, Xu X, Geisbrecht BV, Rubenstein DA, Kaplan AP, Peerschke EI, Ghebrehiwet B. SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems. Front Immunol 2021;12:767347. [PMID: 34804054 DOI: 10.3389/fimmu.2021.767347] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Fani M, Teimoori A, Ghafari S. Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections. Future Virology 2020;15:317-23. [DOI: 10.2217/fvl-2020-0050] [Cited by in Crossref: 44] [Cited by in F6Publishing: 11] [Article Influence: 22.0] [Reference Citation Analysis]
270 Ngo ST, Nguyen HM, Thuy Huong LT, Quan PM, Truong VK, Tung NT, Vu VV. Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations. RSC Adv 2020;10:40284-90. [DOI: 10.1039/d0ra07352k] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
271 Venugopal PP, Chakraborty D. Molecular mechanism of inhibition of COVID-19 main protease by β-adrenoceptor agonists and adenosine deaminase inhibitors using in silico methods. J Biomol Struct Dyn 2021;:1-16. [PMID: 33397209 DOI: 10.1080/07391102.2020.1868337] [Reference Citation Analysis]
272 Czubryt MP, Stecy T, Popke E, Aitken R, Jabusch K, Pound R, Lawes P, Ramjiawan B, Pierce GN. N95 mask reuse in a major urban hospital: COVID-19 response process and procedure. J Hosp Infect 2020;106:277-82. [PMID: 32745590 DOI: 10.1016/j.jhin.2020.07.035] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
273 Rajarshi K, Khan R, Singh MK, Ranjan T, Ray S, Ray S. Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19. Gene 2021;768:145313. [PMID: 33220345 DOI: 10.1016/j.gene.2020.145313] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
274 Pluskota-Karwatka D, Hoffmann M, Barciszewski J. Reducing SARS-CoV-2 Pathological Protein Activity with Small Molecules. J Pharm Anal 2021. [PMID: 33842018 DOI: 10.1016/j.jpha.2021.03.012] [Reference Citation Analysis]
275 Wondmkun YT, Mohammed OA. A Review on Novel Drug Targets and Future Directions for COVID-19 Treatment. Biologics 2020;14:77-82. [PMID: 32921981 DOI: 10.2147/BTT.S266487] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
276 Charoute H, Elkarhat Z, Elkhattabi L, El Fahime E, Oukkache N, Rouba H, Barakat A. Computational screening of potential drugs against COVID-19 disease: the Neuropilin-1 receptor as molecular target. VirusDis . [DOI: 10.1007/s13337-021-00751-x] [Reference Citation Analysis]
277 Tutunchi H, Naeini F, Ostadrahimi A, Hosseinzadeh-Attar MJ. Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19. Phytother Res 2020;34:3137-47. [PMID: 32613637 DOI: 10.1002/ptr.6781] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 16.5] [Reference Citation Analysis]
278 Atanasov P, Ivanova S, Kobakova Y, Moneva-sakelarieva M, Obreshkova D, Petkova V, Laleva-jordanova P. Immunogenesis in patients with medium and severe coronavirus infection – dynamics in different age groups. PHAR 2022;69:157-65. [DOI: 10.3897/pharmacia.69.e81063] [Reference Citation Analysis]
279 Kumar M, Taki K, Gahlot R, Sharma A, Dhangar K. A chronicle of SARS-CoV-2: Part-I - Epidemiology, diagnosis, prognosis, transmission and treatment. Sci Total Environ 2020;734:139278. [PMID: 32434058 DOI: 10.1016/j.scitotenv.2020.139278] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 23.5] [Reference Citation Analysis]
280 Dutta S, Das N, Mukherjee P. Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses. Front Microbiol 2020;11:1990. [PMID: 32983015 DOI: 10.3389/fmicb.2020.01990] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
281 Sharma A, Kontodimas K, Bosmann M. Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19. Front Med (Lausanne) 2021;8:648005. [PMID: 34150793 DOI: 10.3389/fmed.2021.648005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
282 Marak BN, Dowarah J, Khiangte L, Singh VP. Step toward repurposing drug discovery for COVID-19 therapeutics through in silico approach. Drug Dev Res 2021;82:374-92. [PMID: 33170521 DOI: 10.1002/ddr.21757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
283 Ju CR, Lian QY, Zhang JH, Qiu T, Cai ZT, Jiang WY, Zhang J, Cheng Q, Chen G, Li N, Wang CY, He JX. Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients. Chronic Dis Transl Med 2020;6:87-97. [PMID: 32363045 DOI: 10.1016/j.cdtm.2020.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
284 Boson B, Legros V, Zhou B, Siret E, Mathieu C, Cosset FL, Lavillette D, Denolly S. The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles. J Biol Chem 2021;296:100111. [PMID: 33229438 DOI: 10.1074/jbc.RA120.016175] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
285 Yang CJ, Wei YJ, Chang HL, Chang PY, Tsai CC, Chen YH, Hsueh PR. Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review. J Microbiol Immunol Infect 2021;54:27-36. [PMID: 33060041 DOI: 10.1016/j.jmii.2020.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
286 White N, Seelig JD, Loyalka SK. Computation of drag and diffusion coefficient for coronavirus: I. J Aerosol Sci 2021;157:105806. [PMID: 33976456 DOI: 10.1016/j.jaerosci.2021.105806] [Reference Citation Analysis]
287 Jakhmola S, Indari O, Kashyap D, Varshney N, Das A, Manivannan E, Jha HC. Mutational analysis of structural proteins of SARS-CoV-2. Heliyon 2021;7:e06572. [PMID: 33778179 DOI: 10.1016/j.heliyon.2021.e06572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
288 Lin N, Verma D, Saini N, Arbi R, Munir M, Jovic M, Turak A. Antiviral nanoparticles for sanitizing surfaces: A roadmap to self-sterilizing against COVID-19. Nano Today 2021;40:101267. [PMID: 34404999 DOI: 10.1016/j.nantod.2021.101267] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
289 Câmara DAD, Porcacchia AS, Lizier NF, De-sá-júnior PL. A COVID-19 Overview and Potential Applications of Cell Therapy. Biologics 2021;1:177-88. [DOI: 10.3390/biologics1020011] [Reference Citation Analysis]
290 Gül Ş. In silico drug repositioning against human NRP1 to block SARS-CoV-2 host entry. Turk J Biol 2021;45:442-58. [PMID: 34803446 DOI: 10.3906/biy-2012-52] [Reference Citation Analysis]
291 Zeng C, Hou X, Yan J, Zhang C, Li W, Zhao W, Du S, Dong Y. Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In Vivo. Adv Mater 2020;32:e2004452. [PMID: 32875709 DOI: 10.1002/adma.202004452] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
292 Moabelo KL, Martin DR, Fadaka AO, Sibuyi NRS, Meyer M, Madiehe AM. Nanotechnology-Based Strategies for Effective and Rapid Detection of SARS-CoV-2. Materials (Basel) 2021;14:7851. [PMID: 34947447 DOI: 10.3390/ma14247851] [Reference Citation Analysis]
293 Shanmugarajan D, P. P, Kumar BRP, Suresh B. Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets. RSC Adv 2020;10:31385-99. [DOI: 10.1039/d0ra03167d] [Cited by in Crossref: 10] [Article Influence: 5.0] [Reference Citation Analysis]
294 Renn A, Fu Y, Hu X, Hall MD, Simeonov A. Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2. Trends Pharmacol Sci 2020;41:815-29. [PMID: 32829936 DOI: 10.1016/j.tips.2020.07.004] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 24.0] [Reference Citation Analysis]
295 Bhattacharya M, Sharma AR, Mallick B, Sharma G, Lee SS, Chakraborty C. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex. Infect Genet Evol 2020;85:104587. [PMID: 33039603 DOI: 10.1016/j.meegid.2020.104587] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
296 Dagasso G, Urban J, Kwiatkowska M. Incorporating Time Delays in the Mathematical Modelling of the Human Immune Response in Viral Infections. Procedia Comput Sci 2021;185:144-51. [PMID: 34131452 DOI: 10.1016/j.procs.2021.05.016] [Reference Citation Analysis]
297 Cao Y, Yang R, Lee I, Zhang W, Sun J, Wang W, Meng X. Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors. Protein Sci 2021;30:1114-30. [PMID: 33813796 DOI: 10.1002/pro.4075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
298 Docea AO, Tsatsakis A, Albulescu D, Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou M, Drakoulis N, Dumanov JM, Tutelyan VA, Onischenko GG, Aschner M, Spandidos DA, Calina D. A new threat from an old enemy: Re‑emergence of coronavirus (Review). Int J Mol Med 2020;45:1631-43. [PMID: 32236624 DOI: 10.3892/ijmm.2020.4555] [Cited by in Crossref: 30] [Cited by in F6Publishing: 92] [Article Influence: 15.0] [Reference Citation Analysis]
299 Puray-Chavez M, LaPak KM, Schrank TP, Elliott JL, Bhatt DP, Agajanian MJ, Jasuja R, Lawson DQ, Davis K, Rothlauf PW, Liu Z, Jo H, Lee N, Tenneti K, Eschbach JE, Shema Mugisha C, Cousins EM, Cloer EW, Vuong HR, VanBlargan LA, Bailey AL, Gilchuk P, Crowe JE Jr, Diamond MS, Hayes DN, Whelan SPJ, Horani A, Brody SL, Goldfarb D, Major MB, Kutluay SB. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell. Cell Rep 2021;36:109364. [PMID: 34214467 DOI: 10.1016/j.celrep.2021.109364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
300 Liang Y, Wang ML, Chien CS, Yarmishyn AA, Yang YP, Lai WY, Luo YH, Lin YT, Chen YJ, Chang PC, Chiou SH. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection. Front Immunol 2020;11:1022. [PMID: 32574260 DOI: 10.3389/fimmu.2020.01022] [Cited by in Crossref: 101] [Cited by in F6Publishing: 58] [Article Influence: 50.5] [Reference Citation Analysis]
301 Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, Singh KP, Chaicumpa W, Bonilla-Aldana DK, Rodriguez-Morales AJ. Coronavirus Disease 2019-COVID-19. Clin Microbiol Rev. 2020;33. [PMID: 32580969 DOI: 10.1128/cmr.00028-20] [Cited by in Crossref: 222] [Cited by in F6Publishing: 125] [Article Influence: 111.0] [Reference Citation Analysis]
302 Hendaus MA. Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary. J Biomol Struct Dyn 2021;39:3787-92. [PMID: 32396771 DOI: 10.1080/07391102.2020.1767691] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
303 Siddique F, Abbas RZ, Mansoor MK, Alghamdi ES, Saeed M, Ayaz MM, Rahman M, Mahmood MS, Iqbal A, Manzoor M, Abbas A, Javaid A, Hussain I. An Insight Into COVID-19: A 21st Century Disaster and Its Relation to Immunocompetence and Food Antioxidants. Front Vet Sci 2020;7:586637. [PMID: 33521076 DOI: 10.3389/fvets.2020.586637] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
304 Kolokouris D, Kalenderoglou IE, Kolocouris A. Inside and Out of the Pore: Comparing Interactions and Molecular Dynamics of Influenza A M2 Viroporin Complexes in Standard Lipid Bilayers. J Chem Inf Model 2021;61:5550-68. [PMID: 34714655 DOI: 10.1021/acs.jcim.1c00264] [Reference Citation Analysis]
305 Barrantes FJ. Structural biology of coronavirus ion channels. Acta Crystallogr D Struct Biol 2021;77:391-402. [PMID: 33825700 DOI: 10.1107/S2059798321001431] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
306 Roy K, Agarwal S, Banerjee R, Paul MK, Purbey PK. COVID-19 and gut immunomodulation. World J Gastroenterol 2021; 27(46): 7925-7942 [DOI: 10.3748/wjg.v27.i46.7925] [Reference Citation Analysis]
307 Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J Med Virol. 2020;92:479-490. [PMID: 32052466 DOI: 10.1002/jmv.25707] [Cited by in Crossref: 489] [Cited by in F6Publishing: 430] [Article Influence: 244.5] [Reference Citation Analysis]
308 Smits VAJ, Hernández-Carralero E, Paz-Cabrera MC, Cabrera E, Hernández-Reyes Y, Hernández-Fernaud JR, Gillespie DA, Salido E, Hernández-Porto M, Freire R. The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients. Biochem Biophys Res Commun 2021;543:45-9. [PMID: 33515911 DOI: 10.1016/j.bbrc.2021.01.073] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
309 Khodajou-Masouleh H, Shahangian SS, Rasti B. Reinforcing our defense or weakening the enemy? A comparative overview of defensive and offensive strategies developed to confront COVID-19. Drug Metab Rev 2021;:1-34. [PMID: 33980089 DOI: 10.1080/03602532.2021.1928686] [Reference Citation Analysis]
310 Kumar K, Lupoli TJ. Exploiting Existing Molecular Scaffolds for Long-Term COVID Treatment. ACS Med Chem Lett 2020;11:1357-60. [PMID: 32665808 DOI: 10.1021/acsmedchemlett.0c00254] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
311 Poon WCK, Brown AT, Direito SOL, Hodgson DJM, Le Nagard L, Lips A, MacPhee CE, Marenduzzo D, Royer JR, Silva AF, Thijssen JHJ, Titmuss S. Soft matter science and the COVID-19 pandemic. Soft Matter 2020;16:8310-24. [PMID: 32909024 DOI: 10.1039/d0sm01223h] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
312 Huang W, Guo Y, Li N, Feng Y, Xiao L. Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2. Infect Genet Evol 2021;89:104736. [PMID: 33516969 DOI: 10.1016/j.meegid.2021.104736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
313 Guo YY, Wang PH, Pan YQ, Shi RZ, Li YQ, Guo F, Xing L. The Characteristics of Spike Glycoprotein Gene of Swine Acute Diarrhea Syndrome Coronavirus Strain CH/FJWT/2018 Isolated in China. Front Vet Sci 2021;8:687079. [PMID: 34368275 DOI: 10.3389/fvets.2021.687079] [Reference Citation Analysis]
314 Galkin SO, Anisenko AN, Shadrina OA, Gottikh MB. Genetic Engineering Systems to Study Human Viral Pathogens from the Coronaviridae Family. Mol Biol 2022;56:72-89. [DOI: 10.1134/s0026893322010022] [Reference Citation Analysis]
315 Duma Z, Chuturgoon AA, Ramsuran V, Edward V, Naidoo P, Mpaka-mbatha MN, Bhengu KN, Nembe N, Pillay R, Singh R, Mkhize-kwitshana ZL. The challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in low-middle income countries and possible cost-effective measures in resource-limited settings. Global Health 2022;18. [DOI: 10.1186/s12992-022-00796-7] [Reference Citation Analysis]
316 Guzman NA, Guzman DE. A Two-Dimensional Affinity Capture and Separation Mini-Platform for the Isolation, Enrichment, and Quantification of Biomarkers and Its Potential Use for Liquid Biopsy. Biomedicines 2020;8:E255. [PMID: 32751506 DOI: 10.3390/biomedicines8080255] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
317 Moulahoum H, Ghorbanizamani F, Zihnioglu F, Turhan K, Timur S. How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing. Talanta 2021;222:121534. [PMID: 33167242 DOI: 10.1016/j.talanta.2020.121534] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
318 Bò L, Miotto M, Di Rienzo L, Milanetti E, Ruocco G. Exploring the Association Between Sialic Acid and SARS-CoV-2 Spike Protein Through a Molecular Dynamics-Based Approach. Front Med Technol 2020;2:614652. [PMID: 35047894 DOI: 10.3389/fmedt.2020.614652] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
319 Singh P, Tripathi MK, Yasir M, Khare R, Tripathi MK, Shrivastava R. Potential Inhibitors for SARS-CoV-2 and Functional Food Components as Nutritional Supplement for COVID-19: A Review. Plant Foods Hum Nutr 2020;75:458-66. [PMID: 33037564 DOI: 10.1007/s11130-020-00861-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
320 Gong Y, Qin S, Dai L, Tian Z. The glycosylation in SARS-CoV-2 and its receptor ACE2. Signal Transduct Target Ther 2021;6:396. [PMID: 34782609 DOI: 10.1038/s41392-021-00809-8] [Reference Citation Analysis]
321 Mehta M, Prasher P, Sharma M, Shastri MD, Khurana N, Vyas M, Dureja H, Gupta G, Anand K, Satija S, Chellappan DK, Dua K. Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis. Med Hypotheses 2020;144:110254. [PMID: 33254559 DOI: 10.1016/j.mehy.2020.110254] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
322 Rasmi Y, Babaei G, Nisar MF, Noreen H, Gholizadeh-Ghaleh Aziz S. Revealed pathophysiological mechanisms of crosslinking interaction of affected vital organs in COVID-19. Comp Clin Path 2021;:1-17. [PMID: 34539310 DOI: 10.1007/s00580-021-03269-2] [Reference Citation Analysis]
323 Lin S, Lowary TL. Synthesis of a Highly Branched Nonasaccharide Chlorella Virus N-Glycan Using a "Counterclockwise" Assembly Approach. Org Lett 2020;22:7645-9. [PMID: 32940477 DOI: 10.1021/acs.orglett.0c02839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
324 Sagaya Jansi R, Khusro A, Agastian P, Alfarhan A, Al-Dhabi NA, Arasu MV, Rajagopal R, Barcelo D, Al-Tamimi A. Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents. Sci Total Environ 2021;759:143539. [PMID: 33234268 DOI: 10.1016/j.scitotenv.2020.143539] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
325 Korkmaz E, Balmert SC, Sumpter TL, Carey CD, Erdos G, Falo LD Jr. Microarray patches enable the development of skin-targeted vaccines against COVID-19. Adv Drug Deliv Rev 2021;171:164-86. [PMID: 33539853 DOI: 10.1016/j.addr.2021.01.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
326 Manhas S, Anjali A, Mansoor S, Sharma V, Ahmad A, Rehman MU, Ahmad P. Covid-19 Pandemic and Current Medical Interventions. Arch Med Res 2020;51:473-81. [PMID: 32499154 DOI: 10.1016/j.arcmed.2020.05.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
327 Tilocca B, Soggiu A, Sanguinetti M, Babini G, De Maio F, Britti D, Zecconi A, Bonizzi L, Urbani A, Roncada P. Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19. Microbes Infect 2020;22:182-7. [PMID: 32446902 DOI: 10.1016/j.micinf.2020.05.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
328 Roy C, Mandal SM, Mondal SK, Mukherjee S, Mapder T, Ghosh W, Chakraborty R. Trends of mutation accumulation across global SARS-CoV-2 genomes: Implications for the evolution of the novel coronavirus. Genomics 2020;112:5331-42. [PMID: 33161087 DOI: 10.1016/j.ygeno.2020.11.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
329 Hati S, Bhattacharyya S. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor. ACS Omega 2020;5:16292-8. [PMID: 32656452 DOI: 10.1021/acsomega.0c02125] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 22.0] [Reference Citation Analysis]
330 Chen W, Wang Z, Wang Y, Li Y. Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2. Front Pharmacol 2021;12:702472. [PMID: 34483904 DOI: 10.3389/fphar.2021.702472] [Reference Citation Analysis]
331 Mahtarin R, Islam S, Islam MJ, Ullah MO, Ali MA, Halim MA. Structure and dynamics of membrane protein in SARS-CoV-2. J Biomol Struct Dyn 2020;:1-14. [PMID: 33353499 DOI: 10.1080/07391102.2020.1861983] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
332 Kim C, Mahasenan KV, Bhardwaj A, Wiest O, Chang M, Mobashery S. Production of Proteins of the SARS-CoV-2 Proteome for Drug Discovery. ACS Omega 2021;6:19983-94. [PMID: 34337272 DOI: 10.1021/acsomega.1c02984] [Reference Citation Analysis]
333 Tati S, Alisaraie L. Recruitment of dynein and kinesin to viral particles. The FASEB Journal 2022;36. [DOI: 10.1096/fj.202101900rr] [Reference Citation Analysis]
334 Bhutta ZA, Kanwal A, Ali M, Kulyar MF, Yao W, Shoaib M, Ashar A, Mahfooz A, Ijaz M, Ijaz N, Asif M, Nawaz S, Mahfooz MR, Kanwal T. Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic. Nanotechnology 2021;32. [PMID: 34320471 DOI: 10.1088/1361-6528/ac189e] [Reference Citation Analysis]
335 Ghafouri F, Cohan RA, Noorbakhsh F, Samimi H, Haghpanah V. An in-silico approach to develop of a multi-epitope vaccine candidate against SARS-CoV-2 envelope (E) protein. Res Sq 2020:rs. [PMID: 32702713 DOI: 10.21203/rs.3.rs-30374/v1] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
336 Sun G, Xue L, He Q, Zhao Y, Xu W, Wang Z. Structural insights into SARS-CoV-2 infection and therapeutics development. Stem Cell Res 2021;52:102219. [PMID: 33550140 DOI: 10.1016/j.scr.2021.102219] [Reference Citation Analysis]
337 Pigarova EA, Povalyaeva AA, Dzeranova LK, Rozhinskaya LY, Mokrysheva NG. [The role of vitamin D in seasonal acute respiratory viral infections and COVID-19]. Ter Arkh 2020;92:98-105. [PMID: 33720613 DOI: 10.26442/00403660.2020.11.000785] [Reference Citation Analysis]
338 Nimesh S, Akram M, Ahmad MI, Ahmad A, Kumari P, Lal M. Immunity-Boosting Natural Herbs to Combat COVID-19 Pandemic: A Narrative Review. Borneo J Pharm 2021;4:260-72. [DOI: 10.33084/bjop.v4i4.2534] [Reference Citation Analysis]
339 Chazal N. Coronavirus, the King Who Wanted More Than a Crown: From Common to the Highly Pathogenic SARS-CoV-2, Is the Key in the Accessory Genes? Front Microbiol 2021;12:682603. [PMID: 34335504 DOI: 10.3389/fmicb.2021.682603] [Reference Citation Analysis]
340 Ebenezer O, Bodede O, Awolade P, Jordaan MA, Ogunsakin RE, Shapi M. Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis. Acta Pharmaceutica 2022;72:199-224. [DOI: 10.2478/acph-2022-0021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
341 Saleemi MA, Ahmad B, Benchoula K, Vohra MS, Mea HJ, Chong PP, Palanisamy NK, Wong EH. Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics. Infect Genet Evol 2020;85:104583. [PMID: 33035643 DOI: 10.1016/j.meegid.2020.104583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
342 Zahedi A, Monis P, Deere D, Ryan U. Wastewater-based epidemiology-surveillance and early detection of waterborne pathogens with a focus on SARS-CoV-2, Cryptosporidium and Giardia. Parasitol Res 2021. [PMID: 33409629 DOI: 10.1007/s00436-020-07023-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
343 Lv DF, Ying QM, He YW, Liang J, Zhang JH, Lu BB, Qian GQ, Chu JG, Weng XB, Chen XQ, Mu QT. Differential diagnosis of coronavirus disease 2019 pneumonia or influenza A pneumonia by clinical characteristics and laboratory findings. J Clin Lab Anal 2021;35:e23685. [PMID: 33576536 DOI: 10.1002/jcla.23685] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
344 Ji T, Liu Z, Wang G, Guo X, Akbar Khan S, Lai C, Chen H, Huang S, Xia S, Chen B, Jia H, Chen Y, Zhou Q. Detection of COVID-19: A review of the current literature and future perspectives. Biosens Bioelectron 2020;166:112455. [PMID: 32739797 DOI: 10.1016/j.bios.2020.112455] [Cited by in Crossref: 97] [Cited by in F6Publishing: 70] [Article Influence: 48.5] [Reference Citation Analysis]
345 Medeiros-Silva J, Somberg NH, Wang HK, McKay MJ, Mandala VS, Dregni AJ, Hong M. pH- and Calcium-Dependent Aromatic Network in the SARS-CoV-2 Envelope Protein. J Am Chem Soc 2022. [PMID: 35380805 DOI: 10.1021/jacs.2c00973] [Reference Citation Analysis]
346 Loras C, Sanz JC. Información preliminar de las características virológicas del nuevo coronavirus SARS-CoV-2. REMASP 2020;4:1-10. [DOI: 10.36300/remasp.2020.061] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
347 Yamoah MA, Thai PN, Zhang XD. Transgene Delivery to Human Induced Pluripotent Stem Cells Using Nanoparticles. Pharmaceuticals (Basel) 2021;14:334. [PMID: 33917388 DOI: 10.3390/ph14040334] [Reference Citation Analysis]
348 Park JG, Oladunni FS, Chiem K, Ye C, Pipenbrink M, Moran T, Walter MR, Kobie J, Martinez-Sobrido L. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2. J Virol Methods 2021;287:113995. [PMID: 33068703 DOI: 10.1016/j.jviromet.2020.113995] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
349 Mandala VS, McKay MJ, Shcherbakov AA, Dregni AJ, Kolocouris A, Hong M. Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. Nat Struct Mol Biol 2020;27:1202-8. [PMID: 33177698 DOI: 10.1038/s41594-020-00536-8] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 35.0] [Reference Citation Analysis]
350 Wang B, Dai T, Sun W, Wei Y, Ren J, Zhang L, Zhang M, Zhou F. Protein N-myristoylation: functions and mechanisms in control of innate immunity. Cell Mol Immunol 2021;18:878-88. [PMID: 33731917 DOI: 10.1038/s41423-021-00663-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
351 Kaundal RK, Kalvala AK, Kumar A. Neurological Implications of COVID-19: Role of Redox Imbalance and Mitochondrial Dysfunction. Mol Neurobiol 2021. [PMID: 34110602 DOI: 10.1007/s12035-021-02412-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
352 Ngo ST, Quynh Anh Pham N, Thi Le L, Pham DH, Vu VV. Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease. J Chem Inf Model 2020;60:5771-80. [PMID: 32530282 DOI: 10.1021/acs.jcim.0c00491] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 27.5] [Reference Citation Analysis]
353 Mandal S, Roychowdhury T, Bhattacharya A. Pattern of genomic variation in SARS-CoV-2 (COVID-19) suggests restricted nonrandom changes: Analysis using Shewhart control charts. J Biosci 2021;46. [DOI: 10.1007/s12038-020-00131-5] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
354 Celewicz A, Celewicz M, Michalczyk M, Woźniakowska-Gondek P, Krejczy K, Misiek M, Rzepka R. Pregnancy as a Risk Factor of Severe COVID-19. J Clin Med 2021;10:5458. [PMID: 34830740 DOI: 10.3390/jcm10225458] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
355 Teng S, Sobitan A, Rhoades R, Liu D, Tang Q. Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity. Brief Bioinform 2021;22:1239-53. [PMID: 33006605 DOI: 10.1093/bib/bbaa233] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 15.0] [Reference Citation Analysis]
356 Ashik AI, Hasan M, Tasnim AT, Chowdhury MB, Hossain T, Ahmed S. An immunoinformatics study on the spike protein of SARS-CoV-2 revealing potential epitopes as vaccine candidates. Heliyon 2020;6:e04865. [PMID: 32923731 DOI: 10.1016/j.heliyon.2020.e04865] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
357 Song P, Li W, Xie J, Hou Y, You C. Cytokine storm induced by SARS-CoV-2. Clin Chim Acta 2020;509:280-7. [PMID: 32531256 DOI: 10.1016/j.cca.2020.06.017] [Cited by in Crossref: 174] [Cited by in F6Publishing: 155] [Article Influence: 87.0] [Reference Citation Analysis]
358 Mazur FG, Morinisi LM, Martins JO, Guerra PPB, Freire CCM. Exploring Virome Diversity in Public Data in South America as an Approach for Detecting Viral Sources From Potentially Emerging Viruses. Front Genet 2022;12:722857. [DOI: 10.3389/fgene.2021.722857] [Reference Citation Analysis]
359 Rodriguez JH, Gupta A. Contact residue contributions to interaction energies between SARS-CoV-1 spike proteins and human ACE2 receptors. Sci Rep 2021;11:1156. [PMID: 33441985 DOI: 10.1038/s41598-020-80942-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
360 Bachus S, Akkerman N, Fulham L, Graves D, Stephanson C, Memon H, Miller MS, Pelka P, Imperiale MJ. Adenovirus 5 Vectors Expressing SARS-CoV-2 Proteins. mSphere. [DOI: 10.1128/msphere.00998-21] [Reference Citation Analysis]
361 [DOI: 10.1101/2020.03.26.994756] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
362 Hutchison JM, Capone R, Luu DD, Hadziselimovic A, Van Horn WD, Sanders CR. Delivery of recombinant SARS-CoV-2 envelope protein into human cells. bioRxiv 2021:2021. [PMID: 33619482 DOI: 10.1101/2021.02.18.431684] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
363 Siddiquie RY, Agrawal A, Joshi SS. Surface Alterations to Impart Antiviral Properties to Combat COVID-19 Transmission. Trans Indian Natl Acad Eng 2020;5:343-7. [DOI: 10.1007/s41403-020-00096-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
364 Rahimi H, Salehiabar M, Barsbay M, Ghaffarlou M, Kavetskyy T, Sharafi A, Davaran S, Chauhan SC, Danafar H, Kaboli S, Nosrati H, Yallapu MM, Conde J. CRISPR Systems for COVID-19 Diagnosis. ACS Sens 2021;6:1430-45. [PMID: 33502175 DOI: 10.1021/acssensors.0c02312] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
365 Silva LR, da Silva Santos-Júnior PF, de Andrade Brandão J, Anderson L, Bassi ÊJ, Xavier de Araújo-Júnior J, Cardoso SH, da Silva-Júnior EF. Druggable targets from coronaviruses for designing new antiviral drugs. Bioorg Med Chem 2020;28:115745. [PMID: 33007557 DOI: 10.1016/j.bmc.2020.115745] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
366 Prakash P, Meena R, Stanley Abraham L, Sunkar S, Govindaraju K, Pully D, Samrot AV. Evidence-based traditional Siddha formulations for prophylaxis and management of respiratory symptoms in COVID-19 pandemic-a review. Biocatal Agric Biotechnol 2021;35:102056. [PMID: 34122672 DOI: 10.1016/j.bcab.2021.102056] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
367 Kumar V, Parate S, Yoon S, Lee G, Lee KW. Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2. Front Microbiol 2021;12:647295. [PMID: 33967984 DOI: 10.3389/fmicb.2021.647295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
368 Cervantes-avilés P, Moreno-andrade I, Carrillo-reyes J. Approaches applied to detect SARS-CoV-2 in wastewater and perspectives post-COVID-19. Journal of Water Process Engineering 2021;40:101947. [DOI: 10.1016/j.jwpe.2021.101947] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
369 Xia B, Shen X, He Y, Pan X, Liu FL, Wang Y, Yang F, Fang S, Wu Y, Duan Z, Zuo X, Xie Z, Jiang X, Xu L, Chi H, Li S, Meng Q, Zhou H, Zhou Y, Cheng X, Xin X, Jin L, Zhang HL, Yu DD, Li MH, Feng XL, Chen J, Jiang H, Xiao G, Zheng YT, Zhang LK, Shen J, Li J, Gao Z. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target. Cell Res 2021;31:847-60. [PMID: 34112954 DOI: 10.1038/s41422-021-00519-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
370 Kumar N, Sarma H, Sastry GN. Repurposing of approved drug molecules for viral infectious diseases: a molecular modelling approach. J Biomol Struct Dyn 2021;:1-17. [PMID: 33810775 DOI: 10.1080/07391102.2021.1905558] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
371 Mardanly SG, Avdonina AS, Mamedova SG. Development of an enzyme-linked immunosorbent assay for the detection of IgG-antibodies to the causative agent of COVID-19 in human serum (plasma). Klin Lab Diagn 2020;65:683-7. [PMID: 33301657 DOI: 10.18821/0869-2084-2020-65-11-683-687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
372 Nazari E, Shahriari MH, Dadgarmoghaddam M, Saki A, Nahidi M, Mehrabian A, Tabesh H. Home quarantine is a useful strategy to prevent the coronavirus outbreak: Identifying the reasons for non-compliance in some Iranians. Inform Med Unlocked 2020;21:100487. [PMID: 33251325 DOI: 10.1016/j.imu.2020.100487] [Reference Citation Analysis]
373 Jamiu AT, Pohl CH, Bello S, Adedoja T, Sabiu S. A review on molecular docking analysis of phytocompounds against SARS-CoV-2 druggable targets. All Life 2021;14:1100-28. [DOI: 10.1080/26895293.2021.2013327] [Reference Citation Analysis]
374 Wißmann JE, Kirchhoff L, Brüggemann Y, Todt D, Steinmann J, Steinmann E. Persistence of Pathogens on Inanimate Surfaces: A Narrative Review. Microorganisms 2021;9:343. [PMID: 33572303 DOI: 10.3390/microorganisms9020343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
375 Seah I, Su X, Lingam G. Revisiting the dangers of the coronavirus in the ophthalmology practice. Eye (Lond) 2020;34:1155-7. [PMID: 32029919 DOI: 10.1038/s41433-020-0790-7] [Cited by in Crossref: 60] [Cited by in F6Publishing: 38] [Article Influence: 30.0] [Reference Citation Analysis]
376 Verma N, Patel D, Pandya A. Emerging diagnostic tools for detection of COVID-19 and perspective. Biomed Microdevices 2020;22:83. [PMID: 33230627 DOI: 10.1007/s10544-020-00534-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
377 Prates-Syed WA, Chaves LCS, Crema KP, Vuitika L, Lira A, Côrtes N, Kersten V, Guimarães FEG, Sadraeian M, Barroso da Silva FL, Cabral-Marques O, Barbuto JAM, Russo M, Câmara NOS, Cabral-Miranda G. VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants. Vaccines (Basel) 2021;9:1409. [PMID: 34960155 DOI: 10.3390/vaccines9121409] [Reference Citation Analysis]
378 Bhalla N, Pan Y, Yang Z, Payam AF. Opportunities and Challenges for Biosensors and Nanoscale Analytical Tools for Pandemics: COVID-19. ACS Nano 2020;14:7783-807. [PMID: 32551559 DOI: 10.1021/acsnano.0c04421] [Cited by in Crossref: 99] [Cited by in F6Publishing: 74] [Article Influence: 49.5] [Reference Citation Analysis]
379 Silva Andrade B, Ghosh P, Barh D, Tiwari S, José Santana Silva R, Rodrigues de Assis Soares W, Silva Melo T, Santos Freitas A, González-Grande P, Sousa Palmeira L, Carlos Junior Alcantara L, Giovanetti M, Góes-Neto A, Ariston de Carvalho Azevedo V. Computational screening for potential drug candidates against the SARS-CoV-2 main protease. F1000Res 2020;9:ISCB Comm J-514. [PMID: 33447372 DOI: 10.12688/f1000research.23829.2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
380 Rabiu Abubakar A, Ahmad R, Rowaiye AB, Rahman S, Iskandar K, Dutta S, Oli AN, Dhingra S, Tor MA, Etando A, Kumar S, Irfan M, Gowere M, Chowdhury K, Akter F, Jahan D, Schellack N, Haque M. Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm. Life 2022;12:478. [DOI: 10.3390/life12040478] [Reference Citation Analysis]
381 Tahmasebi S, Khosh E, Esmaeilzadeh A. The outlook for diagnostic purposes of the 2019-novel coronavirus disease. J Cell Physiol 2020;235:9211-29. [PMID: 32452050 DOI: 10.1002/jcp.29804] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
382 Owji H, Negahdaripour M, Hajighahramani N. Immunotherapeutic approaches to curtail COVID-19. Int Immunopharmacol 2020;88:106924. [PMID: 32877828 DOI: 10.1016/j.intimp.2020.106924] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
383 Rizzo P, Vieceli Dalla Sega F, Fortini F, Marracino L, Rapezzi C, Ferrari R. COVID-19 in the heart and the lungs: could we "Notch" the inflammatory storm? Basic Res Cardiol. 2020;115:31. [PMID: 32274570 DOI: 10.1007/s00395-020-0791-5] [Cited by in Crossref: 94] [Cited by in F6Publishing: 81] [Article Influence: 47.0] [Reference Citation Analysis]
384 Ali SI, Sheikh WM, Rather MA, Venkatesalu V, Muzamil Bashir S, Nabi SU. Medicinal plants: Treasure for antiviral drug discovery. Phytother Res 2021;35:3447-83. [PMID: 33590931 DOI: 10.1002/ptr.7039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
385 Fedorov V, Kholina E, Khruschev S, Kovalenko I, Rubin A, Strakhovskaya M. What Binds Cationic Photosensitizers Better: Brownian Dynamics Reveals Key Interaction Sites on Spike Proteins of SARS-CoV, MERS-CoV, and SARS-CoV-2. Viruses 2021;13:1615. [PMID: 34452480 DOI: 10.3390/v13081615] [Reference Citation Analysis]
386 Vijayan P P, P G C, Abraham P, George JS, Maria HJ, T S, Thomas S. Nanocoatings: Universal antiviral surface solution against COVID-19. Prog Org Coat 2022;163:106670. [PMID: 34955586 DOI: 10.1016/j.porgcoat.2021.106670] [Reference Citation Analysis]
387 Hussain A, Yadav S, Hadda V, Suri TM, Tiwari P, Mittal S, Madan K, Mohan A. Covid-19: a comprehensive review of a formidable foe and the road ahead. Expert Rev Respir Med. 2020;14:869-879. [PMID: 32529866 DOI: 10.1080/17476348.2020.1782198] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
388 da Costa VG, Moreli ML, Saivish MV. The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century. Arch Virol 2020;165:1517-26. [PMID: 32322993 DOI: 10.1007/s00705-020-04628-0] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 32.5] [Reference Citation Analysis]
389 Meftahi GH, Jangravi Z, Sahraei H, Bahari Z. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging". Inflamm Res. 2020;69:825-839. [PMID: 32529477 DOI: 10.1007/s00011-020-01372-8] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 39.0] [Reference Citation Analysis]
390 Bracquemond D, Muriaux D. Betacoronavirus Assembly: Clues and Perspectives for Elucidating SARS-CoV-2 Particle Formation and Egress. mBio 2021;12:e0237121. [PMID: 34579570 DOI: 10.1128/mBio.02371-21] [Reference Citation Analysis]
391 An X, Zhang Y, Duan L, Jin, Zhao S, Zhou R, Duan Y, Lian F, Tong X. The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19. Biomed Pharmacother 2021;137:111267. [PMID: 33508618 DOI: 10.1016/j.biopha.2021.111267] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
392 [DOI: 10.1101/2020.04.14.20064923] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
393 Tiwari V, Beer JC, Sankaranarayanan NV, Swanson-Mungerson M, Desai UR. Discovering small-molecule therapeutics against SARS-CoV-2. Drug Discov Today 2020;25:1535-44. [PMID: 32574699 DOI: 10.1016/j.drudis.2020.06.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 21.5] [Reference Citation Analysis]
394 Babcock S, Beverley J, Cowell LG, Smith B. The Infectious Disease Ontology in the age of COVID-19. J Biomed Semantics 2021;12:13. [PMID: 34275487 DOI: 10.1186/s13326-021-00245-1] [Reference Citation Analysis]
395 Alomari AH, Aga O, El Sahmarany L, Hegazi M, Almulla L. Public perception towards medical waste generated in the environment during the COVID-19 pandemic in Eastern Province, Saudi Arabia. Heliyon 2021;7:e08363. [PMID: 34786514 DOI: 10.1016/j.heliyon.2021.e08363] [Reference Citation Analysis]
396 AlGhamdi NA, Alsuwat HS, Borgio JF, AbdulAzeez S. Emerging of composition variations of SARS-CoV-2 spike protein and human ACE2 contribute to the level of infection: in silico approaches. J Biomol Struct Dyn 2020;:1-12. [PMID: 33138699 DOI: 10.1080/07391102.2020.1841032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
397 Andrew M, Jayaraman G. Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19). Carbohydr Res 2021;505:108326. [PMID: 34015720 DOI: 10.1016/j.carres.2021.108326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
398 Hossain MF, Hasana S, Mamun AA, Uddin MS, Wahed MII, Sarker S, Behl T, Ullah I, Begum Y, Bulbul IJ, Amran MS, Rahman MH, Bin-Jumah MN, Alkahtani S, Mousa SA, Aleya L, Abdel-Daim MM. COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management. Front Pharmacol 2020;11:563478. [PMID: 33178016 DOI: 10.3389/fphar.2020.563478] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
399 Thakur S, Mayank, Sarkar B, Ansari AJ, Khandelwal A, Arya A, Poduri R, Joshi G. Exploring the magic bullets to identify Achilles' heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update. Food Chem Toxicol 2021;147:111887. [PMID: 33253764 DOI: 10.1016/j.fct.2020.111887] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
400 Sosnowski TR. Inhaled aerosols: Their role in COVID-19 transmission, including biophysical interactions in the lungs. Curr Opin Colloid Interface Sci 2021;54:101451. [PMID: 33782631 DOI: 10.1016/j.cocis.2021.101451] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
401 Tahir Ul Qamar M, Shahid F, Aslam S, Ashfaq UA, Aslam S, Fatima I, Fareed MM, Zohaib A, Chen LL. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2. Infect Dis Poverty 2020;9:132. [PMID: 32938504 DOI: 10.1186/s40249-020-00752-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
402 Park SH, Siddiqi H, Castro DV, De Angelis AA, Oom AL, Stoneham CA, Lewinski MK, Clark AE, Croker BA, Carlin AF, Guatelli J, Opella SJ. Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity. PLoS Pathog 2021;17:e1009519. [PMID: 34003853 DOI: 10.1371/journal.ppat.1009519] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
403 Eslami H, Das S, Zhou T, Müller-Plathe F. How Alcoholic Disinfectants Affect Coronavirus Model Membranes: Membrane Fluidity, Permeability, and Disintegration. J Phys Chem B 2020;124:10374-85. [PMID: 33172260 DOI: 10.1021/acs.jpcb.0c08296] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
404 Borges E Jr, Setti AS, Iaconelli A Jr, Braga DPAF. Current status of the COVID-19 and male reproduction: A review of the literature. Andrology 2021;9:1066-75. [PMID: 33998143 DOI: 10.1111/andr.13037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
405 Jaber AA, Chowdhury ZM, Bhattacharjee A, Mourin M, Keya CA, Bhuyan ZA. Elucidating molecular mechanisms of acquired resistance to BRAF inhibitors in melanoma using a microfluidic device and deep sequencing. Genomics Inform 2021;19:e48. [PMID: 33840166 DOI: 10.5808/gi.21040] [Reference Citation Analysis]
406 He L, Zhao J, Wang L, Liu Q, Fan Y, Li B, Yu YL, Chen C, Li YF. Using nano-selenium to combat Coronavirus Disease 2019 (COVID-19)? Nano Today 2021;36:101037. [PMID: 33250930 DOI: 10.1016/j.nantod.2020.101037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
407 Shang J, Du L, Han N, Lv D, Wang J, Yang H, Bai L, Tang H. Severe acute respiratory syndrome coronavirus 2 for physicians: Molecular characteristics and host immunity (Review). Mol Med Rep 2021;23:262. [PMID: 33576464 DOI: 10.3892/mmr.2021.11901] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
408 McClenaghan C, Hanson A, Lee SJ, Nichols CG. Coronavirus Proteins as Ion Channels: Current and Potential Research. Front Immunol 2020;11:573339. [PMID: 33154751 DOI: 10.3389/fimmu.2020.573339] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
409 Ibrahim Fouad G. The neuropathological impact of COVID-19: a review. Bull Natl Res Cent 2021;45:19. [PMID: 33456304 DOI: 10.1186/s42269-020-00478-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
410 Sarkar M, Saha S. Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies. PLoS One 2020;15:e0237300. [PMID: 32785274 DOI: 10.1371/journal.pone.0237300] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 15.5] [Reference Citation Analysis]
411 Nicholls CMR, Sevvana M, Kuhn RJ. Structure-guided paradigm shifts in flavivirus assembly and maturation mechanisms. Adv Virus Res 2020;108:33-83. [PMID: 33837721 DOI: 10.1016/bs.aivir.2020.08.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
412 Dharmaraj S, Ashokkumar V, Hariharan S, Manibharathi A, Show PL, Chong CT, Ngamcharussrivichai C. The COVID-19 pandemic face mask waste: A blooming threat to the marine environment. Chemosphere 2021;272:129601. [PMID: 33497928 DOI: 10.1016/j.chemosphere.2021.129601] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 20.0] [Reference Citation Analysis]
413 Pekel H, Ilter M, Sensoy O. Inhibition of SARS-CoV-2 main protease: a repurposing study that targets the dimer interface of the protein. J Biomol Struct Dyn 2021;:1-16. [PMID: 33847241 DOI: 10.1080/07391102.2021.1910571] [Reference Citation Analysis]
414 Xia X, Wang Y, Zheng J. COVID-19 and Alzheimer's disease: how one crisis worsens the other. Transl Neurodegener 2021;10:15. [PMID: 33941272 DOI: 10.1186/s40035-021-00237-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
415 Banerjee S, Majumder K, Gutierrez GJ, Gupta D, Mittal B. Immuno-informatics approach for multi-epitope vaccine designing against SARS-CoV-2. bioRxiv 2020:2020. [PMID: 32743567 DOI: 10.1101/2020.07.23.218529] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
416 Das C, Paul SS, Saha A, Singh T, Saha A, Im J, Biswas G. Silver-Based Nanomaterials as Therapeutic Agents Against Coronaviruses: A Review. Int J Nanomedicine 2020;15:9301-15. [PMID: 33262589 DOI: 10.2147/IJN.S280976] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
417 Chikhale RV, Gurav SS, Patil RB, Sinha SK, Prasad SK, Shakya A, Shrivastava SK, Gurav NS, Prasad RS. Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach. J Biomol Struct Dyn 2021;39:4510-21. [PMID: 32568012 DOI: 10.1080/07391102.2020.1778539] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 13.5] [Reference Citation Analysis]
418 Silva TF, Tomiotto-Pellissier F, Sanfelice RA, Gonçalves MD, da Silva Bortoleti BT, Detoni MB, Rodrigues ACJ, Carloto ACM, Concato VM, Siqueira EDS, Costa IN, Pavanelli WR, Conchon-Costa I, Miranda-Sapla MM. A 21st Century Evil: Immunopathology and New Therapies of COVID-19. Front Immunol 2020;11:562264. [PMID: 33193331 DOI: 10.3389/fimmu.2020.562264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
419 Ferreira G, Santander A, Savio F, Guirado M, Sobrevia L, Nicolson GL. SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases. Biochim Biophys Acta Mol Basis Dis 2021;1867:166264. [PMID: 34481867 DOI: 10.1016/j.bbadis.2021.166264] [Reference Citation Analysis]
420 [DOI: 10.1101/2020.04.01.20050526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
421 Jindal A, Noronha M, Mysore V. Dermatological procedures amidst COVID-19: When and how to resume. Dermatol Ther 2020;33:e13561. [PMID: 32396655 DOI: 10.1111/dth.13561] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
422 Kaur M, Sharma A, Kumar S, Singh G, Barnwal RP. SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development. Int J Biol Macromol 2021;179:45-60. [PMID: 33662418 DOI: 10.1016/j.ijbiomac.2021.02.212] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
423 Suthar S, Das S, Nagpure A, Madhurantakam C, Tiwari SB, Gahlot P, Tyagi VK. Epidemiology and diagnosis, environmental resources quality and socio-economic perspectives for COVID-19 pandemic. J Environ Manage 2021;280:111700. [PMID: 33261988 DOI: 10.1016/j.jenvman.2020.111700] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
424 Duart G, García-Murria MJ, Grau B, Acosta-Cáceres JM, Martínez-Gil L, Mingarro I. SARS-CoV-2 envelope protein topology in eukaryotic membranes. Open Biol 2020;10:200209. [PMID: 32898469 DOI: 10.1098/rsob.200209] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
425 Hathout RM, Kassem DH. Positively Charged Electroceutical Spun Chitosan Nanofibers Can Protect Health Care Providers From COVID-19 Infection: An Opinion. Front Bioeng Biotechnol 2020;8:885. [PMID: 32974290 DOI: 10.3389/fbioe.2020.00885] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
426 Alturaiki W, Mubarak A, Al Jurayyan A, Hemida MG. The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2. Hum Vaccin Immunother 2021;17:3297-309. [PMID: 34114940 DOI: 10.1080/21645515.2021.1935172] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
427 Ingraham NE, Barakat AG, Reilkoff R, Bezdicek T, Schacker T, Chipman JG, Tignanelli CJ, Puskarich MA. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review. Eur Respir J 2020;56:2000912. [PMID: 32341103 DOI: 10.1183/13993003.00912-2020] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 34.5] [Reference Citation Analysis]
428 Kumar A, Kodidela S, Tadrous E, Cory TJ, Walker CM, Smith AM, Mukherjee A, Kumar S. Extracellular Vesicles in Viral Replication and Pathogenesis and Their Potential Role in Therapeutic Intervention. Viruses 2020;12:E887. [PMID: 32823684 DOI: 10.3390/v12080887] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
429 Hoque MN, Chaudhury A, Akanda MAM, Hossain MA, Islam MT. Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease. PeerJ 2020;8:e9689. [PMID: 33005486 DOI: 10.7717/peerj.9689] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
430 Palmeira A, Sousa E, Köseler A, Sabirli R, Gören T, Türkçüer İ, Kurt Ö, Pinto MM, Vasconcelos MH. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection. Pharmaceuticals (Basel) 2020;13:E132. [PMID: 32630514 DOI: 10.3390/ph13060132] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
431 Chouw A, Milanda T, Sartika CR, Kirana MN, Halim D, Faried A. Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19. Regen Eng Transl Med 2021;:1-12. [PMID: 33723519 DOI: 10.1007/s40883-021-00202-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
432 Hadi J, Dunowska M, Wu S, Brightwell G. Control Measures for SARS-CoV-2: A Review on Light-Based Inactivation of Single-Stranded RNA Viruses. Pathogens 2020;9:E737. [PMID: 32911671 DOI: 10.3390/pathogens9090737] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
433 Araf Y, Faruqui NA, Anwar S, Hosen MJ. SARS-CoV-2: a new dimension to our understanding of coronaviruses. Int Microbiol 2021;24:19-24. [PMID: 33231780 DOI: 10.1007/s10123-020-00152-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
434 Shaffaf T, Ghafar-Zadeh E. COVID-19 Diagnostic Strategies Part II: Protein-Based Technologies. Bioengineering (Basel) 2021;8:54. [PMID: 33925032 DOI: 10.3390/bioengineering8050054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
435 Gonzalez Lomeli F, Elmaraghy N, Castro A, Osuna Guerrero CV, Newcomb LL. Conserved Targets to Prevent Emerging Coronaviruses. Viruses 2022;14:563. [DOI: 10.3390/v14030563] [Reference Citation Analysis]
436 El-Sayed A, Abdel-Daim MM, Kamel M. Causes of respiratory failure in COVID-19 patients. Environ Sci Pollut Res Int 2021;28:28825-30. [PMID: 33954917 DOI: 10.1007/s11356-021-14200-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
437 Pabbaraju K, Wong AA, Douesnard M, Ma R, Gill K, Dieu P, Fonseca K, Zelyas N, Tipples GA. Development and validation of RT-PCR assays for testing for SARS-CoV-2. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 2021;6:16-22. [DOI: 10.3138/jammi-2020-0026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
438 Zalzala HH. Diagnosis of COVID-19: facts and challenges. New Microbes New Infect 2020;38:100761. [PMID: 32953123 DOI: 10.1016/j.nmni.2020.100761] [Reference Citation Analysis]
439 Pandey A, Nikam AN, Shreya AB, Mutalik SP, Gopalan D, Kulkarni S, Padya BS, Fernandes G, Mutalik S, Prassl R. Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements. Life Sci 2020;256:117883. [PMID: 32497632 DOI: 10.1016/j.lfs.2020.117883] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 25.0] [Reference Citation Analysis]
440 Tadesse DB, Wahdey S, Negash M, Ayele E, Haile TG, Kiros KG, Tesfamichael YA, Gebrekidan KB. The outcome of COVID-19 among the geriatric age group in African countries: protocol for a systematic review and meta-analysis. Asthma Res Pract 2020;6:11. [PMID: 33047071 DOI: 10.1186/s40733-020-00064-8] [Reference Citation Analysis]
441 Hemmat N, Asadzadeh Z, Ahangar NK, Alemohammad H, Najafzadeh B, Derakhshani A, Baghbanzadeh A, Baghi HB, Javadrashid D, Najafi S, Ar Gouilh M, Baradaran B. The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV. Arch Virol 2021;166:675-96. [PMID: 33462671 DOI: 10.1007/s00705-021-04958-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 20.0] [Reference Citation Analysis]
442 Yalcinkaya M, Liu W, Islam MN, Kotini AG, Gusarova GA, Fidler TP, Papapetrou EP, Bhattacharya J, Wang N, Tall AR. Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein. Sci Rep 2021;11:24432. [PMID: 34952919 DOI: 10.1038/s41598-021-04133-7] [Reference Citation Analysis]
443 Labeau A, Fery-Simonian L, Lefevre-Utile A, Pourcelot M, Bonnet-Madin L, Soumelis V, Lotteau V, Vidalain PO, Amara A, Meertens L. Characterization and functional interrogation of the SARS-CoV-2 RNA interactome. Cell Rep 2022;39:110744. [PMID: 35477000 DOI: 10.1016/j.celrep.2022.110744] [Reference Citation Analysis]
444 Nardella C, Visconti L, Malagrinò F, Pagano L, Bufano M, Nalli M, Coluccia A, La Regina G, Silvestri R, Gianni S, Toto A. Targeting PDZ domains as potential treatment for viral infections, neurodegeneration and cancer. Biol Direct 2021;16:15. [PMID: 34641953 DOI: 10.1186/s13062-021-00303-9] [Reference Citation Analysis]
445 Atif M, Naz F, Akhtar J, Imran M, Saleem S, Akram J, Imran M, Ullah MI. From Molecular Pathology of COVID 19 to Nigella Sativum as a Treatment Option: Scientific Based Evidence of Its Myth or Reality. Chin J Integr Med 2021. [PMID: 34586557 DOI: 10.1007/s11655-021-3311-z] [Reference Citation Analysis]
446 Ma Z, Li Z, Dong L, Yang T, Xiao S. Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae. Adv Virus Res 2020;107:383-416. [PMID: 32711735 DOI: 10.1016/bs.aivir.2020.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
447 Chakravarty D, Nair SS, Hammouda N, Ratnani P, Gharib Y, Wagaskar V, Mohamed N, Lundon D, Dovey Z, Kyprianou N, Tewari AK. Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer. Commun Biol 2020;3:374. [PMID: 32641750 DOI: 10.1038/s42003-020-1088-9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 26.5] [Reference Citation Analysis]
448 Kaur A, Chopra M, Bhushan M, Gupta S, Kumari P H, Sivagurunathan N, Shukla N, Rajagopal S, Bhalothia P, Sharma P, Naravula J, Suravajhala R, Gupta A, Abbasi BA, Goswami P, Singh H, Narang R, Polavarapu R, Medicherla KM, Valadi J, Kumar S A, Chaubey G, Singh KK, Bandapalli OR, Kavi Kishor PB, Suravajhala P. The Omic Insights on Unfolding Saga of COVID-19. Front Immunol 2021;12:724914. [PMID: 34745097 DOI: 10.3389/fimmu.2021.724914] [Reference Citation Analysis]
449 Gentile D, Fuochi V, Rescifina A, Furneri PM. New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine. Int J Mol Sci 2020;21:E5856. [PMID: 32824072 DOI: 10.3390/ijms21165856] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
450 Lv DF, Ying QM, Weng YS, Shen CB, Chu JG, Kong JP, Sun DH, Gao X, Weng XB, Chen XQ. Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient. Clin Chim Acta 2020;506:172-5. [PMID: 32229107 DOI: 10.1016/j.cca.2020.03.032] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
451 Onyilagha C, Mistry H, Marszal P, Pinette M, Kobasa D, Tailor N, Berhane Y, Nfon C, Pickering B, Mubareka S, Bulir D, Chong S, Kozak R, Ambagala A. Evaluation of mobile real-time polymerase chain reaction tests for the detection of severe acute respiratory syndrome coronavirus 2. Sci Rep 2021;11:9387. [PMID: 33931684 DOI: 10.1038/s41598-021-88625-6] [Reference Citation Analysis]
452 Praissman JL, Wells L. Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research. Mol Cell Proteomics 2021;20:100103. [PMID: 34089862 DOI: 10.1016/j.mcpro.2021.100103] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
453 Jastrzębska AM, Vasilchenko AS. Smart and Sustainable Nanotechnological Solutions in a Battle against COVID-19 and Beyond: A Critical Review. ACS Sustain Chem Eng 2021;9:601-22. [PMID: 34192094 DOI: 10.1021/acssuschemeng.0c06565] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
454 Yoshimoto FK. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19. Protein J. 2020;39:198-216. [PMID: 32447571 DOI: 10.1007/s10930-020-09901-4] [Cited by in Crossref: 156] [Cited by in F6Publishing: 152] [Article Influence: 78.0] [Reference Citation Analysis]
455 Shi X, Chen M, Zhang Y. The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19. Mol Biol Rep 2021;48:1763-71. [PMID: 33483864 DOI: 10.1007/s11033-021-06148-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
456 Donde OO, Atoni E, Muia AW, Yillia PT. COVID-19 pandemic: Water, sanitation and hygiene (WASH) as a critical control measure remains a major challenge in low-income countries. Water Res 2021;191:116793. [PMID: 33388470 DOI: 10.1016/j.watres.2020.116793] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
457 Pilaquinga F, Morey J, Torres M, Seqqat R, Piña MLN. Silver nanoparticles as a potential treatment against SARS-CoV-2: A review. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1707. [PMID: 33638618 DOI: 10.1002/wnan.1707] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
458 Haque SM, Ashwaq O, Sarief A, Azad John Mohamed AK. A comprehensive review about SARS-CoV-2. Future Virol 2020;15:625-48. [PMID: 33224265 DOI: 10.2217/fvl-2020-0124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
459 Sadoughi F, Maleki Dana P, Hallajzadeh J, Asemi Z, Mansournia MA, Yousefi B. Coagulopathy: Another side effect of coronavirus infection. J Cardiovasc Thorac Res 2021;13:15-22. [PMID: 33815697 DOI: 10.34172/jcvtr.2020.59] [Reference Citation Analysis]
460 Mazzotta C, Giancipoli E. Anterior Acute Uveitis Report in a SARS-CoV-2 Patient Managed with Adjunctive Topical Antiseptic Prophylaxis Preventing 2019-nCoV Spread Through the Ocular Surface Route. Int Med Case Rep J 2020;13:513-20. [PMID: 33116943 DOI: 10.2147/IMCRJ.S260252] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
461 Erickson MA, Rhea EM, Knopp RC, Banks WA. Interactions of SARS-CoV-2 with the Blood-Brain Barrier. Int J Mol Sci 2021;22:2681. [PMID: 33800954 DOI: 10.3390/ijms22052681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
462 Tabibzadeh A, Esghaei M, Soltani S, Yousefi P, Taherizadeh M, Safarnezhad Tameshkel F, Golahdooz M, Panahi M, Ajdarkosh H, Zamani F, Karbalaie Niya MH. Evolutionary study of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emerging coronavirus: Phylogenetic analysis and literature review. Vet Med Sci 2021;7:559-71. [PMID: 33210477 DOI: 10.1002/vms3.394] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
463 Xu J, Xue Y, Zhou R, Shi PY, Li H, Zhou J. Drug repurposing approach to combating coronavirus: Potential drugs and drug targets. Med Res Rev 2021;41:1375-426. [PMID: 33277927 DOI: 10.1002/med.21763] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
464 Smith TP, Flaxman S, Gallinat AS, Kinosian SP, Stemkovski M, Unwin HJT, Watson OJ, Whittaker C, Cattarino L, Dorigatti I, Tristem M, Pearse WD. Temperature and population density influence SARS-CoV-2 transmission in the absence of nonpharmaceutical interventions. Proc Natl Acad Sci U S A 2021;118:e2019284118. [PMID: 34103391 DOI: 10.1073/pnas.2019284118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
465 Bardooli FK, Hasan J, Hussain T, Abdulrahman A, Al Shaikh S. Influence of COVID-19 Pandemic on Cardiac Services in Bahrain: Building Cardiovascular Protocol for Future Pandemics. Heart Views 2021;22:174-83. [PMID: 34760048 DOI: 10.4103/heartviews.heartviews_81_21] [Reference Citation Analysis]
466 Makarov V, Riabova O, Ekins S, Pluzhnikov N, Chepur S. The past, present and future of RNA respiratory viruses: influenza and coronaviruses. Pathog Dis 2020;78:ftaa046. [PMID: 32860686 DOI: 10.1093/femspd/ftaa046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
467 Boopathi S, Poma AB, Kolandaivel P. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn 2021;39:3409-18. [PMID: 32306836 DOI: 10.1080/07391102.2020.1758788] [Cited by in Crossref: 188] [Cited by in F6Publishing: 166] [Article Influence: 94.0] [Reference Citation Analysis]
468 Mahendiratta S, Batra G, Sarma P, Kumar H, Bansal S, Kumar S, Prakash A, Sehgal R, Medhi B. Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review. Life Sci 2020;258:118207. [PMID: 32777301 DOI: 10.1016/j.lfs.2020.118207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
469 Dey D, Borkotoky S, Banerjee M. In silico identification of Tretinoin as a SARS-CoV-2 envelope (E) protein ion channel inhibitor. Comput Biol Med 2020;127:104063. [PMID: 33126128 DOI: 10.1016/j.compbiomed.2020.104063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
470 Ngo ST. 501Y.V2 spike protein resists the neutralizing antibody in atomistic simulations. Computational Biology and Chemistry 2022;97:107636. [DOI: 10.1016/j.compbiolchem.2022.107636] [Reference Citation Analysis]
471 Priyadarsini AJ, Karan K, Arulselvi S. The Convalescent Plasma Craze! Where Does India Stand? J Lab Physicians 2021;13:183-91. [PMID: 34483567 DOI: 10.1055/s-0041-1730753] [Reference Citation Analysis]
472 McCoy K, Gudapati S, He L, Horlander E, Kartchner D, Kulkarni S, Mehra N, Prakash J, Thenot H, Vanga SV, Wagner A, White B, Mitchell CS. Biomedical Text Link Prediction for Drug Discovery: A Case Study with COVID-19. Pharmaceutics 2021;13:794. [PMID: 34073456 DOI: 10.3390/pharmaceutics13060794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
473 Karakasiliotis I, Lagopati N, Evangelou K, Gorgoulis VG. Cellular senescence as a source of SARS-CoV-2 quasispecies. FEBS J 2021. [PMID: 34653312 DOI: 10.1111/febs.16230] [Reference Citation Analysis]
474 Rafi MO, Al-khafaji K, Sarker MT, Taskin-tok T, Rana AS, Rahman MS. Design of a multi-epitope vaccine against SARS-CoV-2: immunoinformatic and computational methods. RSC Adv 2022;12:4288-310. [DOI: 10.1039/d1ra06532g] [Reference Citation Analysis]
475 Abdelmageed MI, Abdelmoneim AH, Mustafa MI, Elfadol NM, Murshed NS, Shantier SW, Makhawi AM. Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach. Biomed Res Int 2020;2020:2683286. [PMID: 32461973 DOI: 10.1155/2020/2683286] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 28.0] [Reference Citation Analysis]
476 Azeez SA, Alhashim ZG, Al Otaibi WM, Alsuwat HS, Ibrahim AM, Almandil NB, Borgio JF. State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2. Arch Med Sci 2020;16:497-507. [PMID: 32399095 DOI: 10.5114/aoms.2020.94046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
477 Silva Andrade B, Ghosh P, Barh D, Tiwari S, José Santana Silva R, Rodrigues de Assis Soares W, Silva Melo T, Santos Freitas A, González-Grande P, Sousa Palmeira L, Carlos Junior Alcantara L, Giovanetti M, Góes-Neto A, Ariston de Carvalho Azevedo V. Computational screening for potential drug candidates against the SARS-CoV-2 main protease. F1000Res 2020;9:ISCB Comm J-514. [PMID: 33447372 DOI: 10.12688/f1000research.23829.2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
478 Liang C, Hui N, Liu Y, Qiao G, Li J, Tian L, Ju X, Jia M, Liu H, Cao W, Yu P, Li H, Ren X. Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic. Phytomedicine Plus 2021;1:100027. [DOI: 10.1016/j.phyplu.2021.100027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
479 Quilliam RS, Weidmann M, Moresco V, Purshouse H, O'Hara Z, Oliver DM. COVID-19: The environmental implications of shedding SARS-CoV-2 in human faeces. Environ Int 2020;140:105790. [PMID: 32388248 DOI: 10.1016/j.envint.2020.105790] [Cited by in Crossref: 49] [Cited by in F6Publishing: 31] [Article Influence: 24.5] [Reference Citation Analysis]
480 Umthong S, Lynch B, Timilsina U, Waxman B, Ivey EB, Stavrou S. Elucidating the Antiviral Mechanism of Different MARCH Factors. mBio 2021;12:e03264-20. [PMID: 33653895 DOI: 10.1128/mBio.03264-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
481 Rudrapal M, Khairnar SJ, Borse LB, Jadhav AG. Coronavirus Disease-2019 (COVID-19): An Updated Review. Drug Res (Stuttg) 2020;70:389-400. [PMID: 32746481 DOI: 10.1055/a-1217-2397] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
482 Zhou T, Wu Z, Das S, Eslami H, Müller-Plathe F. How Ethanolic Disinfectants Disintegrate Coronavirus Model Membranes: A Dissipative Particle Dynamics Simulation Study. J Chem Theory Comput 2022. [PMID: 35286098 DOI: 10.1021/acs.jctc.1c01120] [Reference Citation Analysis]
483 [DOI: 10.1101/2020.03.14.988345] [Cited by in Crossref: 271] [Cited by in F6Publishing: 48] [Reference Citation Analysis]
484 Prashantha CN, Gouthami K, Lavanya L, Bhavanam S, Jakhar A, Shakthiraju RG, Suraj V, Sahana KV, Sujana HS, Guruprasad NM, Ramachandra R. Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus. J Mol Graph Model 2021;102:107769. [PMID: 33152616 DOI: 10.1016/j.jmgm.2020.107769] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
485 Abdulamir AS, Hafidh RR. The Possible Immunological Pathways for the Variable Immunopathogenesis of COVID—19 Infections among Healthy Adults, Elderly and Children. Electron J Gen Med 2020;17:em202. [DOI: 10.29333/ejgm/7850] [Cited by in Crossref: 68] [Cited by in F6Publishing: 22] [Article Influence: 34.0] [Reference Citation Analysis]
486 Florindo HF, Kleiner R, Vaskovich-Koubi D, Acúrcio RC, Carreira B, Yeini E, Tiram G, Liubomirski Y, Satchi-Fainaro R. Immune-mediated approaches against COVID-19. Nat Nanotechnol 2020;15:630-45. [PMID: 32661375 DOI: 10.1038/s41565-020-0732-3] [Cited by in Crossref: 108] [Cited by in F6Publishing: 107] [Article Influence: 54.0] [Reference Citation Analysis]
487 Alexandrova R, Beykov P, Vassilev D, Jukić M, Podlipnik Č. The virus that shook the world: questions and answers about SARS-CoV-2 and COVID-19. Biotechnology & Biotechnological Equipment 2021;35:74-102. [DOI: 10.1080/13102818.2020.1847683] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
488 Pushparajah D, Jimenez S, Wong S, Alattas H, Nafissi N, Slavcev RA. Advances in gene-based vaccine platforms to address the COVID-19 pandemic. Adv Drug Deliv Rev 2021;170:113-41. [PMID: 33422546 DOI: 10.1016/j.addr.2021.01.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
489 Uludağ H, Parent K, Aliabadi HM, Haddadi A. Prospects for RNAi Therapy of COVID-19. Front Bioeng Biotechnol 2020;8:916. [PMID: 32850752 DOI: 10.3389/fbioe.2020.00916] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
490 Vartak R, Patil SM, Saraswat A, Patki M, Kunda NK, Patel K. Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro. Nanomedicine (Lond) 2021;16:1187-202. [PMID: 33982600 DOI: 10.2217/nnm-2020-0475] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
491 Ehsani S. COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein. Biol Direct 2020;15:19. [PMID: 33066821 DOI: 10.1186/s13062-020-00275-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
492 Rashidzadeh H, Danafar H, Rahimi H, Mozafari F, Salehiabar M, Rahmati MA, Rahamooz-Haghighi S, Mousazadeh N, Mohammadi A, Ertas YN, Ramazani A, Huseynova I, Khalilov R, Davaran S, Webster TJ, Kavetskyy T, Eftekhari A, Nosrati H, Mirsaeidi M. Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives. Nanomedicine (Lond) 2021;16:497-516. [PMID: 33683164 DOI: 10.2217/nnm-2020-0441] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
493 Lin B, Liu J, Liu Y, Qin X. Progress in understanding COVID-19: insights from the omics approach. Crit Rev Clin Lab Sci 2021;58:242-52. [PMID: 33375876 DOI: 10.1080/10408363.2020.1851167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
494 Kratochvil HT, Newberry RW, Mensa B, Mravic M, DeGrado WF. Spiers Memorial Lecture: Analysis and de novo design of membrane-interactive peptides. Faraday Discuss 2021. [PMID: 34693965 DOI: 10.1039/d1fd00061f] [Reference Citation Analysis]
495 Singh D, Joshi K, Samuel A, Patra J, Mahindroo N. Alcohol-based hand sanitisers as first line of defence against SARS-CoV-2: a review of biology, chemistry and formulations. Epidemiol Infect 2020;148:e229. [PMID: 32988431 DOI: 10.1017/S0950268820002319] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
496 Jardim Vaz de Mello L, Guimaraes Silva E, Oliveira Correa Rabelo G, Evaristo Leite M, Vieira NR, Bahadori M, Seifi A, Godoy DA. Neurologic Compromise in COVID-19: A Literature Review. J Neurol Res 2020;10:164-72. [PMID: 33984100 DOI: 10.14740/jnr619] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
497 Janik E, Ceremuga M, Niemcewicz M, Bijak M. Dangerous Pathogens as a Potential Problem for Public Health. Medicina (Kaunas) 2020;56:E591. [PMID: 33172013 DOI: 10.3390/medicina56110591] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
498 Artika IM, Dewantari AK, Wiyatno A. Molecular biology of coronaviruses: current knowledge. Heliyon. 2020;6:e04743. [PMID: 32835122 DOI: 10.1016/j.heliyon.2020.e04743] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
499 Rayan RA. Seasonal variation and COVID-19 infection pattern: A gap from evidence to reality. Curr Opin Environ Sci Health 2021;20:100238. [PMID: 33644502 DOI: 10.1016/j.coesh.2021.100238] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
500 Tawakul AA, Alharbi AH, Basahal AM, Almalki AM, Alharbi B, Almaghrabi M, Imam A. Neurological Symptoms and Complications of COVID-19 Among Patients in a Tertiary Hospital in Saudi Arabia. Cureus 2021;13:e19200. [PMID: 34873535 DOI: 10.7759/cureus.19200] [Reference Citation Analysis]
501 Liu X, Wang XJ. Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines. J Genet Genomics 2020;47:119-21. [PMID: 32173287 DOI: 10.1016/j.jgg.2020.02.001] [Cited by in Crossref: 157] [Cited by in F6Publishing: 167] [Article Influence: 78.5] [Reference Citation Analysis]
502 Kumar D, Batra L, Malik MT. Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment. AIMS Microbiol 2020;6:183-203. [PMID: 33134740 DOI: 10.3934/microbiol.2020013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
503 Heijink IH, Hackett TL, Pouwels SD. Effects of cigarette smoking on SARS-CoV-2 receptor ACE2 expression in the respiratory epithelium. J Pathol 2021;253:351-4. [PMID: 33368245 DOI: 10.1002/path.5607] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
504 Shahid MA, Rahim A, Chowdhury MA, Kashem MA. Development of antibacterial nanofibrous wound dressing and conceptual reaction mechanism to deactivate the viral protein by Nigella sativa extract. ADV TRADIT MED (ADTM). [DOI: 10.1007/s13596-020-00538-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
505 Rahman MS, Hoque MN, Islam MR, Akter S, Rubayet Ul Alam ASM, Siddique MA, Saha O, Rahaman MM, Sultana M, Crandall KA, Hossain MA. Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach. PeerJ 2020;8:e9572. [PMID: 33194329 DOI: 10.7717/peerj.9572] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 17.5] [Reference Citation Analysis]
506 Jakhar R, Gakhar SK. An Immunoinformatics Study to Predict Epitopes in the Envelope Protein of SARS-CoV-2. Can J Infect Dis Med Microbiol 2020;2020:7079356. [PMID: 33299503 DOI: 10.1155/2020/7079356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
507 Gupta SP. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2. Curr Top Med Chem 2020;20:2362-78. [PMID: 32962613 DOI: 10.2174/1568026620666200922112300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
508 Mihaescu G, Chifiriuc MC, Iliescu C, Vrancianu CO, Ditu LM, Marutescu LG, Grigore R, Berteșteanu Ș, Constantin M, Gradisteanu Pircalabioru G. SARS-CoV-2: From Structure to Pathology, Host Immune Response and Therapeutic Management. Microorganisms 2020;8:E1468. [PMID: 32987852 DOI: 10.3390/microorganisms8101468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
509 O'Callahan B, Qafoku O, Balema V, Negrete OA, Passian A, Engelhard MH, Waters KM. Atomic Force Microscopy and Infrared Nanospectroscopy of COVID-19 Spike Protein for the Quantification of Adhesion to Common Surfaces. Langmuir 2021;37:12089-97. [PMID: 34609882 DOI: 10.1021/acs.langmuir.1c01910] [Reference Citation Analysis]
510 Liu C, von Brunn A, Zhu D. Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19. Med Drug Discov 2020;7:100056. [PMID: 32835213 DOI: 10.1016/j.medidd.2020.100056] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
511 Ghaemi F, Amiri A, Bajuri MY, Yuhana NY, Ferrara M. Role of different types of nanomaterials against diagnosis, prevention and therapy of COVID-19. Sustain Cities Soc 2021;72:103046. [PMID: 34055576 DOI: 10.1016/j.scs.2021.103046] [Reference Citation Analysis]
512 Zhang J, Garrett S, Sun J. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19. Genes Dis 2021;8:385-400. [PMID: 33521210 DOI: 10.1016/j.gendis.2020.08.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
513 Wu J, Zha P. Treatment Strategies for Reducing Damages to Lungs In Patients with Coronavirus and Other Infections. SSRN Journal. [DOI: 10.2139/ssrn.3533279] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
514 Das G, Das T, Chowdhury N, Chatterjee D, Bagchi A, Ghosh Z. Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19. Genomics 2021;113:1129-40. [PMID: 33189776 DOI: 10.1016/j.ygeno.2020.11.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
515 Sampson AT, Heeney J, Cantoni D, Ferrari M, Sans MS, George C, Di Genova C, Mayora Neto M, Einhauser S, Asbach B, Wagner R, Baxendale H, Temperton N, Carnell G. Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses. Viruses 2021;13:1579. [PMID: 34452443 DOI: 10.3390/v13081579] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
516 Jena N. Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2. Chemical Physics Impact 2021;2:100011. [DOI: 10.1016/j.chphi.2021.100011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
517 Alam ASMRU, Islam OK, Hasan MS, Islam MR, Mahmud S, Al-Emran HM, Jahid IK, Crandall KA, Hossain MA. Dominant clade-featured SARS-CoV-2 co-occurring mutations reveal plausible epistasis: An in silico based hypothetical model. J Med Virol 2021. [PMID: 34676891 DOI: 10.1002/jmv.27416] [Reference Citation Analysis]
518 Chauhan V, Rungta T, Rawat M, Goyal K, Gupta Y, Singh MP. Excavating SARS-coronavirus 2 genome for epitope-based subunit vaccine synthesis using immunoinformatics approach. J Cell Physiol 2021;236:1131-47. [PMID: 32643158 DOI: 10.1002/jcp.29923] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
519 Rahman MM, Mosaddik A, Alam AK. Traditional foods with their constituent's antiviral and immune system modulating properties. Heliyon 2021;7:e05957. [PMID: 33462562 DOI: 10.1016/j.heliyon.2021.e05957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
520 Gupta MK, Vemula S, Donde R, Gouda G, Behera L, Vadde R. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. J Biomol Struct Dyn 2021;39:2617-27. [PMID: 32238078 DOI: 10.1080/07391102.2020.1751300] [Cited by in Crossref: 78] [Cited by in F6Publishing: 85] [Article Influence: 39.0] [Reference Citation Analysis]
521 Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VYC, Chen H, Mubareka S, Gubbay JB, Chan WCW. Diagnosing COVID-19: The Disease and Tools for Detection. ACS Nano. 2020;14:3822-3835. [PMID: 32223179 DOI: 10.1021/acsnano.0c02624] [Cited by in Crossref: 636] [Cited by in F6Publishing: 511] [Article Influence: 318.0] [Reference Citation Analysis]
522 Bukhari Q, Massaro JM, D'Agostino RB Sr, Khan S. Effects of Weather on Coronavirus Pandemic. Int J Environ Res Public Health 2020;17:E5399. [PMID: 32727067 DOI: 10.3390/ijerph17155399] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
523 Safiabadi Tali SH, LeBlanc JJ, Sadiq Z, Oyewunmi OD, Camargo C, Nikpour B, Armanfard N, Sagan SM, Jahanshahi-Anbuhi S. Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection. Clin Microbiol Rev 2021;34:e00228-20. [PMID: 33980687 DOI: 10.1128/CMR.00228-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
524 S. M, V.r. N, P.s. R, S. RR, L. N. Pervasive computing in the context of COVID-19 prediction with AI-based algorithms. IJPCC 2020;16:477-87. [DOI: 10.1108/ijpcc-07-2020-0082] [Cited by in Crossref: 14] [Article Influence: 7.0] [Reference Citation Analysis]
525 Wang Y, Hao Y, Fa S, Zheng W, Yuan C, Wang W. Nanomedicine for the Diagnosis and Therapy of COVID-19. Front Bioeng Biotechnol 2021;9:758121. [PMID: 34805116 DOI: 10.3389/fbioe.2021.758121] [Reference Citation Analysis]
526 Adusumilli NC, Zhang D, Friedman JM, Friedman AJ. Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19. Nitric Oxide 2020;103:4-8. [PMID: 32681986 DOI: 10.1016/j.niox.2020.07.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
527 Tomar PPS, Krugliak M, Arkin IT. Identification of SARS-CoV-2 E Channel Blockers from a Repurposed Drug Library. Pharmaceuticals (Basel) 2021;14:604. [PMID: 34201587 DOI: 10.3390/ph14070604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
528 Su H, Zhou F, Huang Z, Ma X, Natarajan K, Zhang M, Huang Y, Su H. Molecular Insights into Small-Molecule Drug Discovery for SARS-CoV-2. Angew Chem Int Ed Engl 2021;60:9789-802. [PMID: 32729180 DOI: 10.1002/anie.202008835] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
529 Singh AK, Bhushan B, Maurya A, Mishra G, Singh SK, Awasthi R. Novel coronavirus disease 2019 (COVID-19) and neurodegenerative disorders. Dermatol Ther 2020;33:e13591. [PMID: 32412679 DOI: 10.1111/dth.13591] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
530 Cattel L, Giordano S, Traina S, Lupia T, Corcione S, Angelone L, La Valle G, De Rosa FG, Cattel F. Vaccine development and technology for SARS-CoV-2: Current insight. J Med Virol 2021. [PMID: 34713912 DOI: 10.1002/jmv.27425] [Reference Citation Analysis]
531 Sun Y, Gong L, Yin Y, Zhang L, Sun Q, Feng K, Cui Y, Zhang Q, Zhang X, Deng X, You F, Lu D, Lin Z. A Gradient pH-Sensitive Polymer-Based Antiviral Strategy via Viroporin-Induced Membrane Acidification. Adv Mater 2022;:e2109580. [PMID: 35229371 DOI: 10.1002/adma.202109580] [Reference Citation Analysis]
532 Messina G, Polito R, Monda V, Cipolloni L, Di Nunno N, Di Mizio G, Murabito P, Carotenuto M, Messina A, Pisanelli D, Valenzano A, Cibelli G, Scarinci A, Monda M, Sessa F. Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work. Int J Mol Sci 2020;21:E3104. [PMID: 32354030 DOI: 10.3390/ijms21093104] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 31.0] [Reference Citation Analysis]
533 Stavropoulou E, Bezirtzoglou E. Probiotics in Medicine: A Long Debate. Front Immunol 2020;11:2192. [PMID: 33072084 DOI: 10.3389/fimmu.2020.02192] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
534 Parsa SM. Reliability of thermal desalination (solar stills) for water/wastewater treatment in light of COVID-19 (novel coronavirus "SARS-CoV-2") pandemic: What should consider? Desalination 2021;512:115106. [PMID: 33967299 DOI: 10.1016/j.desal.2021.115106] [Cited by in Crossref: 12] [Article Influence: 12.0] [Reference Citation Analysis]
535 Miserey-Lenkei S, Trajkovic K, D'Ambrosio JM, Patel AJ, Čopič A, Mathur P, Schauer K, Goud B, Albanèse V, Gautier R, Subra M, Kovacs D, Barelli H, Antonny B. A comprehensive library of fluorescent constructs of SARS-CoV-2 proteins and their initial characterisation in different cell types. Biol Cell 2021;113:311-28. [PMID: 33666950 DOI: 10.1111/boc.202000158] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
536 Mukherjee TK, Malik P, Maitra R, Hoidal JR. Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses. Curr Med Res Opin 2021;37:207-17. [PMID: 33306409 DOI: 10.1080/03007995.2020.1862532] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
537 Xian Y, Zhang J, Bian Z, Zhou H, Zhang Z, Lin Z, Xu H. Bioactive natural compounds against human coronaviruses: a review and perspective. Acta Pharm Sin B 2020;10:1163-74. [PMID: 32834947 DOI: 10.1016/j.apsb.2020.06.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 23.5] [Reference Citation Analysis]
538 Dastar S, Gharesouran J, Mortazavi D, Hosseinzadeh H, Kian SJ, Taheri M, Ghafouri-Fard S, Jamali E, Rezazadeh M. COVID-19 pandemic: Insights into genetic susceptibility to SARS-CoV-2 and host genes implications on virus spread, disease severity and outcomes. Hum Antibodies 2021. [PMID: 34864654 DOI: 10.3233/HAB-211506] [Reference Citation Analysis]
539 Ngo ST, Tam NM, Pham MQ, Nguyen TH. Benchmark of Popular Free Energy Approaches Revealing the Inhibitors Binding to SARS-CoV-2 Mpro. J Chem Inf Model 2021;61:2302-12. [PMID: 33829781 DOI: 10.1021/acs.jcim.1c00159] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
540 Akhand MRN, Azim KF, Hoque SF, Moli MA, Joy BD, Akter H, Afif IK, Ahmed N, Hasan M. Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine. Infect Genet Evol 2020;85:104517. [PMID: 32882432 DOI: 10.1016/j.meegid.2020.104517] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
541 Viana SD, Nunes S, Reis F. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis. Ageing Res Rev. 2020;62:101123. [PMID: 32683039 DOI: 10.1016/j.arr.2020.101123] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 18.5] [Reference Citation Analysis]
542 Khiali S, Khani E, Entezari-Maleki T. A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome. J Clin Pharmacol 2020;60:1131-46. [PMID: 32557541 DOI: 10.1002/jcph.1693] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
543 Tufan A, Avanoğlu Güler A, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci 2020;50:620-32. [PMID: 32299202 DOI: 10.3906/sag-2004-168] [Cited by in Crossref: 169] [Cited by in F6Publishing: 152] [Article Influence: 84.5] [Reference Citation Analysis]
544 Suri S, Vandersluis YR, Kochhar AS, Bhasin R, Abdallah MN. Clinical orthodontic management during the COVID-19 pandemic. Angle Orthod 2020;90:473-84. [PMID: 32396601 DOI: 10.2319/033120-236.1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 30.0] [Reference Citation Analysis]
545 Carmona-Gutierrez D, Bauer MA, Zimmermann A, Kainz K, Hofer SJ, Kroemer G, Madeo F. Digesting the crisis: autophagy and coronaviruses. Microb Cell 2020;7:119-28. [PMID: 32391393 DOI: 10.15698/mic2020.05.715] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 20.0] [Reference Citation Analysis]
546 Das S, Meinel MK, Wu Z, Müller-Plathe F. The role of the envelope protein in the stability of a coronavirus model membrane against an ethanolic disinfectant. J Chem Phys 2021;154:245101. [PMID: 34241335 DOI: 10.1063/5.0055331] [Reference Citation Analysis]
547 Wong KK, Lee SWH, Kua KP. N-Acetylcysteine as Adjuvant Therapy for COVID-19 - A Perspective on the Current State of the Evidence. J Inflamm Res 2021;14:2993-3013. [PMID: 34262324 DOI: 10.2147/JIR.S306849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
548 Fraternale A, Zara C, De Angelis M, Nencioni L, Palamara AT, Retini M, Di Mambro T, Magnani M, Crinelli R. Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral Infection. Int J Mol Sci 2021;22:3603. [PMID: 33808471 DOI: 10.3390/ijms22073603] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
549 Ma M, Yang Y, Wu L, Zhou L, Shi Y, Han J, Xu Z, Zhu W. Conserved protein targets for developing pan-coronavirus drugs based on sequence and 3D structure similarity analyses. Comput Biol Med 2022;145:105455. [PMID: 35364304 DOI: 10.1016/j.compbiomed.2022.105455] [Reference Citation Analysis]
550 Kapoor S, Subba P. Predicted peptide patterns from the SARS-CoV-2 proteome for MS-MS based diagnosis. Bioinformation 2020;16:477-82. [PMID: 32884213 DOI: 10.6026/97320630016477] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
551 Puray-Chavez M, LaPak KM, Schrank TP, Elliott JL, Bhatt DP, Agajanian MJ, Jasuja R, Lawson DQ, Davis K, Rothlauf PW, Jo H, Lee N, Tenneti K, Eschbach JE, Mugisha CS, Vuong HR, Bailey AL, Hayes DN, Whelan SPJ, Horani A, Brody SL, Goldfarb D, Major MB, Kutluay SB. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell. bioRxiv 2021:2021. [PMID: 33688646 DOI: 10.1101/2021.03.01.433431] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
552 Khodavirdipour A, Jabbari S, Keramat F, Alikhani MY. Concise Update on Genomics of COVID-19: Approach to Its latest Mutations, Escalated Contagiousness, and Vaccine Resistance. Glob Med Genet 2021;8:85-9. [PMID: 34430958 DOI: 10.1055/s-0041-1725143] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
553 Mahnam K, Ghobadi Z. Finding a prospective dual-target drug for the treatment of coronavirus disease by theoretical study. J Biomol Struct Dyn 2021;:1-21. [PMID: 34514953 DOI: 10.1080/07391102.2021.1973910] [Reference Citation Analysis]
554 Zhang J, Xie B, Hashimoto K. Current status of potential therapeutic candidates for the COVID-19 crisis. Brain Behav Immun 2020;87:59-73. [PMID: 32334062 DOI: 10.1016/j.bbi.2020.04.046] [Cited by in Crossref: 111] [Cited by in F6Publishing: 100] [Article Influence: 55.5] [Reference Citation Analysis]
555 Achak M, Alaoui Bakri S, Chhiti Y, M'hamdi Alaoui FE, Barka N, Boumya W. SARS-CoV-2 in hospital wastewater during outbreak of COVID-19: A review on detection, survival and disinfection technologies. Sci Total Environ 2021;761:143192. [PMID: 33153744 DOI: 10.1016/j.scitotenv.2020.143192] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
556 Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, Behavior, and Immunity 2020;87:18-22. [DOI: 10.1016/j.bbi.2020.03.031] [78495111110.1016/j.bbi.2020.03.031','', '1007-9327')">Reference Citation Analysis]
557 Dutta A, Roy A, Roy L, Chattopadhyay S, Chatterjee S. Immune response and possible therapeutics in COVID-19. RSC Adv 2021;11:960-77. [DOI: 10.1039/d0ra08901j] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
558 Bianchi M, Benvenuto D, Giovanetti M, Angeletti S, Ciccozzi M, Pascarella S. Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics? Biomed Res Int 2020;2020:4389089. [PMID: 32596311 DOI: 10.1155/2020/4389089] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 31.0] [Reference Citation Analysis]
559 Samudrala PK, Kumar P, Choudhary K, Thakur N, Wadekar GS, Dayaramani R, Agrawal M, Alexander A. Virology, pathogenesis, diagnosis and in-line treatment of COVID-19. Eur J Pharmacol 2020;883:173375. [PMID: 32682788 DOI: 10.1016/j.ejphar.2020.173375] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
560 Khurana P, Gupta A, Sugadev R, Sharma YK, Varshney R, Ganju L, Kumar B. nSARS-Cov-2, pulmonary edema and thrombosis: possible molecular insights using miRNA-gene circuits in regulatory networks. ExRNA 2020;2:16. [PMID: 33209992 DOI: 10.1186/s41544-020-00057-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
561 Ghaffari S, Roshanravan N, Tutunchi H, Ostadrahimi A, Pouraghaei M, Kafil B. Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19. Arch Med Res 2020;51:464-7. [PMID: 32327293 DOI: 10.1016/j.arcmed.2020.04.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
562 Kim E, Weisel FJ, Balmert SC, Khan MS, Huang S, Erdos G, Kenniston TW, Carey CD, Joachim SM, Conter LJ, Weisel NM, Okba NMA, Haagmans BL, Percivalle E, Cassaniti I, Baldanti F, Korkmaz E, Shlomchik MJ, Falo LD Jr, Gambotto A. A single subcutaneous or intranasal immunization with adenovirus-based SARS-CoV-2 vaccine induces robust humoral and cellular immune responses in mice. Eur J Immunol 2021;51:1774-84. [PMID: 33772778 DOI: 10.1002/eji.202149167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
563 Tripathy S, Verma DK, Thakur M, Patel AR, Srivastav PP, Singh S, Gupta AK, Chávez-González ML, Aguilar CN, Chakravorty N, Verma HK, Utama GL. Curcumin Extraction, Isolation, Quantification and Its Application in Functional Foods: A Review With a Focus on Immune Enhancement Activities and COVID-19. Front Nutr 2021;8:747956. [PMID: 34621776 DOI: 10.3389/fnut.2021.747956] [Reference Citation Analysis]
564 Sakr MM, Elsayed NS, El-Housseiny GS. Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review. Microb Pathog 2021;154:104809. [PMID: 33647446 DOI: 10.1016/j.micpath.2021.104809] [Reference Citation Analysis]
565 Malkani N, Rashid MU. SARS-COV-2 infection and lung tumor microenvironment. Mol Biol Rep 2021;48:1925-34. [PMID: 33486674 DOI: 10.1007/s11033-021-06149-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
566 Zhou YW, Xie Y, Tang LS, Pu D, Zhu YJ, Liu JY, Ma XL. Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. Signal Transduct Target Ther 2021;6:317. [PMID: 34446699 DOI: 10.1038/s41392-021-00733-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
567 Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, Ganesan S, Venugopal A, Venkatesan D, Ganesan H, Rajagopalan K, Rahman PKSM, Cho SG, Kumar NS, Subramaniam MD. COVID-19: A promising cure for the global panic. Sci Total Environ 2020;725:138277. [PMID: 32278175 DOI: 10.1016/j.scitotenv.2020.138277] [Cited by in Crossref: 225] [Cited by in F6Publishing: 177] [Article Influence: 112.5] [Reference Citation Analysis]
568 Menzella F, Matucci A, Vultaggio A, Barbieri C, Biava M, Scelfo C, Fontana M, Facciolongo NC. COVID-19: general overview, pharmacological options and ventilatory support strategies. Multidiscip Respir Med 2020;15:708. [PMID: 33282284 DOI: 10.4081/mrm.2020.708] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
569 Mothay D, Ramesh KV. Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock. Virusdisease 2020;:1-6. [PMID: 32363219 DOI: 10.1007/s13337-020-00585-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 12.5] [Reference Citation Analysis]
570 Vicidomini C, Roviello V, Roviello GN. Molecular Basis of the Therapeutical Potential of Clove (Syzygium aromaticum L.) and Clues to Its Anti-COVID-19 Utility. Molecules 2021;26:1880. [PMID: 33810416 DOI: 10.3390/molecules26071880] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
571 Khan T, Khan A, Ansari JK, Najmi MH, Wei DQ, Muhammad K, Waheed Y. Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach. Molecules 2022;27:2375. [PMID: 35408772 DOI: 10.3390/molecules27072375] [Reference Citation Analysis]
572 Law WY, Asaruddin MR, Bhawani SA, Mohamad S. Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as MPro inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). BMC Res Notes 2020;13:527. [PMID: 33176880 DOI: 10.1186/s13104-020-05379-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
573 Shadeed S, Alawna S. GIS-based COVID-19 vulnerability mapping in the West Bank, Palestine. Int J Disaster Risk Reduct 2021;64:102483. [PMID: 34312591 DOI: 10.1016/j.ijdrr.2021.102483] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
574 Kumar SU, Priya NM, Nithya SR, Kannan P, Jain N, Kumar DT, Magesh R, Younes S, Zayed H, Doss CGP. A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing. 3 Biotech 2021;11:198. [PMID: 33816047 DOI: 10.1007/s13205-021-02749-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
575 Tam NM, Nam PC, Quang DT, Tung NT, Vu VV, Ngo ST. Binding of inhibitors to the monomeric and dimeric SARS-CoV-2 Mpro. RSC Adv 2021;11:2926-34. [DOI: 10.1039/d0ra09858b] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
576 Zhou R, Zeng R, von Brunn A, Lei J. Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein. Mol Biomed 2020;1. [DOI: 10.1186/s43556-020-00001-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
577 Jawad B, Adhikari P, Podgornik R, Ching WY. Key Interacting Residues between RBD of SARS-CoV-2 and ACE2 Receptor: Combination of Molecular Dynamics Simulation and Density Functional Calculation. J Chem Inf Model 2021;61:4425-41. [PMID: 34428371 DOI: 10.1021/acs.jcim.1c00560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
578 Malek Mahdavi A. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19. Rev Med Virol 2020;30:e2119. [PMID: 32584474 DOI: 10.1002/rmv.2119] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 15.0] [Reference Citation Analysis]
579 Zeng C, Hou X, Yan J, Zhang C, Li W, Zhao W, Du S, Dong Y. Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo. bioRxiv 2020:2020. [PMID: 32511313 DOI: 10.1101/2020.04.01.019877] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 6.5] [Reference Citation Analysis]
580 Rowan NJ, Laffey JG. Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic - Case study from the Republic of Ireland. Sci Total Environ 2020;725:138532. [PMID: 32304970 DOI: 10.1016/j.scitotenv.2020.138532] [Cited by in Crossref: 141] [Cited by in F6Publishing: 104] [Article Influence: 70.5] [Reference Citation Analysis]
581 He W, Chen Q. [Progress in source tracking of SARS-CoV-2]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1838-42. [PMID: 33380405 DOI: 10.12122/j.issn.1673-4254.2020.12.22] [Reference Citation Analysis]
582 Bhattacharya S, Banerjee A, Ray S. Development of new vaccine target against SARS-CoV2 using envelope (E) protein: An evolutionary, molecular modeling and docking based study. Int J Biol Macromol 2021;172:74-81. [PMID: 33385461 DOI: 10.1016/j.ijbiomac.2020.12.192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
583 Zhou M, Han Y, Li M, Ye G, Peng G. Two Inhibitors Against the 3C-Like Proteases of Swine Coronavirus and Feline Coronavirus. Virol Sin 2021. [PMID: 34228261 DOI: 10.1007/s12250-021-00415-6] [Reference Citation Analysis]
584 Schoeman D, Fielding BC. Is There a Link Between the Pathogenic Human Coronavirus Envelope Protein and Immunopathology? A Review of the Literature. Front Microbiol 2020;11:2086. [PMID: 33013759 DOI: 10.3389/fmicb.2020.02086] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
585 Yu A, Pak AJ, He P, Monje-Galvan V, Casalino L, Gaieb Z, Dommer AC, Amaro RE, Voth GA. A multiscale coarse-grained model of the SARS-CoV-2 virion. Biophys J 2021;120:1097-104. [PMID: 33253634 DOI: 10.1016/j.bpj.2020.10.048] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 13.5] [Reference Citation Analysis]
586 Zhang Q, Guo H, Wang J, Zhang Y, Deng P, Li F. Structural Genomic Analysis of SARS-CoV-2 and Other Coronaviruses. Front Genet 2022;13:801902. [DOI: 10.3389/fgene.2022.801902] [Reference Citation Analysis]
587 Yin J, Li C, Ye C, Ruan Z, Liang Y, Li Y, Wu J, Luo Z. Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.01.026] [Reference Citation Analysis]
588 Qaswal AB, Suleiman A, Guzu H, Harb T, Atiyat B. The Potential Role of Lithium as an Antiviral Agent against SARS-CoV-2 via Membrane Depolarization: Review and Hypothesis. Sci Pharm 2021;89:11. [DOI: 10.3390/scipharm89010011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
589 Hasöksüz M, Kiliç S, Saraç F. Coronaviruses and SARS-COV-2. Turk J Med Sci 2020;50:549-56. [PMID: 32293832 DOI: 10.3906/sag-2004-127] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 26.0] [Reference Citation Analysis]
590 Hassan SS, Choudhury PP, Roy B. SARS-CoV2 envelope protein: non-synonymous mutations and its consequences. Genomics 2020;112:3890-2. [PMID: 32640274 DOI: 10.1016/j.ygeno.2020.07.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
591 Shepley-McTaggart A, Sagum CA, Oliva I, Rybakovsky E, DiGuilio K, Liang J, Bedford MT, Cassel J, Sudol M, Mullin JM, Harty RN. SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1. PLoS One 2021;16:e0251955. [PMID: 34106957 DOI: 10.1371/journal.pone.0251955] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
592 Zhang D, Duran SSF, Lim WYS, Tan CKI, Cheong WCD, Suwardi A, Loh XJ. SARS-CoV-2 in wastewater: From detection to evaluation. Materials Today Advances 2022;13:100211. [DOI: 10.1016/j.mtadv.2022.100211] [Reference Citation Analysis]
593 Cariani L, Orena BS, Ambrogi F, Gambazza S, Maraschini A, Dodaro A, Oggioni M, Orlandi A, Pirrone A, Uceda Renteria S, Bernazzani M, Cantù AP, Ceriotti F, Lunghi G. Time Length of Negativization and Cycle Threshold Values in 182 Healthcare Workers with Covid-19 in Milan, Italy: An Observational Cohort Study. Int J Environ Res Public Health 2020;17:E5313. [PMID: 32718008 DOI: 10.3390/ijerph17155313] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
594 Singh P, Mishra N, Singh N, Nisha R, Pal RR, Singh S, Maurya P, Saraf SA. Credible Protein Targets and Curative Strategies for COVID-19: a Review. SN Compr Clin Med 2020;:1-10. [PMID: 33015546 DOI: 10.1007/s42399-020-00526-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
595 Chilamakuri R, Agarwal S. COVID-19: Characteristics and Therapeutics. Cells 2021;10:206. [PMID: 33494237 DOI: 10.3390/cells10020206] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 27.0] [Reference Citation Analysis]
596 Sun YS, Xu F, An Q, Chen C, Yang ZN, Lu HJ, Chen JC, Yao PP, Jiang JM, Zhu HP. A SARS-CoV-2 variant with the 12-bp deletion at E gene. Emerg Microbes Infect 2020;9:2361-7. [PMID: 33118859 DOI: 10.1080/22221751.2020.1837017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
597 Benny R, Khadilkar SV. COVID 19: Neuromuscular Manifestations. Ann Indian Acad Neurol 2020;23:S40-2. [PMID: 32419753 DOI: 10.4103/aian.AIAN_309_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
598 Zhang C, Jin X, Chen X, Qiu L, Leng Q, Qiu T. Antigenic Evolution on a Global Scale Reveals the Potential Natural Selection of Severe Acute Respiratory Syndrome-Coronavirus 2 by Pre-existing Cross-Reactive T-Cell Immunity. Front Microbiol 2021;12:599562. [PMID: 34093454 DOI: 10.3389/fmicb.2021.599562] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
599 Heffron J, Mayer BK. Virus Isoelectric Point Estimation: Theories and Methods. Appl Environ Microbiol 2021;87:e02319-20. [PMID: 33188001 DOI: 10.1128/AEM.02319-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
600 Hassan Z, Kumar ND, Reggiori F, Khan G. How Viruses Hijack and Modify the Secretory Transport Pathway. Cells 2021;10:2535. [PMID: 34685515 DOI: 10.3390/cells10102535] [Reference Citation Analysis]
601 Shakoor H, Feehan J, Mikkelsen K, Al Dhaheri AS, Ali HI, Platat C, Ismail LC, Stojanovska L, Apostolopoulos V. Be well: A potential role for vitamin B in COVID-19.Maturitas. 2021;144:108-111. [PMID: 32829981 DOI: 10.1016/j.maturitas.2020.08.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
602 Güler G, Özdemir H, Omar D, Akdoğan G. Coronavirus disease 2019 (COVID-19): Biophysical and biochemical aspects of SARS-CoV-2 and general characteristics. Prog Biophys Mol Biol 2021;164:3-18. [PMID: 34033836 DOI: 10.1016/j.pbiomolbio.2021.05.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
603 Shin MD, Shukla S, Chung YH, Beiss V, Chan SK, Ortega-rivera OA, Wirth DM, Chen A, Sack M, Pokorski JK, Steinmetz NF. COVID-19 vaccine development and a potential nanomaterial path forward. Nat Nanotechnol 2020;15:646-55. [DOI: 10.1038/s41565-020-0737-y] [Cited by in Crossref: 197] [Cited by in F6Publishing: 172] [Article Influence: 98.5] [Reference Citation Analysis]
604 Yadav D, Agarwal S, Pancham P, Jindal D, Agarwal V, Dubey PK, Jha SK, Mani S, Rachana, Dey A, Jha NK, Kesari KK, Singh M. Probing the Immune System Dynamics of the COVID-19 Disease for Vaccine Designing and Drug Repurposing Using Bioinformatics Tools. Immuno 2022;2:344-71. [DOI: 10.3390/immuno2020022] [Reference Citation Analysis]
605 Ahirwar R, Gandhi S, Komal K, Dhaniya G, Tripathi PP, Shingatgeri VM, Kumar K, Sharma JG, Kumar S. Biochemical composition, transmission and diagnosis of SARS-CoV-2. Biosci Rep 2021;41:BSR20211238. [PMID: 34291285 DOI: 10.1042/BSR20211238] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
606 Kumar M, Al Khodor S. Pathophysiology and treatment strategies for COVID-19. J Transl Med 2020;18:353. [PMID: 32933536 DOI: 10.1186/s12967-020-02520-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
607 Yan W, Zheng Y, Zeng X, He B, Cheng W. Structural biology of SARS-CoV-2: open the door for novel therapies. Signal Transduct Target Ther 2022;7:26. [PMID: 35087058 DOI: 10.1038/s41392-022-00884-5] [Reference Citation Analysis]
608 Pyrillou K, Burzynski LC, Clarke MCH. Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease. Front Immunol 2020;11:613170. [PMID: 33391283 DOI: 10.3389/fimmu.2020.613170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
609 Jorge-Aarón RM, Rosa-Ester MP. N-acetylcysteine as a potential treatment for COVID-19. Future Microbiol 2020;15:959-62. [PMID: 32662664 DOI: 10.2217/fmb-2020-0074] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
610 Menzella F, Biava M, Barbieri C, Livrieri F, Facciolongo N. Pharmacologicaltreatment of COVID-19: lights and shadows. Drugs Context 2020;9:2020-4-6. [PMID: 32499832 DOI: 10.7573/dic.2020-4-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
611 Fallahi HR, Keyhan SO, Zandian D, Kim SG, Cheshmi B. Being a front-line dentist during the Covid-19 pandemic: a literature review. Maxillofac Plast Reconstr Surg 2020;42:12. [PMID: 32341913 DOI: 10.1186/s40902-020-00256-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 37] [Article Influence: 27.5] [Reference Citation Analysis]
612 Al Noman A, Islam MS, Sana S, Mondal P, Meem RI, Rana S, Mondol D, Sana M, Hossain SI, Joarder T, Mazumder K. A review of the genome, epidemiology, clinical features, prevention, and treatment scenario of COVID-19: Bangladesh aspects. Egypt J Bronchol 2021;15. [DOI: 10.1186/s43168-021-00053-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
613 Sompornpisut P, Pandey RB. Self-Organized Morphology and Multiscale Structures of CoVE Proteins. JOM (1989) 2021;:1-9. [PMID: 34075288 DOI: 10.1007/s11837-021-04711-0] [Reference Citation Analysis]
614 Ghidoli M, Colombo F, Sangiorgio S, Landoni M, Giupponi L, Nielsen E, Pilu R. Food Containing Bioactive Flavonoids and Other Phenolic or Sulfur Phytochemicals With Antiviral Effect: Can We Design a Promising Diet Against COVID-19? Front Nutr 2021;8:661331. [PMID: 34222300 DOI: 10.3389/fnut.2021.661331] [Reference Citation Analysis]
615 Segreto R, Deigin Y. The genetic structure of SARS-CoV-2 does not rule out a laboratory origin: SARS-CoV-2 chimeric structure and furin cleavage site might be the result of genetic manipulation. Bioessays. 2021;43:e2000240. [PMID: 33200842 DOI: 10.1002/bies.202000240] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
616 Wu X, Manickam S, Wu T, Pang CH. Insights into the Role of Graphene/Graphene‐hybrid Nanocomposites in Antiviral Therapy. CBEN 2021;8:549-63. [DOI: 10.1002/cben.202100018] [Reference Citation Analysis]
617 Mani JS, Johnson JB, Steel JC, Broszczak DA, Neilsen PM, Walsh KB, Naiker M. Natural product-derived phytochemicals as potential agents against coronaviruses: A review.Virus Res. 2020;284:197989. [PMID: 32360300 DOI: 10.1016/j.virusres.2020.197989] [Cited by in Crossref: 127] [Cited by in F6Publishing: 108] [Article Influence: 63.5] [Reference Citation Analysis]
618 Kumar S, Maurya VK, Prasad AK, Bhatt MLB, Saxena SK. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). Virusdisease. 2020;31:13-21. [PMID: 32206694 DOI: 10.1007/s13337-020-00571-5] [Cited by in Crossref: 92] [Cited by in F6Publishing: 82] [Article Influence: 46.0] [Reference Citation Analysis]
619 Singh DD, Han I, Choi EH, Yadav DK. Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2. Front Cell Dev Biol 2020;8:580202. [PMID: 33240881 DOI: 10.3389/fcell.2020.580202] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
620 Laskar P, Yallapu MM, Chauhan SC. "Tomorrow Never Dies": Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies. Diseases 2020;8:E30. [PMID: 32781617 DOI: 10.3390/diseases8030030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
621 Rodrigues-Diez RR, Tejera-Muñoz A, Marquez-Exposito L, Rayego-Mateos S, Santos Sanchez L, Marchant V, Tejedor Santamaria L, Ramos AM, Ortiz A, Egido J, Ruiz-Ortega M. Statins: Could an old friend help in the fight against COVID-19? Br J Pharmacol 2020;177:4873-86. [PMID: 32562276 DOI: 10.1111/bph.15166] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 23.0] [Reference Citation Analysis]
622 Adhikari N, Amin SA, Jha T. Dissecting the Drug Development Strategies Against SARS-CoV-2 Through Diverse Computational Modeling Techniques. New York: Springer US; 2020. [DOI: 10.1007/7653_2020_46] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
623 Liu B, Li M, Zhou Z, Guan X, Xiang Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J Autoimmun 2020;111:102452. [PMID: 32291137 DOI: 10.1016/j.jaut.2020.102452] [Cited by in Crossref: 311] [Cited by in F6Publishing: 293] [Article Influence: 155.5] [Reference Citation Analysis]
624 Shahrajabian MH, Sun W, Cheng Q. Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2. Hum Vaccin Immunother 2021;17:62-83. [PMID: 32783700 DOI: 10.1080/21645515.2020.1797369] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
625 Heustess AM, Allard MA, Thompson DK, Fasinu PS. Clinical Management of COVID-19: A Review of Pharmacological Treatment Options. Pharmaceuticals (Basel) 2021;14:520. [PMID: 34071185 DOI: 10.3390/ph14060520] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
626 Mishra SK, Tripathi T. One year update on the COVID-19 pandemic: Where are we now? Acta Trop 2021;214:105778. [PMID: 33253656 DOI: 10.1016/j.actatropica.2020.105778] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
627 Dos Santos WG. Natural history of COVID-19 and current knowledge on treatment therapeutic options. Biomed Pharmacother 2020;129:110493. [PMID: 32768971 DOI: 10.1016/j.biopha.2020.110493] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 18.0] [Reference Citation Analysis]
628 Astuti I, Ysrafil. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr 2020;14:407-12. [PMID: 32335367 DOI: 10.1016/j.dsx.2020.04.020] [Cited by in Crossref: 368] [Cited by in F6Publishing: 321] [Article Influence: 184.0] [Reference Citation Analysis]
629 Bai C, Zhong Q, Gao GF. Overview of SARS-CoV-2 genome-encoded proteins. Sci China Life Sci 2021. [PMID: 34387838 DOI: 10.1007/s11427-021-1964-4] [Reference Citation Analysis]
630 [DOI: 10.1101/2020.03.12.20034728] [Cited by in Crossref: 91] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
631 Zhang Y, Hu M, Wang J, Wang P, Shi P, Zhao W, Liu X, Peng Q, Meng B, Feng X, Zhang L. A Bibliometric Analysis of Personal Protective Equipment and COVID-19 Researches. Front Public Health 2022;10:855633. [DOI: 10.3389/fpubh.2022.855633] [Reference Citation Analysis]
632 Tombuloglu H, Sabit H, Al-Suhaimi E, Al Jindan R, Alkharsah KR. Development of multiplex real-time RT-PCR assay for the detection of SARS-CoV-2. PLoS One 2021;16:e0250942. [PMID: 33914804 DOI: 10.1371/journal.pone.0250942] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
633 Hassanzadeganroudsari M, Ahmadi AH, Rashidi N, Hossain MK, Habib A, Apostolopoulos V. Computational Chemistry to Repurposing Drugs for the Control of COVID-19. Biologics 2021;1:111-28. [DOI: 10.3390/biologics1020007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
634 Antony P, Vijayan R. Role of SARS-CoV-2 and ACE2 variations in COVID-19. Biomed J 2021;44:235-44. [PMID: 34193390 DOI: 10.1016/j.bj.2021.04.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
635 Fakhri S, Piri S, Majnooni MB, Farzaei MH, Echeverría J. Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach. Front Pharmacol 2020;11:621099. [PMID: 33708124 DOI: 10.3389/fphar.2020.621099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
636 Ceraolo C, Giorgi FM. Genomic variance of the 2019-nCoV coronavirus. J Med Virol. 2020;. [PMID: 32027036 DOI: 10.1002/jmv.25700] [Cited by in Crossref: 209] [Cited by in F6Publishing: 181] [Article Influence: 104.5] [Reference Citation Analysis]
637 Kumar A, Singh R, Kaur J, Pandey S, Sharma V, Thakur L, Sati S, Mani S, Asthana S, Sharma TK, Chaudhuri S, Bhattacharyya S, Kumar N. Wuhan to World: The COVID-19 Pandemic. Front Cell Infect Microbiol 2021;11:596201. [PMID: 33859951 DOI: 10.3389/fcimb.2021.596201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
638 Khan MI, Khan ZA, Baig MH, Ahmad I, Farouk AE, Song YG, Dong JJ. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight. PLoS One 2020;15:e0238344. [PMID: 32881907 DOI: 10.1371/journal.pone.0238344] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 18.5] [Reference Citation Analysis]
639 Karimi L, Sales C, Crewther SG, Wijeratne T. Acute Ischemic Stroke in SARS-CoV, MERS-CoV, SARS-CoV-2: Neurorehabilitation Implications of Inflammation Induced Immunological Responses Affecting Vascular Systems. Front Neurol 2020;11:565665. [PMID: 33414753 DOI: 10.3389/fneur.2020.565665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
640 Santana FPR, Thevenard F, Gomes KS, Taguchi L, Câmara NOS, Stilhano RS, Ureshino RP, Prado CM, Lago JHG. New perspectives on natural flavonoids on COVID-19-induced lung injuries. Phytother Res 2021. [PMID: 33928690 DOI: 10.1002/ptr.7131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
641 Diniz LRL, Bezerra Filho CDSM, Fielding BC, de Sousa DP. Natural Antioxidants: A Review of Studies on Human and Animal Coronavirus. Oxid Med Cell Longev 2020;2020:3173281. [PMID: 32855764 DOI: 10.1155/2020/3173281] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
642 Stavropoulou E, Bezirtzoglou E. Probiotics as a Weapon in the Fight Against COVID-19. Front Nutr 2020;7:614986. [PMID: 33385008 DOI: 10.3389/fnut.2020.614986] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
643 Satarker S, Nampoothiri M. Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2. Arch Med Res. 2020;51:482-491. [PMID: 32493627 DOI: 10.1016/j.arcmed.2020.05.012] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 41.0] [Reference Citation Analysis]
644 Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: The status and perspectives in delivery points of view. Adv Drug Deliv Rev 2021;170:1-25. [PMID: 33359141 DOI: 10.1016/j.addr.2020.12.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 20.0] [Reference Citation Analysis]
645 Khedri M, Maleki R, Dahri M, Sadeghi MM, Rezvantalab S, Santos HA, Shahbazi MA. Engineering of 2D nanomaterials to trap and kill SARS-CoV-2: a new insight from multi-microsecond atomistic simulations. Drug Deliv Transl Res 2021. [PMID: 34476766 DOI: 10.1007/s13346-021-01054-w] [Reference Citation Analysis]
646 Wartecki A, Rzymski P. On the Coronaviruses and Their Associations with the Aquatic Environment and Wastewater. Water 2020;12:1598. [DOI: 10.3390/w12061598] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 8.5] [Reference Citation Analysis]
647 D'Aoust PM, Graber TE, Mercier E, Montpetit D, Alexandrov I, Neault N, Baig AT, Mayne J, Zhang X, Alain T, Servos MR, Srikanthan N, MacKenzie M, Figeys D, Manuel D, Jüni P, MacKenzie AE, Delatolla R. Catching a resurgence: Increase in SARS-CoV-2 viral RNA identified in wastewater 48 h before COVID-19 clinical tests and 96 h before hospitalizations. Sci Total Environ 2021;770:145319. [PMID: 33508669 DOI: 10.1016/j.scitotenv.2021.145319] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 31.0] [Reference Citation Analysis]
648 Khulood D, Adil MS, Sultana R, Nimra. Convalescent plasma appears efficacious and safe in COVID-19. Ther Adv Infect Dis 2020;7:2049936120957931. [PMID: 33062267 DOI: 10.1177/2049936120957931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
649 Machhi J, Herskovitz J, Senan AM, Dutta D, Nath B, Oleynikov MD, Blomberg WR, Meigs DD, Hasan M, Patel M, Kline P, Chang RC, Chang L, Gendelman HE, Kevadiya BD. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. J Neuroimmune Pharmacol. 2020;15:359-386. [PMID: 32696264 DOI: 10.1007/s11481-020-09944-5] [Cited by in Crossref: 104] [Cited by in F6Publishing: 105] [Article Influence: 52.0] [Reference Citation Analysis]
650 Lee CY, Lin RTP, Renia L, Ng LFP. Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control. Front Immunol 2020;11:879. [PMID: 32391022 DOI: 10.3389/fimmu.2020.00879] [Cited by in Crossref: 130] [Cited by in F6Publishing: 109] [Article Influence: 65.0] [Reference Citation Analysis]
651 Gorkhali R, Koirala P, Rijal S, Mainali A, Baral A, Bhattarai HK. Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins. Bioinform Biol Insights 2021;15:11779322211025876. [PMID: 34220199 DOI: 10.1177/11779322211025876] [Reference Citation Analysis]
652 Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18-22. [PMID: 32240762 DOI: 10.1016/j.bbi.2020.03.031] [Cited by in Crossref: 639] [Cited by in F6Publishing: 633] [Article Influence: 319.5] [Reference Citation Analysis]
653 Olwenyi OA, Dyavar SR, Acharya A, Podany AT, Fletcher CV, Ng CL, Reid SP, Byrareddy SN. Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19). J Mol Med (Berl) 2020;98:1369-83. [PMID: 32808094 DOI: 10.1007/s00109-020-01961-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
654 Murugesan S, Kottekad S, Crasta I, Sreevathsan S, Usharani D, Perumal MK, Mudliar SN. Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants - Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) - A molecular docking and simulation study. Comput Biol Med 2021;136:104683. [PMID: 34329860 DOI: 10.1016/j.compbiomed.2021.104683] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
655 Venkat Kumar G, Jeyanthi V, Ramakrishnan S. A short review on antibody therapy for COVID-19. New Microbes New Infect 2020;35:100682. [PMID: 32313660 DOI: 10.1016/j.nmni.2020.100682] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
656 Gupta S, Singh V, Varadwaj PK, Chakravartty N, Katta AVSKM, Lekkala SP, Thomas G, Narasimhan S, Reddy AR, Reddy Lachagari VB. Secondary metabolites from spice and herbs as potential multitarget inhibitors of SARS-CoV-2 proteins. J Biomol Struct Dyn 2020;:1-20. [PMID: 33107812 DOI: 10.1080/07391102.2020.1837679] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
657 Islam MT, Sarkar C, El-Kersh DM, Jamaddar S, Uddin SJ, Shilpi JA, Mubarak MS. Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data. Phytother Res 2020;34:2471-92. [PMID: 32248575 DOI: 10.1002/ptr.6700] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 32.0] [Reference Citation Analysis]
658 Drew ED, Janes RW. Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity. BMC Mol Cell Biol 2020;21:49. [PMID: 32611313 DOI: 10.1186/s12860-020-00294-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
659 Lamberghini F, Testai FD. COVID-2019 fundamentals. J Am Dent Assoc 2021;152:354-63. [PMID: 33926623 DOI: 10.1016/j.adaj.2021.01.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
660 Ogunrinola OO, Kanmodi RI, Ogunrinola OA. Medicinal plants as immune booster in the palliative management of viral diseases: A perspective on coronavirus. Food Frontiers 2022;3:83-95. [DOI: 10.1002/fft2.107] [Reference Citation Analysis]
661 Kashyap VK, Dhasmana A, Massey A, Kotnala S, Zafar N, Jaggi M, Yallapu MM, Chauhan SC. Smoking and COVID-19: Adding Fuel to the Flame. Int J Mol Sci 2020;21:E6581. [PMID: 32916821 DOI: 10.3390/ijms21186581] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
662 Hassan SS, Choudhury PP, Roy B. Molecular phylogeny and missense mutations at envelope proteins across coronaviruses. Genomics 2020;112:4993-5004. [PMID: 32927009 DOI: 10.1016/j.ygeno.2020.09.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
663 Kumar S. Effect of meteorological parameters on spread of COVID-19 in India and air quality during lockdown. Sci Total Environ 2020;745:141021. [PMID: 32702548 DOI: 10.1016/j.scitotenv.2020.141021] [Cited by in Crossref: 41] [Cited by in F6Publishing: 18] [Article Influence: 20.5] [Reference Citation Analysis]
664 Gupta A, Pradhan A, Maurya VK, Kumar S, Theengh A, Puri B, Saxena SK. Therapeutic approaches for SARS-CoV-2 infection. Methods 2021:S1046-2023(21)00126-2. [PMID: 33962011 DOI: 10.1016/j.ymeth.2021.04.026] [Reference Citation Analysis]
665 Corr M, Christie S, Watson C, Maney J, Fairley D, Ladhani SN, Lyttle MD, McFetridge L, Mitchell H, Shields MD, McGinn C, McKenna J, Mallett P, Ferris K, Rowe-Setz G, Moore R, Foster S, Evans J, Waterfield T. Seroprevalence of SARS-CoV-2 antibodies in children of United Kingdom healthcare workers: a prospective multicentre cohort study protocol. BMJ Open 2020;10:e041661. [PMID: 33444212 DOI: 10.1136/bmjopen-2020-041661] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
666 Almasi F, Mohammadipanah F. Hypothetical targets and plausible drugs of coronavirus infection caused by SARS-CoV-2. Transbound Emerg Dis 2021;68:318-32. [PMID: 32662203 DOI: 10.1111/tbed.13734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
667 Borkotoky S, Banerjee M. A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem). J Biomol Struct Dyn 2021;39:4111-21. [PMID: 32462988 DOI: 10.1080/07391102.2020.1774419] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 15.5] [Reference Citation Analysis]
668 Hosseini N, Nadjafi S, Ashtary B. Overview of COVID-19 and neurological complications. Rev Neurosci 2021;32:671-91. [PMID: 33583157 DOI: 10.1515/revneuro-2020-0116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
669 Gupta AK, Khan MS, Choudhury S, Mukhopadhyay A, Sakshi, Rastogi A, Thakur A, Kumari P, Kaur M, Shalu, Saini C, Sapehia V, Barkha, Patel PK, Bhamare KT, Kumar M. CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2. Front Microbiol 2020;11:1858. [PMID: 32849449 DOI: 10.3389/fmicb.2020.01858] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
670 Papoutsis A, Borody T, Dolai S, Daniels J, Steinberg S, Barrows B, Hazan S. Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing. Gut Pathog. 2021;13:7. [PMID: 33516247 DOI: 10.1186/s13099-021-00398-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
671 [DOI: 10.1101/2020.06.22.165787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
672 Dbouk T, Drikakis D. Fluid dynamics and epidemiology: Seasonality and transmission dynamics. Phys Fluids (1994) 2021;33:021901. [PMID: 33746486 DOI: 10.1063/5.0037640] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 13.0] [Reference Citation Analysis]
673 Efstratiou MA, Tzoraki O. Coronavirus survival on beach sand: Sun vs COVID-19. Mar Pollut Bull 2021;167:112270. [PMID: 33773419 DOI: 10.1016/j.marpolbul.2021.112270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
674 Verkhivker GM, Di Paola L. Dynamic Network Modeling of Allosteric Interactions and Communication Pathways in the SARS-CoV-2 Spike Trimer Mutants: Differential Modulation of Conformational Landscapes and Signal Transmission via Cascades of Regulatory Switches. J Phys Chem B 2021;125:850-73. [PMID: 33448856 DOI: 10.1021/acs.jpcb.0c10637] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]
675 Zhan GF, Wang Y, Yang N, Luo AL, Li SY. Digestive system involvement of infections with SARS-CoV-2 and other coronaviruses: Clinical manifestations and potential mechanisms. World J Gastroenterol 2021; 27(7): 561-575 [PMID: 33642829 DOI: 10.3748/wjg.v27.i7.561] [Reference Citation Analysis]
676 Di Natale C, La Manna S, De Benedictis I, Brandi P, Marasco D. Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic. Front Pharmacol 2020;11:578382. [PMID: 33343349 DOI: 10.3389/fphar.2020.578382] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
677 Mahmood F, Xu R, Awan MUN, Song Y, Han Q, Xia X, Zhang J. PDIA3: Structure, functions and its potential role in viral infections. Biomed Pharmacother 2021;143:112110. [PMID: 34474345 DOI: 10.1016/j.biopha.2021.112110] [Reference Citation Analysis]
678 Javorsky A, Humbert PO, Kvansakul M. Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain. Commun Biol 2021;4:724. [PMID: 34117354 DOI: 10.1038/s42003-021-02250-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
679 Nahalka J. Theoretical Analysis of S, M and N Structural Proteins by the Protein-RNA Recognition Code Leads to Genes/proteins that Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis. Front Genet 2021;12:763995. [PMID: 34659373 DOI: 10.3389/fgene.2021.763995] [Reference Citation Analysis]
680 Durmaz B, Abdulmajed O, Durmaz R. Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor. Medeni Med J 2020;35:253-60. [PMID: 33110678 DOI: 10.5222/MMJ.2020.98048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
681 Yu T, Cai S, Zheng Z, Cai X, Liu Y, Yin S, Peng J, Xu X. Association Between Clinical Manifestations and Prognosis in Patients with COVID-19. Clin Ther 2020;42:964-72. [PMID: 32362344 DOI: 10.1016/j.clinthera.2020.04.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 18.0] [Reference Citation Analysis]
682 Sternberg A, Naujokat C. Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination. Life Sci 2020;257:118056. [PMID: 32645344 DOI: 10.1016/j.lfs.2020.118056] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 25.5] [Reference Citation Analysis]
683 Chen W, Yao M, Fang Z, Lv X, Deng M, Wu Z. A study on clinical effect of Arbidol combined with adjuvant therapy on COVID-19. J Med Virol 2020;92:2702-8. [PMID: 32510169 DOI: 10.1002/jmv.26142] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
684 Corral-Lugo A, López-Siles M, López D, McConnell MJ, Martin-Galiano AJ. Identification and Analysis of Unstructured, Linear B-Cell Epitopes in SARS-CoV-2 Virion Proteins for Vaccine Development. Vaccines (Basel) 2020;8:E397. [PMID: 32698423 DOI: 10.3390/vaccines8030397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
685 Zhou SY, Zhang C, Shu WJ, Chong LY, He J, Xu Z, Pan HF. Emerging roles of coronavirus in autoimmune diseases. Arch Med Res 2021:S0188-4409(21)00083-7. [PMID: 33875273 DOI: 10.1016/j.arcmed.2021.03.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
686 Caillet-Saguy C, Durbesson F, Rezelj VV, Gogl G, Tran QD, Twizere JC, Vignuzzi M, Vincentelli R, Wolff N. Host PDZ-containing proteins targeted by SARS-CoV-2. FEBS J 2021. [PMID: 33864728 DOI: 10.1111/febs.15881] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
687 Asghari A, Naseri M, Safari H, Saboory E, Parsamanesh N. The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options. DNA Cell Biol 2020;39:1741-53. [PMID: 32716648 DOI: 10.1089/dna.2020.5703] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
688 Thankam FG, Agrawal DK. Molecular chronicles of cytokine burst in patients with coronavirus disease 2019 (COVID-19) with cardiovascular diseases. J Thorac Cardiovasc Surg 2021;161:e217-26. [PMID: 32631657 DOI: 10.1016/j.jtcvs.2020.05.083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
689 Wang F, Cao J, Yu Y, Ding J, Eshak ES, Liu K, Mubarik S, Shi F, Wen H, Zeng Z, Bai J, Yu C. Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective observational study. Int J Epidemiol 2021;49:1940-50. [PMID: 33150437 DOI: 10.1093/ije/dyaa180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
690 Kiros M, Andualem H, Kiros T, Hailemichael W, Getu S, Geteneh A, Alemu D, Abegaz WE. COVID-19 pandemic: current knowledge about the role of pets and other animals in disease transmission. Virol J 2020;17:143. [PMID: 33008410 DOI: 10.1186/s12985-020-01416-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
691 Feitosa NM, da Costa Rodrigues B, Petry AC, Nocchi KJCV, de Moraes Brindeiro R, Zilberberg C, Monteiro-de-Barros C, Mury FB, de Souza-Menezes J, Nepomuceno-Silva JL, da Silva ML, de Medeiros MJ, de Souza Gestinari R, da Silva de Alvarenga A, Pozzobon APB, Silva CAO, das Graças Dos Santos D, Silvestre DH, de Sousa GF, de Almeida JF, da Silva JN, Brandão LM, de Oliveira Drummond L, Neto LRG, de Mello Carpes R, Dos Santos RC, Portal TM, Tanuri A, Nunes-da-Fonseca R. Molecular testing and analysis of disease spreading during the emergence of COVID-19 in Macaé, the Brazilian National Capital of Oil. Sci Rep 2021;11:20121. [PMID: 34635707 DOI: 10.1038/s41598-021-99475-7] [Reference Citation Analysis]
692 Uzunova K, Filipova E, Pavlova V, Vekov T. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2. Biomed Pharmacother 2020;131:110668. [PMID: 32861965 DOI: 10.1016/j.biopha.2020.110668] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 16.5] [Reference Citation Analysis]
693 Vallamkondu J, John A, Wani WY, Ramadevi SP, Jella KK, Reddy PH, Kandimalla R. SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets. Biochim Biophys Acta Mol Basis Dis 2020;1866:165889. [PMID: 32603829 DOI: 10.1016/j.bbadis.2020.165889] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
694 Ding J, Hostallero DE, El Khili MR, Fonseca GJ, Milette S, Noorah N, Guay-Belzile M, Spicer J, Daneshtalab N, Sirois M, Tremblay K, Emad A, Rousseau S. A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes' interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19. PLoS Comput Biol 2021;17:e1008810. [PMID: 33684134 DOI: 10.1371/journal.pcbi.1008810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
695 Shen Y, Anwar TB, Mulchandani A. Current status, advances, challenges and perspectives on biosensors for COVID-19 diagnosis in resource-limited settings. Sensors and Actuators Reports 2021;3:100025. [DOI: 10.1016/j.snr.2021.100025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
696 Shang W, Yang Y, Rao Y, Rao X. The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines. NPJ Vaccines 2020;5:18. [PMID: 32194995 DOI: 10.1038/s41541-020-0170-0] [Cited by in Crossref: 118] [Cited by in F6Publishing: 106] [Article Influence: 59.0] [Reference Citation Analysis]
697 Hassanipour S, Faradonbeh SB, Momeni K, Heidarifard Z, Khosousi MJ, Khosousi L, Ameri H, Arab-Zozani M. A systematic review and meta-analysis of pregnancy and COVID-19: Signs and symptoms, laboratory tests, and perinatal outcomes. Int J Reprod Biomed 2020;18:1005-18. [PMID: 33426411 DOI: 10.18502/ijrm.v18i12.8022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
698 Kume Y, Hashimoto K, Shirato K, Norito S, Suwa R, Chishiki M, Ono T, Mashiyama F, Mochizuki I, Sato M, Ishibashi N, Suzuki S, Sakuma H, Takahashi H, Takeda M, Hosoya M. Epidemiological and clinical characteristics of infections with seasonal human coronavirus and respiratory syncytial virus in hospitalized children immediately before the coronavirus disease 2019 pandemic. Journal of Infection and Chemotherapy 2022. [DOI: 10.1016/j.jiac.2022.03.001] [Reference Citation Analysis]
699 Batra M, Tian R, Zhang C, Clarence E, Sacher CS, Miranda JN, De La Fuente JRO, Mathew M, Green D, Patel S, Bastidas MVP, Haddadi S, Murthi M, Gonzalez MS, Kambali S, Santos KHM, Asif H, Modarresi F, Faghihi M, Mirsaeidi M. Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes. Sci Rep 2021;11:3455. [PMID: 33568776 DOI: 10.1038/s41598-021-83108-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
700 Li M, Zeng J, Li R, Wen Z, Cai Y, Wallin J, Shu Y, Du X, Sun C. Rational Design of a Pan-Coronavirus Vaccine Based on Conserved CTL Epitopes. Viruses 2021;13:333. [PMID: 33670023 DOI: 10.3390/v13020333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
701 Singh DD, Han I, Choi EH, Yadav DK. Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2. Comput Struct Biotechnol J 2020;18:3774-87. [PMID: 33235690 DOI: 10.1016/j.csbj.2020.11.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
702 Nayar G, Seabolt EE, Kunitomi M, Agarwal A, Beck KL, Mukherjee V, Kaufman JH. Analysis and forecasting of global real time RT-PCR primers and probes for SARS-CoV-2. Sci Rep 2021;11:8988. [PMID: 33903676 DOI: 10.1038/s41598-021-88532-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
703 Sriwilaijaroen N, Suzuki Y. Host Receptors of Influenza Viruses and Coronaviruses-Molecular Mechanisms of Recognition. Vaccines (Basel) 2020;8:E587. [PMID: 33036202 DOI: 10.3390/vaccines8040587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
704 Zhao J, Zhao S, Ou J, Zhang J, Lan W, Guan W, Wu X, Yan Y, Zhao W, Wu J, Chodosh J, Zhang Q. COVID-19: Coronavirus Vaccine Development Updates. Front Immunol 2020;11:602256. [PMID: 33424848 DOI: 10.3389/fimmu.2020.602256] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 18.5] [Reference Citation Analysis]
705 Lotfinejad P, Asadzadeh Z, Najjary S, Somi MH, Hajiasgharzadeh K, Mokhtarzadeh A, Derakhshani A, Roshani E, Baradaran B. COVID-19 Infection: Concise Review Based on the Immunological Perspective. Immunol Invest 2020;:1-20. [PMID: 32981399 DOI: 10.1080/08820139.2020.1825480] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
706 Chang MC, Baek JH, Park D. Lessons from South Korea Regarding the Early Stage of the COVID-19 Outbreak. Healthcare (Basel) 2020;8:E229. [PMID: 32722174 DOI: 10.3390/healthcare8030229] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
707 Khalil H, Abd ElHady A, Elawdan KA, Mohamed D, Mohamed DD, Abd El Maksoud AI, El-Chennawi FA, El-Fikiy B, El-Sayed IH. The Mechanical Autophagy as a Part of Cellular Immunity; Facts and Features in Treating the Medical Disorders. Immunol Invest 2020;:1-24. [PMID: 32993405 DOI: 10.1080/08820139.2020.1828453] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
708 Rossi G, Galosi L, Gavazza A, Cerquetella M, Mangiaterra S. Therapeutic approaches to coronavirus infection according to "One Health" concept. Res Vet Sci 2021;136:81-8. [PMID: 33588098 DOI: 10.1016/j.rvsc.2021.02.009] [Reference Citation Analysis]
709 Zare Marzouni H, Dashtgard A, Hamounpeyma E. Ascending and Descending of Coronavirus Disease 2019 (COVID-19). Galen Med J 2020;9:e1880. [PMID: 34466604 DOI: 10.31661/gmj.v9i0.1880] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
710 Machado JAT, Rocha-Neves JM, Andrade JP. Computational analysis of the SARS-CoV-2 and other viruses based on the Kolmogorov's complexity and Shannon's information theories. Nonlinear Dyn 2020;:1-20. [PMID: 32836811 DOI: 10.1007/s11071-020-05771-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
711 Choi HM, Moon SY, Yang HI, Kim KS. Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics. Int J Mol Sci 2021;22:1737. [PMID: 33572274 DOI: 10.3390/ijms22041737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
712 Cabrera-Garcia D, Bekdash R, Abbott GW, Yazawa M, Harrison NL. The envelope protein of SARS-CoV-2 increases intra-Golgi pH and forms a cation channel that is regulated by pH. J Physiol 2021;599:2851-68. [PMID: 33709461 DOI: 10.1113/JP281037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
713 Bates TA, Weinstein JB, Farley SE, Leier HC, Messer WB, Tafesse FG. Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2. bioRxiv 2020:2020. [PMID: 32766589 DOI: 10.1101/2020.07.30.229377] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
714 Gocer S, Turk C, Ozguven SV, Doganay M. Coronavirus disease 2019 vaccine: An overview of the progression and current use. North Clin Istanb 2021;8:529-36. [PMID: 34909595 DOI: 10.14744/nci.2021.99075] [Reference Citation Analysis]
715 Farouq MAH, Al Qaraghuli MM, Kubiak-Ossowska K, Ferro VA, Mulheran PA. Biomolecular interactions with nanoparticles: applications for coronavirus disease 2019. Curr Opin Colloid Interface Sci 2021;54:101461. [PMID: 33907504 DOI: 10.1016/j.cocis.2021.101461] [Reference Citation Analysis]
716 Jiang Y, Zhang H, Wippold JA, Gupta J, Dai J, de Figueiredo P, Leibowitz JL, Han A. Sub-second heat inactivation of coronavirus using a betacoronavirus model. Biotechnol Bioeng 2021;118:2067-75. [PMID: 33615450 DOI: 10.1002/bit.27720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
717 Ghosh S, Malik YS. Drawing Comparisons between SARS-CoV-2 and the Animal Coronaviruses. Microorganisms 2020;8:E1840. [PMID: 33238451 DOI: 10.3390/microorganisms8111840] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
718 Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 2021. [PMID: 34611326 DOI: 10.1038/s41580-021-00418-x] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
719 Haldar R, Kannaujia AK, Shamim R, Dongare P, Mondal H, Agarwal A. A national survey evaluating the effect of COVID-19 pandemic on the teaching and training of anaesthesiology postgraduate students in India. Indian J Anaesth 2020;64:S227-34. [PMID: 33311724 DOI: 10.4103/ija.IJA_645_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
720 Mohammad T, Choudhury A, Habib I, Asrani P, Mathur Y, Umair M, Anjum F, Shafie A, Yadav DK, Hassan MI. Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach. Front Cell Infect Microbiol 2021;11:765039. [PMID: 34722346 DOI: 10.3389/fcimb.2021.765039] [Reference Citation Analysis]
721 Quiros Roldan E, Biasiotto G, Magro P, Zanella I. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? Pharmacol Res 2020;158:104904. [PMID: 32430286 DOI: 10.1016/j.phrs.2020.104904] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 24.0] [Reference Citation Analysis]
722 Saraste J, Prydz K. Assembly and Cellular Exit of Coronaviruses: Hijacking an Unconventional Secretory Pathway from the Pre-Golgi Intermediate Compartment via the Golgi Ribbon to the Extracellular Space. Cells 2021;10:503. [PMID: 33652973 DOI: 10.3390/cells10030503] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
723 Yılmaz K, Gozupirinççioğlu A, Aktar F, Akın A, Karabel M, Yolbas I, Uzel VH, Şen V. Evaluation of the novel coronavirus disease in Turkish children: Preliminary outcomes. Pediatr Pulmonol 2020;55:3587-94. [PMID: 32991038 DOI: 10.1002/ppul.25095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
724 Lopez-Cantu DO, Wang X, Carrasco-Magallanes H, Afewerki S, Zhang X, Bonventre JV, Ruiz-Esparza GU. From Bench to the Clinic: The Path to Translation of Nanotechnology-Enabled mRNA SARS-CoV-2 Vaccines. Nanomicro Lett 2022;14:41. [PMID: 34981278 DOI: 10.1007/s40820-021-00771-8] [Reference Citation Analysis]
725 Chen K, Xiao F, Hu D, Ge W, Tian M, Wang W, Pan P, Wu K, Wu J. SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production. Viruses 2020;13:E47. [PMID: 33396605 DOI: 10.3390/v13010047] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
726 Sun S, Karki C, Aguilera J, Lopez Hernandez AE, Sun J, Li L. Computational Study on the Function of Palmitoylation on the Envelope Protein in SARS-CoV-2. J Chem Theory Comput 2021;17:6483-90. [PMID: 34516136 DOI: 10.1021/acs.jctc.1c00359] [Reference Citation Analysis]
727 Pohl MO, Busnadiego I, Kufner V, Glas I, Karakus U, Schmutz S, Zaheri M, Abela I, Trkola A, Huber M, Stertz S, Hale BG. SARS-CoV-2 variants reveal features critical for replication in primary human cells. PLoS Biol 2021;19:e3001006. [PMID: 33760807 DOI: 10.1371/journal.pbio.3001006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
728 Wu C, Yin W, Jiang Y, Xu HE. Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19. Acta Pharmacol Sin. [DOI: 10.1038/s41401-021-00851-w] [Reference Citation Analysis]
729 Glanz A, Chakravarty S, Varghese M, Kottapalli A, Fan S, Chakravarti R, Chattopadhyay S. Transcriptional and Non-Transcriptional Activation, Posttranslational Modifications, and Antiviral Functions of Interferon Regulatory Factor 3 and Viral Antagonism by the SARS-Coronavirus. Viruses 2021;13:575. [PMID: 33805458 DOI: 10.3390/v13040575] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
730 Ashraf UM, Abokor AA, Edwards JM, Waigi EW, Royfman RS, Hasan SA, Smedlund KB, Hardy AMG, Chakravarti R, Koch LG. SARS-CoV-2, ACE2 expression, and systemic organ invasion. Physiol Genomics 2021;53:51-60. [PMID: 33275540 DOI: 10.1152/physiolgenomics.00087.2020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
731 Franchini M, Farrugia A, Velati C, Zanetti A, Romanò L, Grazzini G, Lopez N, Pati I, Marano G, Pupella S, Liumbruno GM. The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy. Vox Sang 2020;115:603-5. [PMID: 32240543 DOI: 10.1111/vox.12928] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
732 Dodig S, Čepelak I, Čepelak Dodig D, Laškaj R. SARS-CoV-2 - a new challenge for laboratory medicine. Biochem Med (Zagreb) 2020;30:030503. [PMID: 32774121 DOI: 10.11613/BM.2020.030503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
733 Compton SR. Overview of Coronaviruses in Veterinary Medicine. Comp Med 2021;71:333-41. [PMID: 34412731 DOI: 10.30802/AALAS-CM-21-000007] [Reference Citation Analysis]
734 Yu A, Pak AJ, He P, Monje-Galvan V, Casalino L, Gaieb Z, Dommer AC, Amaro RE, Voth GA. A Multiscale Coarse-grained Model of the SARS-CoV-2 Virion. bioRxiv 2020:2020. [PMID: 33024966 DOI: 10.1101/2020.10.02.323915] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
735 Castaño N, Cordts SC, Kurosu Jalil M, Zhang KS, Koppaka S, Bick AD, Paul R, Tang SKY. Fomite Transmission, Physicochemical Origin of Virus-Surface Interactions, and Disinfection Strategies for Enveloped Viruses with Applications to SARS-CoV-2. ACS Omega 2021;6:6509-27. [PMID: 33748563 DOI: 10.1021/acsomega.0c06335] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
736 Chu KB, Kang HJ, Yoon KW, Lee HA, Moon EK, Han BK, Quan FS. Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains. Vaccines (Basel) 2021;9:920. [PMID: 34452044 DOI: 10.3390/vaccines9080920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
737 Kiani AK, Dhuli K, Anpilogov K, Bressan S, Dautaj A, Dundar M, Beccari T, Ergoren MC, Bertelli M. Natural compounds as inhibitors of SARS-CoV-2 endocytosis: A promising approach against COVID-19. Acta Biomed 2020;91:e2020008. [PMID: 33170174 DOI: 10.23750/abm.v91i13-S.10520] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
738 Yamamoto V, Bolanos JF, Fiallos J, Strand SE, Morris K, Shahrokhinia S, Cushing TR, Hopp L, Tiwari A, Hariri R, Sokolov R, Wheeler C, Kaushik A, Elsayegh A, Eliashiv D, Hedrick R, Jafari B, Johnson JP, Khorsandi M, Gonzalez N, Balakhani G, Lahiri S, Ghavidel K, Amaya M, Kloor H, Hussain N, Huang E, Cormier J, Wesson Ashford J, Wang JC, Yaghobian S, Khorrami P, Shamloo B, Moon C, Shadi P, Kateb B. COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications. J Alzheimers Dis 2020;77:459-504. [PMID: 32925078 DOI: 10.3233/JAD-200831] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 12.5] [Reference Citation Analysis]
739 Fernández-Cuadros ME, Albaladejo-Florín MJ, Peña-Lora D, Álava-Rabasa S, Pérez-Moro OS. Ozone (O3) and SARS-CoV-2: Physiological Bases and Their Therapeutic Possibilities According to COVID-19 Evolutionary Stage. SN Compr Clin Med 2020;:1-9. [PMID: 32838159 DOI: 10.1007/s42399-020-00328-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
740 P N, R N, B V, S R, A S. COVID-19: Invasion, pathogenesis and possible cure - A review. J Virol Methods 2022;300:114434. [PMID: 34919978 DOI: 10.1016/j.jviromet.2021.114434] [Reference Citation Analysis]
741 Yu R, Mao Y, Li K, Zhai Y, Zhang Y, Liu S, Gao Y, Chen Z, Liu Y, Fang T, Zhao M, Li R, Xu J, Chen W. Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection. Mediators Inflamm 2021;2021:9979032. [PMID: 33967626 DOI: 10.1155/2021/9979032] [Reference Citation Analysis]
742 Han YJ, Ren ZG, Li XX, Yan JL, Ma CY, Wu DD, Ji XY. Advances and challenges in the prevention and treatment of COVID-19. Int J Med Sci 2020;17:1803-10. [PMID: 32714083 DOI: 10.7150/ijms.47836] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
743 Arslan H, Arslan H. A new COVID-19 detection method from human genome sequences using CpG island features and KNN classifier. Engineering Science and Technology, an International Journal 2021;24:839-47. [DOI: 10.1016/j.jestch.2020.12.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
744 Baytaroglu C, Sevgili E. Characteristics of YouTube Videos About Peripheral Artery Disease During COVID-19 Pandemic. Cureus 2021;13:e16203. [PMID: 34367806 DOI: 10.7759/cureus.16203] [Reference Citation Analysis]
745 Iqbal Yatoo M, Hamid Z, Parray OR, Wani AH, Ul Haq A, Saxena A, Patel SK, Pathak M, Tiwari R, Malik YS, Sah R, Rabaan AA, Rodriguez Morales AJ, Dhama K. COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines. Hum Vaccin Immunother 2020;16:2891-904. [PMID: 32703064 DOI: 10.1080/21645515.2020.1788310] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
746 Tsai PH, Wang ML, Yang DM, Liang KH, Chou SJ, Chiou SH, Lin TH, Wang CT, Chang TJ. Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). J Chin Med Assoc 2020;83:725-32. [PMID: 32773643 DOI: 10.1097/JCMA.0000000000000387] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
747 Requena D, Médico A, Chacón RD, Ramírez M, Marín-Sánchez O. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country. Front Immunol 2020;11:2008. [PMID: 33013857 DOI: 10.3389/fimmu.2020.02008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
748 [DOI: 10.1101/2021.03.10.434722] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
749 Rudrapal M, Gogoi N, Chetia D, Khan J, Banwas S, Alshehri B, Alaidarous MA, Laddha UD, Khairnar SJ, Walode SG. Repurposing of Phytomedicine-Derived Bioactive Compounds with Promising Anti-SARS-CoV-2 Potential: Molecular Docking, MD Simulation and Drug-Likeness/ ADMET Studies. Saudi J Biol Sci 2021. [PMID: 34924801 DOI: 10.1016/j.sjbs.2021.12.018] [Reference Citation Analysis]
750 Collins LT, Elkholy T, Mubin S, Hill D, Williams R, Ezike K, Singhal A. Elucidation of SARS-Cov-2 Budding Mechanisms through Molecular Dynamics Simulations of M and E Protein Complexes. J Phys Chem Lett 2021;12:12249-55. [PMID: 34928612 DOI: 10.1021/acs.jpclett.1c02955] [Reference Citation Analysis]
751 Eskandari V. Repurposing the natural compounds as potential therapeutic agents for COVID-19 based on the molecular docking study of the main protease and the receptor-binding domain of spike protein. J Mol Model 2022;28:153. [PMID: 35578055 DOI: 10.1007/s00894-022-05138-3] [Reference Citation Analysis]
752 Tanner JE, Alfieri C. The Fatty Acid Lipid Metabolism Nexus in COVID-19. Viruses 2021;13:90. [PMID: 33440724 DOI: 10.3390/v13010090] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
753 [DOI: 10.1101/2020.01.29.924100] [Cited by in Crossref: 36] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
754 Bates TA, Weinstein JB, Farley S, Leier HC, Messer WB, Tafesse FG. Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2. Cell Rep 2021;34:108737. [PMID: 33545052 DOI: 10.1016/j.celrep.2021.108737] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
755 Massalska MA, Gober HJ. How Children Are Protected From COVID-19? A Historical, Clinical, and Pathophysiological Approach to Address COVID-19 Susceptibility. Front Immunol 2021;12:646894. [PMID: 34177895 DOI: 10.3389/fimmu.2021.646894] [Reference Citation Analysis]
756 Mohammed MEA. The percentages of SARS-CoV-2 protein similarity and identity with SARS-CoV and BatCoV RaTG13 proteins can be used as indicators of virus origin. J Proteins Proteom 2021;:1-11. [PMID: 33850392 DOI: 10.1007/s42485-021-00060-3] [Reference Citation Analysis]
757 Pourrajab F, Zare-Khormizi MR, Sheikhha MH. Molecular Basis for Pathogenicity of Human Coronaviruses. Infect Drug Resist 2020;13:2385-405. [PMID: 32765013 DOI: 10.2147/IDR.S255156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
758 Žerovnik E. Viroporins vs. Other Pore-Forming Proteins: What Lessons Can We Take? Front Chem 2021;9:626059. [PMID: 33681145 DOI: 10.3389/fchem.2021.626059] [Reference Citation Analysis]
759 Ahmed MU, Hanif M, Ali MJ, Haider MA, Kherani D, Memon GM, Karim AH, Sattar A. Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review. Front Neurol. 2020;11:518. [PMID: 32574248 DOI: 10.3389/fneur.2020.00518] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 33.0] [Reference Citation Analysis]